Target Information

General Information of This Target (ID: PATR0CXRBX)

Target Name	Microtubule (MT)
Function	Microtubules are polymers of tubulin that form part of the cytoskeleton and provide structure and shape to eukaryotic cells. Microtubules play an important role in a number of cellular processes. They are involved in maintaining the structure of the cell and, together with microfilaments and intermediate filaments, they form the cytoskeleton. They also make up the internal structure of cilia and flagella. They provide platforms for intracellular transport and are involved in a variety of cellular processes, including the movement of secretory vesicles, organelles, and intracellular macromolecular assemblies. Click to Show/Hide

Full List of The ADC Related to This Target

Approved in 2019

Click To Hide/Show 10 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Polatuzumab vedotin ^[4]	Polatuzumab	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Brentuximab vedotin	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Telisotuzumab vedotin	Telisotuzumab	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab emtansine ^[5]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Disitamab vedotin	Hertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Tisotumab vedotin ^[6]	Tisotumab	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Mirvetuximab soravtansine ^[7]	Mirvetuximab	Folate receptor alpha (FOLR1)	DM4	Sulfo-SPDB	ADC Info
Enfortumab vedotin ^[8]	Enfortumab	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Belantamab mafodotin ^[9]	Belantamab	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Becotatug vedotin	Becotatug	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info

Phase 3

Click To Hide/Show 8 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Trastuzumab envedotin	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	NH2-PEG3-Val-Cit-PABC	ADC Info
Tusamitamab ravtansine	Tusamitamab	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Upifitamab rilsodotin	Upifitamab	Sodium-dependent phosphate transport protein 2B (SLC34A2)	AF-HPA	Dolaflexin polymer	ADC Info
Tecotabart vedotin	Tecotabart	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Sonesitatug vedotin	Sonesitatug	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Fetrastobart vedotin	Anti-PD-L1 SGN-PDL1V mAb	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Sigvotatug vedotin	Sigvotatug	Integrin beta-6 (ITGB6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Recombinant anti-HER2 humanized mAb-DM1	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info

Phase 3 (discontinued)

Click To Hide/Show 2 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
TAA-013	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
BAT8001	BAT0606	Receptor tyrosine-protein kinase erbB-2 (HER2)	Batansine	Maleimido-caproyl	ADC Info

Phase 2/3 (discontinued)

Click To Hide/Show 1 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Luveltamab tazevibulin	Luveltamab	Folate receptor alpha (FOLR1)	SC209	DBCO-Val-Cit-PABA	ADC Info

Phase 2 (discontinued)

Click To Hide/Show 11 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Praluzatamab ravtansine	Praluzatamab	CD166 antigen (ALCAM)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
BB-1701	Anti-HER2 antibody	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	Mal-PEG2-Val-Cit-PABC	ADC Info
Ozuriftamab vedotin	Ozuriftamab	Tyrosine-protein kinase transmembrane receptor ROR2 (ROR2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Ladiratuzumab vedotin	Ladiratuzumab	Zinc transporter ZIP6 (SLC39A6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anvatabart opadotin	Anvatabart	Receptor tyrosine-protein kinase erbB-2 (HER2)	Amberstatin 269 (AS269)	Hydroxylamine-PEG4	ADC Info
Zilovertamab vedotin	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RC108	Anti-c-Met antibody	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
DX126-262	DX-CHO9	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tub114	Mal-PEG10 based linker	ADC Info
FOR46	YS5	Membrane cofactor protein (CD46)	Monomethyl auristatin E	A cleavable linker	ADC Info
MRG001	Chimeric anti-CD20 mAb	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SHR-4602	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	ER300	Stable enzyme-cleavable linker	ADC Info

Phase 2 (discontinued)

Click To Hide/Show 11 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
AGS-16C3F	Anti-ENPP3 AGS-16C3F mAb	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Naratuximab emtansine	Naratuximab	Leukocyte antigen CD37 (CD37)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Lifastuzumab vedotin	Lifastuzumab	Sodium-dependent phosphate transport protein 2B (SLC34A2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anetumab ravtansine	Anetumab	Mesothelin (MSLN)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Indusatumab vedotin	Indusatumab	GC-C	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Lorvotuzumab mertansine	Lorvotuzumab	Neural cell adhesion molecule 1 (NCAM1)	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Coltuximab ravtansine	Coltuximab	B-lymphocyte antigen CD19 (CD19)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Glembatumumab vedotin	Glembatumumab	Transmembrane glycoprotein NMB (GPNMB)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cantuzumab ravtansine	Cantuzumab	Mucin-1 (MUC1)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
PSMA ADC	Fully human anti-PSMA IgG1 mAb	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SAR566658	huDS6	Carbonic anhydrase 6 (CA6)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info

Phase 1/2

Click To Hide/Show 17 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
PEN-221	Undisclosed	Somatostatin receptor type 2 (SSTR2)	Mertansine DM1	Disulfide cleavable linker	ADC Info
Mecbotamab vedotin	Mecbotamab	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CX-2029	Anti-CD71 CX-151 probody	Transferrin receptor protein 1 (TFRC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Farletuzumab ecteribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2-Val-Cit-PABC	ADC Info
Bulumtatug fuvedotin	Bulumtatug	Nectin-4 (NECTIN4)	Monomethyl auristatin E	IDM-Val-Cit-PBCA	ADC Info
BB-1705	Anti-EGFR antibody	Epidermal growth factor receptor (EGFR)	Eribulin	Mal-PEG2-Val-Cit-PABC	ADC Info
BIO-106	Anti-TROP2 antibody	Tumor-associated calcium signal transducer 2 (TACSTD2)	TAMTM	A non-cleavable linker	ADC Info
Vemzatatug vedotin	Anti-GPRC5D antibody	G-protein coupled receptor family C group 5 member D (GPRC5D)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
MRG-004A	Undisclosed	Tissue factor (F3)	Monomethyl auristatin E	Valine-Citrulline (BCN-valyl-citrulline; Protease-cleavable linker)	ADC Info
Ciletatug vedotin	Ciletatug	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Misitatug blivedotin	Misitatug	Mesothelin (MSLN)	Monomethyl auristatin E	PY-MAA-Val-Cit-PABC	ADC Info
REGN5093-M114	REGN5093	Hepatocyte growth factor receptor (MET)	Maytansine derivative M24	SC-Val-Cit-PABC	ADC Info
SYS6002	Anti-Nectin-4 antibody	Nectin-4 (NECTIN4)	Monomethyl auristatin E	NH2-PEG3-Val-Cit-PABC	ADC Info
JK06	Anti-5T4 antibody	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ILB-3101	Anti-B7H3 antibody	CD276 antigen (CD276)	Eribulin	A cleavable linker	ADC Info
LCB84	Hu2G10	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	β-glucuronide linker	ADC Info
PRO1107	Anti-PTK7 antibody	Inactive tyrosine-protein kinase 7 (PTK7)	Monomethyl auristatin E	A cleavable linker	ADC Info

Phase 1/2 (discontinued)

Click To Hide/Show 10 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
OBI-999	OBI-888	Globo H (globotriaosylceramide)	Monomethyl auristatin E	ThioBridge-PEG24-Val-Cit-PABC	ADC Info
Bezetabart debotansine	Bezetabart	HLA class II histocompatibility antigen gamma chain (CD74)	SC347	Cys-12 ADC linker	ADC Info
Enapotamab vedotin	Enapotamab	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Depatuxizumab mafodotin	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
BMS-986148	BMS-986021	Mesothelin (MSLN)	Tubulysin	Mc-Val-Cit	ADC Info
Lonigutamab ugodotin	Lonigutamab	Insulin-like growth factor 1 receptor (IGF1R)	F554443	Maleimido-caproyl	ADC Info
STI-6129	STI-5171	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duostatin 5.2	Non-polyethylene glycol linker	ADC Info
MEDI4276	MEDI-4276	Receptor tyrosine-protein kinase erbB-2 (HER2 ECD2); Receptor tyrosine-protein kinase erbB-2 (HER2 ECD4)	AZ13599185	Maleimido-caproyl based linker	ADC Info
MLN2704	MLN591	Glutamate carboxypeptidase 2 (FOLH1)	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
BMS-986183	Anti-GPC3 antibody	Glypican-3 (GPC3)	Tubulysin	Val-Cit dipeptide linker	ADC Info

Phase 1 (discontinued)

Click To Hide/Show 41 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Felmetatug vedotin	Felmetatug	V-set domain-containing T-cell activation inhibitor 1 (VTCN1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B-003	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
GQ1001	Trastuzumab variant	Receptor tyrosine-protein kinase erbB-2 (HER2)	DM1	K'-MCC'	ADC Info
AMT-151	Ab-151	Folate receptor alpha (FOLR1)	Duostatin 5	Pip-Val-Cit linker	ADC Info
AGX101	Anti-TM4SF1 antibody	Transmembrane 4 L6 family member 1 (TM4SF1)	Maytansine derivative	A non-cleavable linker	ADC Info
ARX-305	Humanized anti-CD70 mAb	CD70 antigen (CD70)	Monomethyl auristatin F	Oxime-PEG3	ADC Info
ASN004	Anti-5T4 scFv-Fc mAb	Trophoblast glycoprotein (TPBG)	AF-HPA	Fleximer polymer	ADC Info
ATG-022	Anti-CLDN18.2 antibody	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB-1709	Anti-CD73 antibody	Thymidylate 5'-phosphatase (NT5E)	Monomethyl auristatin E	Undisclosed	ADC Info
BC3195	Anti-CDH3 antibody	Cadherin-3 (CDH3)	Monomethyl auristatin E	Val-Cit dipeptide linker	ADC Info
DXC009	Humanized anti-BCMA mAb	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Undisclosed	Undisclosed	ADC Info
JS107	Anti-CLDN18.2 mAb	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Maleimide linker of vc PAB	ADC Info
M1231 ^[10]	An antibody scaffold targeting MUC1 and EGFR	Epidermal growth factor receptor (EGFR); Mucin-1 (MUC1)	SC209	DBCO-Val-Cit-PABA	ADC Info
MEN-1309	MBH-1309	Lymphocyte antigen 75 (LY75)	Mertansine DM4	N-succinimidyl 4- (2-pyridyldithio) butanoate (SPDB)	ADC Info
MYTX-011	Anti-c-MET pH-dependent mAb	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NBT508	Anti-CD79b antibody	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	TetraM-Val-Cit-PABC	ADC Info
PR301	Anti-CLDN18.2 antibody	Claudin-18.2 (CLDN18.2)	Duostatin 5	A cleavable linker	ADC Info
Micvotabart pelidotin	Micvotabart	EDB-FN	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC	ADC Info
KM501	Trastuzumab/Pertuzumab biparatopic bsAb	Receptor tyrosine-protein kinase erbB-2 (HER2 ECD2); Receptor tyrosine-protein kinase erbB-2 (HER2 ECD4)	Monomethyl auristatin E	Undisclosed	ADC Info
DXC005	Anti-Muc1 antibody	Mucin-1 (MUC1)	Tub201	Undisclosed	ADC Info
Ixotatug vedotin	Ixotatug	Claudin-6 (CLDN6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TRS005	Anti-CD20 antibody	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Emiltatug ledadotin	Emiltatug	V-set domain-containing T-cell activation inhibitor 1 (VTCN1)	AF-HPA	A cleavable ester linker	ADC Info
EBC-129	Anti N256-glycosylated CEACAM5 and CEACAM6 antibody	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5); Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BA1302	Anti-CD228 antibody	Melanotransferrin (MELTF)	Monomethyl auristatin E	MC-β-Ala-(glucuronide)-PABC	ADC Info
DXC-004A	Nimotuzumab derivative	Epidermal growth factor receptor (EGFR)	Tubulysin B analog	Undisclosed	ADC Info
XB010	Anti-5T4 antibody	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	RED-601 linker	ADC Info
BRY-812	Undisclosed	Zinc transporter ZIP6 (SLC39A6)	Monomethyl auristatin E	Undisclosed	ADC Info
NN3201	NN2101	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	Bis-sulfone-(PEG24)-Glu-Val-Cit-PAB	ADC Info
SMP-656	Anti-HER2 antibody	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	SuperHydraTM linker	ADC Info
ADRX-0706	Anti-Nectin-4 antibody	Nectin-4 (NECTIN4)	AP052	Adcentrx' proprietary linker	ADC Info
Opugotamig olatansine	Opugotamig	Folate receptor alpha (FOLR1)	DM21-C	Stable cleavable peptide linker	ADC Info
F0002-ADC	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Zarutatug vedotin	Zarutatug	Cadherin-17 (CDH17)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
roltotatug vedotin	Roltotatug	Protein delta homolog 1 (DLK1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BL-B16D1	Anti-EGFR/HER3 bsAb	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	WA-00	Undisclosed	ADC Info
DXC007	A recombinant anti-CD33 mAb	Myeloid cell surface antigen CD33 (CD33)	Tub255	Undisclosed	ADC Info
BL-M17D1	Anti-HER2 antibody	Receptor tyrosine-protein kinase erbB-2 (HER2)	WA-00	Undisclosed	ADC Info
LNCB74	Anti-B7-H4 IgG1k mAb	V-set domain-containing T-cell activation inhibitor 1 (VTCN1)	Monomethyl auristatin E	β-glucuronide linker	ADC Info
INA03	Anti-CD71 mAb	Transferrin receptor protein 1 (TFRC)	Monomethyl auristatin E	APN-PEG5-Val-Cit-PABC	ADC Info
SGN-35T	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Mp-D-leucine-alanine-glutamate-PABC	ADC Info

Phase 1 (discontinued)

Click To Hide/Show 62 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Samrotamab vedotin	Samrotamab	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Denintuzumab mafodotin	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Cantuzumab mertansine	Cantuzumab	Mucin-1 (MUC1)	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
ALT-P7	Trastuzumab variant	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Val-Cit dipeptide linker	ADC Info
Zanidatamab zovodotin	Zanidatamab	Receptor tyrosine-protein kinase erbB-2 (HER2 ECD2); Receptor tyrosine-protein kinase erbB-2 (HER2 ECD4)	ZD02044	Mc-PEG3-Val-Cit	ADC Info
Pinatuzumab vedotin	Pinatuzumab	B-cell receptor CD22 (CD22)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Vorsetuzumab mafodotin	Vorsetuzumab	CD70 antigen (CD70)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Sofituzumab vedotin	Sofituzumab	Mucin-16 (MUC16)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Azintuxizumab vedotin	Azintuxizumab	SLAM family member 7 (SLAMF7)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AVE9633	HuMy9-6	Myeloid cell surface antigen CD33 (CD33)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
BIIB015	HuB3F6	Teratocarcinoma-derived growth factor 1 (TDGF1)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
PCA062	CQY684	Cadherin-3 (CDH3)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
CDX-014	CR014	Hepatitis A virus cellular receptor 1 (HAVCR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
XMT-1592	Anti-NaPi-2b antibody	Sodium-dependent phosphate transport protein 2B (SLC34A2)	AF-HPA	Cys-13 ADC linker	ADC Info
AbGn-107	Anti-AbGn-7 antibody	AbGn-7 antigen	DM4	Val-Cit dipeptide linker	ADC Info
AGS67E	AGS67C	Leukocyte antigen CD37 (CD37)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AMG 224	Anti-human BCMA IgG1 mAb	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	DM1	4-[N-maleimidomethyl] cyclohexane-1-carboxylate (MCC)	ADC Info
PF-06804103	Trastuzumab-(κK183C+K290C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC	ADC Info
Aprutumab ixadotin	Aprutumab	Fibroblast growth factor receptor 2 (FGFR2)	Auristatin W	Caproyl acid	ADC Info
Cofetuzumab pelidotin	Cofetuzumab	Inactive tyrosine-protein kinase 7 (PTK7)	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC	ADC Info
DAC-002	Anti-TROP2 antibody	Tumor-associated calcium signal transducer 2 (TACSTD2)	Tubulysin 196	2,3-disubstituted long side-chain hydrolysis-resistant linker	ADC Info
GB251	Anti-HER2 antibody	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	BiM-Val-Cit-PABC	ADC Info
Iladatuzumab vedotin	Iladatuzumab	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Ispectamab debotansine	Ispectamab	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	SC347	Cys-12 ADC linker	ADC Info
JBH492	121G12	C-C chemokine receptor type 7 (CCR7)	DM4	A cleavable linker	ADC Info
Losatuxizumab vedotin	Losatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Lupartumab amadotin	Lupartumab	Ly6/PLAUR domain-containing protein 3 (LYPD3)	Auristatin W derivative	Mc-hydrazide linker	ADC Info
RG7841	MLYE4489A	Lymphocyte antigen 6E (LY6E)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SGN-ALPV	H12F3	Phospholipase A-2-activating protein; Alkaline phosphatase, germ cell type (ALPG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SGN-CD228A	HL49	Melanotransferrin (MELTF)	Monomethyl auristatin E	Mal PEG12 based β-glucuronide linker	ADC Info
SGN-CD48A	Anti-SLAMF2 mAb	CD48 antigen (CD48)	Monomethyl auristatin E	PEGylated β-glucuronide linker	ADC Info
SGN-STNV	Anti-Onco-foetal sialyl-Tn antibody	Onco-foetal sialyl-Tn	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SHR-A1201	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
SHR-A1403	Anti-c-MET IgG2 mAb	Hepatocyte growth factor receptor (MET)	SHR152852	L2-MC	ADC Info
Sirtratumab vedotin	Sirtratumab	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SYSA1801	Anti-CLDN18.2 mAb	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	PEG3-Val-Cit-PABC	ADC Info
TRPH-222	Anti-CD20 antibody	B-cell receptor CD22 (CD22)	DM1	HIPS-4AP	ADC Info
Samatatug zovodotin	Samatatug	Tissue factor (F3)	ZD02044	Mc-PEG3-Val-Cit	ADC Info
PF-06263507	PF-06281192	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
ASG-5ME	Anti-SLC44A4 IgG2 mAb	Choline transporter-like protein 4 (SLC44A4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AGS62P1	Anti-FLT3 IgG1κ mAb	Receptor-type tyrosine-protein kinase FLT3 (FLT3)	AGD-0182	Alkoxyamine linker	ADC Info
LOP628	LMJ729	Mast/stem cell growth factor receptor Kit (KIT)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
BAT8003	Anti-TROP2 antibody	Tumor-associated calcium signal transducer 2 (TACSTD2)	Batansine	Maleimido-caproyl	ADC Info
BAY 79-4620	3ee9	Carbonic anhydrase 9 (CA9)	Monomethyl auristatin E	Val-Cit dipeptide linker	ADC Info
Bivatuzumab mertansine	Bivatuzumab	CD44 antigen (CD44)	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HKT288	Anti-CDH6 HKT-288 mAb	Cadherin-6 (CDH6)	DM4	Sulfo-SPDB	ADC Info
IMGN388	Intetumumab	Integrin alpha-V (ITGAV)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Laprituximab emtansine	Laprituximab	Epidermal growth factor receptor (EGFR)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MEDI-547	Anti-EPHA2 (1C1) mAb	Ephrin type-A receptor 2 (EPHA2)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
PF-06650808	Hu28	Neurogenic locus notch homolog protein 3 (NOTCH3)	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC	ADC Info
PF-06664178	PF-06478924	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101 (Aur0101)	AcLys-Val-Cit-PABC	ADC Info
RG7598	MFRF3266A	Fc receptor-like protein 5 (FCRL5)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RG7636	MEDN6000A	ETB	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RG7882	MMUC3333A	Mucin-16 (MUC16)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Vandortuzumab vedotin	Vandortuzumab	Metalloreductase STEAP1 (STEAP1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
XMT-1522	XMT-1519	Receptor tyrosine-protein kinase erbB-2 (HER2)	AF-HPA	Fleximer polymer	ADC Info
SAR428926	Anti-LAMP-1 antibody	Lysosome-associated membrane glycoprotein 1 (LAMP1)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
LY3076226	IMC-D11	Fibroblast growth factor receptor 3 (FGFR3)	DM4	Sulfo-SPDB	ADC Info
AMG 172	Anti-CD70 mAb	CD70 antigen (CD70)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
RG7600 ^[11]	H7D9.v3	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AMG 595	Anti-EGFRvIII mAb	Epidermal growth factor receptor variant III (EGFRvIII)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
SGN-CD47M	Humanized anti-CD47 IgG1 mAb	Leukocyte surface antigen CD47 (CD47)	Monomethyl auristatin E	Metalloproteinases cleavable linker	ADC Info

Clinical candidate

Click To Hide/Show 1960 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Cirmtuzumab vedotin ^[12]	Cirmtuzumab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Lysine-linker	ADC Info
Mirvetuximab-SPP-DM1 ^[13]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Mirvetuximab-SPDB-DM4 ^[14]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Mirvetuximab-SMCC-DM1 ^[13]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuFR1-48-SMCC-DM1 ^[13]	Anti-FOLR1 huFR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuFR1-49-SMCC-DM1 ^[13]	Anti-FOLR1 huFR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuFR1-57-SMCC-DM1 ^[13]	Anti-FOLR1 huFR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuFR1-65-SMCC-DM1 ^[13]	Anti-FOLR1 huFR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
54E-Val-Cit-MMAE ^[15]	Anit-TF mAb 54E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
43Ea-Val-Cit-MMAE ^[15]	Anit-TF mAb 43Ea	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
43D7-Val-Cit-MMAE ^[15]	Anit-TF mAb 43D7	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
43B1-Val-Cit-MMAE ^[15]	Anit-TF mAb 43B1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
39A-Val-Cit-MMAE ^[15]	Anit-TF mAb 39A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
29E-Val-Cit-MMAE ^[15]	Anit-TF mAb 29E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
25G1-Val-Cit-MMAE ^[15]	Anit-TF mAb 25G1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
25A3-Val-Cit-MMAE ^[15]	Anit-TF mAb 25A3	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
25A-Val-Cit-MMAE ^[15]	Anit-TF mAb 25A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RcEDB-ADC ^[16]	Reverse chimeric (rc) Anti-EDB-FN L19	Fibronectin (FN1)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
PODO447-ADC ^[17]	PODO447	Podocalyxin (PODXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-PIEZO1-MMAE ^[18]	Anti-PIEZO1 mAb	Piezo-type mechanosensitive ion channel component 1 (PIEZO1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
C12G1-DM1 ^[19]	Anti-NECTIN2 mAb c12G1	Nectin-2 (NECTIN2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HzMUC1-MMAE ^[20]	HzMUC1	Mucin-1 (MUC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LSR-ADC ^[21]	Anti-LSR mAb	Lipolysis-stimulated lipoprotein receptor (LSR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LRG1-ADC 5 ^[22]	Magacizumab	Leucine-rich alpha-2-glycoprotein (LRG1)	Monomethyl auristatin E	Dipeptide-diBrPD (dibromopyridazinedione )	ADC Info
1131-MMAE ^[23]	C-1131	Kita-kyushu lung cancer antigen 1 (CT83)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab-SYNtansine ^[24]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Ahx-maytansine	BCN-HydraSpace-Val-Cit-PABC	ADC Info
Tmab-SPP-DM1 ^[25]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Tmab-SSNPP-DM3 ^[25]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Tmab-SSNPP-DM4 ^[25]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Trastuzumab-AJICAP-maytansinoid ^[26]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	AJICAP	ADC Info
Mil40-12B ^[27]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleamic methyl ester-based linker 12B	ADC Info
ADAPT6-ABD-mcDM1 ^[28]	ADAPT6-ABD	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Maleimidocaproyl (Ser3-Gly)3	ADC Info
HA15-1C25F ^[29]	Anti-SLITRK6 mAb Ha15-1c25	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
HA15-1C25E ^[30]	Anti-SLITRK6 mAb Ha15-1c25	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HA15-1ABE16F ^[29]	Anti-SLITRK6 mAb Ha15-1abe16	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
HA15-1ABE16E ^[30]	Anti-SLITRK6 mAb Ha15-1abe16	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HA15-10AC14F ^[29]	Anti-SLITRK6 mAb Ha15-10ac14	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
HA15-10AC14E ^[30]	Anti-SLITRK6 mAb Ha15-10ac14	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
GPC1-ADC-MMAE ^[31]	Anti-GPC1 GPC1-ADC (MMAE) mAb	Glypican-1 (GPC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
GPC1-ADC-MMAF ^[32]	Anti-GPC1 GPC1-ADC mAb	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
LR004-Val-Cit-MMAE ^[33]	LR004	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EDB-ADC ^[16]	Anti-EDB-FN L19	Fibronectin (FN1)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
4C9-DM1 ^[19]	Anti-KIT mAb 4C9	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
NN2101-DM1 ^[34]	NN2101	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
CDH6-SPDB-DM4 ^[35]	Human Anti-CDH6 mAb	Cadherin-6 (CDH6)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
1F6-Val-Cit-PABC-MMAF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Monomethyl auristatin F	Mal-Val-Cit-PABC	ADC Info
1F6-Ile-Pro-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Ile-Pro	ADC Info
1F6-Me3-Lys-Pro-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Me3Lys-Pro	ADC Info
1F6-NorVal- (D)Asp-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-NorVal-D-Asp	ADC Info
1F6-beta-Ala- (D)Asp-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-bata-Ala-D-Asp	ADC Info
1F6-PhenylGly- (D)Lys-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-PhenylGly-D-Lys	ADC Info
1F6-Met- (D)Lys-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Met-D-Lys	ADC Info
1F6-Asn- (D)Lys-AM ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin M	Mal-Asn-D-Lys	ADC Info
1F6-Met- (D)Lys-AW ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	L-Alanyl-L-tryptophan	Mal-Met-D-Lys	ADC Info
CAC10-Gly5-MAY ^[37]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Gly5	ADC Info
CBR96-Phe-Lys-MMAE ^[38]	Anti-Lewis-Y mAb cBR96	Lewis Y	Monomethyl auristatin E	Mc-Phe-Lys-PABC	ADC Info
BT062-SPDB-DM4 ^[39]	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
B-B4-DM1 ^[40]	Cantuzumab	Syndecan-1 (SDC1)	Mertansine DM1	Undisclosed	ADC Info
AXL02 ^[41]	AXL Anti-ody YW327.6S2	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-733-MMAE ^[42]	AXL-733	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-726-M101L-MMAE ^[42]	AXL-726-M101L	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-613-MMAE ^[42]	AXL-613	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-511-MMAE ^[42]	AXL-511	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-183-N52Q-MMAE ^[42]	AXL-183-N52Q	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-171-MMAE ^[42]	AXL-171	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-154-M103L-MMAE ^[42]	AXL-154-M103L	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AXL-148-MMAE ^[42]	AXL-148	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ASG-15MF ^[29]	Sirtratumab	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-IL13RA2-ADC ^[43]	Anti-IL13RA2 PF-06473811 mAb	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
ADC MMAE/F 4+2 ^[44]	Trastuzumab N297A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E+Monomethyl auristatin F	DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC	ADC Info
ADC MMAE/F 2+4 ^[44]	Trastuzumab N297A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E+Monomethyl auristatin F	DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC	ADC Info
HuIgG1-SPDB-DM4 ^[13]	Undisclosed	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Brentuximab-8 ^[45]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Alkyl phosphoramide-PEG24-Val-Cit-PAB	ADC Info
Brentuximab-7 ^[45]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Alkyl phosphoramide-PEG12-Val-Cit-PAB	ADC Info
Trastuzumab DVD-ADC ^[46]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Hexapeptide linker ASTKGP	ADC Info
PD-L1 ADC 1 ^[47]	Avelumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
PD-L1 ADC 2 ^[47]	Avelumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
PD-L1 ADC 3 ^[47]	Atezolizumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
T-CpHK-Tet-ADC ^[48]	Trastuzumab-CpHK	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Tetrazine-PEG5-Val-Ala-PABC	ADC Info
T-CpHK-Mal-ADC ^[48]	Trastuzumab-CpHK	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab-Man-beta-1,4GlcNAc-MMAE ^[49]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc	ADC Info
Trastuzumab-Glc-beta-1,4GlcNAc-MMAE ^[49]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Glc-beta-1,4GlcNAc	ADC Info
Trastuzumab-Gal-beta-1,4GlcNAc-MMAE ^[49]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Gal-beta-1,4-GlcNAc	ADC Info
Trastuzumab-MMAE conjugate DAR2 ^[50]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	ADC Info
Trastuzumab-MMAE conjugate DAR4 ^[50]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	ADC Info
Trastuzumab-MMAE conjugate DAR6 ^[50]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	ADC Info
Trastuzumab-MMAE conjugate DAR8 ^[50]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	ADC Info
Trastuzumab-MMAE conjugate DAR12 ^[50]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	ADC Info
Anti-HER2 DVD-IgG1-h38c2-K99C_MMAF ^[51]	Anti-HER2 DVD-IgG1-H38c2-K99C	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	ADC Info
Anti-HER2 DVD-Fab-h38c2-K99C_MMAF ^[51]	Anti-HER2 DVD-Fab-h38c2-K99C	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	ADC Info
Anti-HER2 DVD-IgG1_MMAF ^[51]	Anti-HER2 DVD-IgG1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	ADC Info
Anti-HER2 DVD-Fab_MMAF ^[51]	Anti-HER2 DVD-Fab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	ADC Info
Mil40-12A ^[27]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleamic methyl ester-based linker 12A	ADC Info
Mil40-12C ^[27]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleamic methyl ester-based linker 12C	ADC Info
Tras-Gly5-May ^[37]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Gly5	ADC Info
Fcab-1-MMAE ^[52]	Fcab-1	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	ADC Info
Fcab-2-MMAE ^[52]	Fcab-2	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	ADC Info
Fcab-3-MMAE ^[52]	Fcab-3	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	ADC Info
HuFc-MMAE ^[52]	Anti-EGFR huFc	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	ADC Info
C-Fab-MMAE ^[52]	Cetuximab Fab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	ADC Info
C-IgG-Val-Cit-MMAE ^[52]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	ADC Info
ADC MMAE/F 2+2 ^[44]	Trastuzumab N297A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E+Monomethyl auristatin F	DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC	ADC Info
Septuximab vedotin ^[53]	Septuximab	Frizzled-7 (FZD7)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
PeptibodyC19-PEG4-Val-Cit-MMAE ^[54]	Peptibody C19	Fibroblast growth factor receptor 1 (FGFR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
40H3-MCVCPAB-MMAE ^[55]	Anti-EGFR mAb 40H3	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
40H3-SMCC-DM1 ^[55]	Anti-EGFR mAb 40H3	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Cet-DM1 ^[56]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
1F6-Ile-Val-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Ile-Val	ADC Info
1F6-Asp-Val-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Asp-Val	ADC Info
1F6-His-Val-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-His-Val	ADC Info
1F6-Met-Lys-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Met-Lys	ADC Info
1F6-Asn-Lys-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Asn-Lys	ADC Info
1F6-Pro- (D)Lys-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Pro-D-Lys	ADC Info
1F6-Met- (D)Lys-MMAF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Monomethyl auristatin F	Mal-Met-D-Lys	ADC Info
1F6-Asn- (D)Lys-MMAF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Monomethyl auristatin F	Mal-Asn-D-Lys	ADC Info
1F6-Met- (D)Lys-AM ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin M	Mal-Met-D-Lys	ADC Info
1F6-Asn- (D)Lys-AW ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	L-Alanyl-L-tryptophan	Mal-Asn-D-Lys	ADC Info
MAb-DMBA-SIL-MMAE ^[57]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	DMBA-SIL	ADC Info
Alb-DMBA-SIL-MMAE ^[57]	Alb	Albumin (ALB)	Monomethyl auristatin E	DMBA-SIL	ADC Info
HB22.7-SAP ^[58]	Anti-CD22 mAb HB22.7	B-cell receptor CD22 (CD22)	Saporin	Undisclosed	ADC Info
GMF-1A3-MMAE ^[59]	Anti-cleaved-AREG 1A3 Anti-ody	Amphiregulin (AREG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
OMTX705 ^[60]	OMTX005	Prolyl endopeptidase FAP (FAP)	TAM470	Mc-Val-Cit-PABC-PEG3	ADC Info
Izeltabart tapatansine ^[61]	Izeltabart	Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)	DM21-C	Mc-Ala-Ala-Ala	ADC Info
SHR-A1307 ^[62]	Anti-EGFR mAb hR3-YTE	Epidermal growth factor receptor (EGFR)	SHR152852	L2-MC	ADC Info
CD38-077 ^[63]	STI-5171	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duostatin 5.2	Non-polyethylene glycol linker	ADC Info
BCMA-077 ^[64]	Undisclosed	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Duostatin 5.2	Proprietary Concortis linker	ADC Info
BCMA-024 ^[64]	Undisclosed	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Duostatin 5.2	Proprietary Concortis linker	ADC Info
1959-SSS-DM3 ^[65]	Undisclosed	Galectin-3-binding protein (LGALS3BP)	Maytansinoid DM3	Undisclosed	ADC Info
RN927C ^[66]	Humanized Anti-Trop-2 hIgG1 Anti-ody	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
RN765C ^[67]	EGFR Ab-L	Epidermal growth factor receptor (EGFR)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-N3(i)-vc0101 ^[68]	Anti-NOTCH3(i) mAb	Neurogenic locus notch homolog protein 3 (NOTCH3)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
Anti-N3-vc0101 ^[68]	Anti-NOTCH3 mAb	Neurogenic locus notch homolog protein 3 (NOTCH3)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
Alpha-CLDN-VC0101 ^[69]	Undisclosed	Claudin-18.2 (CLDN18.2)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
MP-1959-ADC ^[70]	Anti-LGALS3BP mAb 1959-sss	Galectin-3-binding protein (LGALS3BP)	Maytansinoid	Undisclosed	ADC Info
M9346A Sulfo-SPDB DM4 ^[13]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FcRL5-SPDB-DM4 ^[71]	Anti-FcRL5 mAb	Fc receptor-like protein 5 (FCRL5)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-CD22-SPDB-DM4 ^[72]	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-CD22-K149C-MBT-DM4 ^[72]	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM4	MBT	ADC Info
HuRH105-SSPDB-DM4 ^[73]	Undisclosed	Endoglin (ENG)	Mertansine DM4	Sulfo-SPDB	ADC Info
IMB-102 ^[74]	Undisclosed	Cathepsin D (CTSD)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
CBX-13 ^[75]	Undisclosed	Undisclosed	Mertansine DM4	Undisclosed	ADC Info
Oberotatug ravtansine ^[76]	Oberotatug	Lymphocyte antigen 75 (LY75)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Oba01 ^[77]	Zaptuzumab	Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)	Monomethyl auristatin E	PY-MAA-Val-Cit-PABC	ADC Info
Anti-HER2 antibody-drug conjugate (Spirea) ^[78]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
TTZ-Mc-NPV-MMAE ^[79]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Asn-Pro-Val-PABC	ADC Info
Adcitmer ^[80]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pyridino-caproic-Val-Cit-PABC	ADC Info
Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-MMAE ^[24]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	BCN-HydraSpace-Val-Cit-PABC	ADC Info
MF-TTZ-MMAE ^[81]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Dibromomethyl pyridine-Val-Cit-PABC	ADC Info
FGM-TTZ-MMAE ^[81]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NC-ADC ^[82]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Divinylpyrimidine-PEG4	ADC Info
C-ADC ^[82]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Divinylpyrimidine-PEG4-Val-Ala-PABC	ADC Info
RC68-PY-Val-Cit-PABC-MMAE ^[83]	RC68	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	PY-VC-PABC	ADC Info
RC68-Mc-Val-Cit-PABC-MMAE ^[83]	RC68	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
PCM-MET01-MMAE ^[84]	PCM-MET01	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Pab-001-MMAE ^[85]	Pab-001	Mucin-1 (MUC1)	Monomethyl auristatin E	Undisclosed	ADC Info
OBI-998 ^[86]	OBI-898	Stage-specific embryonic antigen-4 (SSEA-4)	Monomethyl auristatin E	Maleimide and PEGylated cleavable linker	ADC Info
Anti-ICOS-MMAE ^[87]	Murine Anti-ICOS Anti-ody	Inducible T-cell costimulator (ICOS)	Monomethyl auristatin E	Undisclosed	ADC Info
Mil40-12B ^[27]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Magacizumab PD-MMAE ADC 5 ^[22]	Magacizumab	Leucine-rich alpha-2-glycoprotein (LRG1)	Monomethyl auristatin E	Mepstra-PD-PEG3-Mal-Cit-PABC	ADC Info
1F-Val-Cit-MMAE ^[15]	Anit-TF mAb 1F	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BVD-TEM8 ADC ^[88]	Anti-TEM8 mAb m825	Anthrax toxin receptor 1 (ANTXR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IMAB362-Val-Cit-MMAE ^[89]	IMAB362	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IMAB027-Val-Cit-MMAE ^[90]	IMAB027	Claudin-6 (CLDN6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SS1-Val-Cit-MMAE ^[91]	Anti-MSLN IgG1-SS1	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CHS8-Val-Cit-MMAE ^[91]	Anti-MSLN IgG1-CHS8	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CHS7-Val-Cit-MMAE ^[91]	Anti-MSLN IgG1-CHS7	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CHS5-Val-Cit-MMAE ^[91]	Anti-MSLN IgG1-CHS5	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ALA12-Val-Cit-MMAE ^[91]	Anti-MSLN IgG1-ALA12	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Bstrongximab ADC ^[92]	Bstrongximab	TRA-1-60	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
T-Fc-Val-Cit-MMAE ^[93]	Human Anti-FGFR1 Fc	Fibroblast growth factor receptor 1 (FGFR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-CD7 MMAE ADC ^[94]	Human Anti-CD7 mAb IgG1	T-cell antigen CD7 (CD7)	Monomethyl auristatin E	PermaLink-PEG4-Val-Cit-PAB	ADC Info
PCM5B14-MMAE ^[95]	H5B14	Macrophage-stimulating protein receptor (MST1R)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
GB7008-01-Val-Cit-MMAE ^[96]	GB7008-01	Claudin-6 (CLDN6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
F7-ADC ^[53]	F7-Chimeric Ab	Frizzled-7 (FZD7)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cirmtuzumab-ADC-7 ^[97]	Cirmtuzumab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Undisclosed	ADC Info
CDX3379-MMAE ^[98]	CDX3379	Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
MF-BTX-MMAE ^[99]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Dibromomethyl pyridine-Val-Cit-PABC	ADC Info
ADC-AVP-04 ^[100]	AVP04	Tumor-associated glycoprotein 72 (TAG-72)	Monomethyl auristatin E	Maleimide-functionalized TCO	ADC Info
Atezolizumab ADC ^[47]	Atezolizumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
S3F-CL-MMAE ^[101]	Anti-sTn mAb S3F	Onco-foetal sialyl-Tn	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
¹¹¹In-DTPA-D2B-DAR4-MMAE ^[102]	Anti-PSMA IgG1 mAb D2B	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
¹¹¹In-DTPA-D2B-DAR2-MMAE ^[102]	Anti-PSMA IgG1 mAb D2B	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-FcRL5-Mc-vcPAB-MMAE ^[103]	Anti-FcRL5 mAb	Fc receptor-like protein 5 (FCRL5)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
DAR8-alphaCD30-mDPR-Gluc-MMAE ^[104]	Anti-CD30 DAR8-alphaCD30-mDPR-gluc-MMAE mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Quaternary ammonium linker Gluc	ADC Info
A7R-ADC-MMAE ^[105]	Anti-IL7R mAb A7R	Interleukin-7 receptor subunit alpha (IL7R)	Monomethyl auristatin E	Mal-PEG12-Val-Cit-PABC	ADC Info
S7-E430G ADC ^[106]	9G8-7D12-Fc with E430G	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
S7 ADC ^[106]	9G8-7D12-Fc	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
7H5-Val-Cit-MMAE ^[107]	Anti-TIP1 mAb 7H5	Tax1-binding protein 3 (TAX1BP3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
N41mab-Val-Cit-MMAE ^[108]	Undisclosed	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ST1 ^[109]	Undisclosed	Onco-foetal sialyl-Tn	Monomethyl auristatin E	Undisclosed	ADC Info
JY207 ^[110]	Undisclosed	Leukocyte surface antigen CD47 (CD47); Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Undisclosed	ADC Info
Hertuzumab vedotin ^[111]	Hertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LCB-97 ^[112]	Undisclosed	AF4/FMR2 family member 4 (AFF4)	Monomethyl auristatin E	Undisclosed	ADC Info
LCB-67 ^[113]	Undisclosed	Protein delta homolog 1 (DLK1)	Monomethyl auristatin E	Undisclosed	ADC Info
Anti-endosialin-Mc-Val-Cit-PABC-MMAE ^[114]	Undisclosed	Endosialin (CD248)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-NaPi3b antibody-drug conjugate (Genentech/Roche) ^[115]	Undisclosed	Sodium-dependent phosphate transport protein 2B (SLC34A2)	Monomethyl auristatin E	Undisclosed	ADC Info
DM003 ^[116]	Undisclosed	Inactive tyrosine-protein kinase 7 (PTK7); Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Undisclosed	ADC Info
MSLN ADC (Development Center for Biotechnology) ^[117]	Undisclosed	Mesothelin (MSLN)	Monomethyl auristatin E	Undisclosed	ADC Info
CBX-15 ^[75]	Undisclosed	Poly [ADP-ribose] polymerase 1 (PARP1)	Monomethyl auristatin E	Undisclosed	ADC Info
YH-012 ^[118]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2); Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
YH-013 ^[119]	Undisclosed	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
DM004 ^[120]	Undisclosed	Trophoblast glycoprotein (TPBG); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
BSA01 ^[121]	Undisclosed	Epidermal growth factor receptor (EGFR); Mucin-1 (MUC1)	Monomethyl auristatin E	Undisclosed	ADC Info
BCG033 ^[122]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2); Inactive tyrosine-protein kinase 7 (PTK7)	Monomethyl auristatin E	Undisclosed	ADC Info
BCG022 ^[123]	Undisclosed	Receptor tyrosine-protein kinase erbB-3 (HER3); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
BA-3361 ^[124]	Undisclosed	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CD46 CAB-ADC ^[125]	Undisclosed	Membrane cofactor protein (CD46)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ARC-02 ^[126]	Undisclosed	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Undisclosed	ADC Info
MSLN MMAE ^[127]	Undisclosed	Mesothelin (MSLN)	Monomethyl auristatin E	Undisclosed	ADC Info
B7H3-MMAE ^[128]	Undisclosed	CD276 antigen (CD276)	Monomethyl auristatin E	Undisclosed	ADC Info
Tmab-SPDP-DM1 ^[25]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
REGN2878-DM1 ^[129]	REGN2878	Prolactin receptor (PRLR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
BT062-SPP-DM1 ^[39]	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
BT062-SMCC-DM1 ^[39]	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MD1.22-DM1 ^[130]	mD1.22	Envelope glycoprotein gp160 (env)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
LR-DM1 ^[131]	LR004	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HJAA-F11 ADC ^[132]	JAA-F11	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IIIA4-USAN ^[133]	Anti-EPHA3 mAb IIIA4	Ephrin type-A receptor 3 (EPHA3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IgG78-DM1 ^[134]	Anti-CD248 mAb IgG78	Endosialin (CD248)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
ICAM1-DM1 ADC ^[135]	Anti-ICAM1 mAb	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
DS6-DM1 ^[136]	Anti-MUC1 mAb DS6	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
DL35D-DM1 ^[130]	DL35D	Envelope glycoprotein gp160 (env); Envelope glycoprotein gp41 (env)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Zt/g4-DM1 ^[137]	Anti-RON Zt/g4 (IgG1 kappa)	Macrophage-stimulating protein receptor (MST1R)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-SSTR2 ADC ^[138]	Anti-human and mouse SSTR2 mAb (IgG1 kappa)	Somatostatin receptor type 2 (SSTR2)	Mertansine DM1	Sulfo-SMCC	ADC Info
FMOD-ADC ^[139]	Anti-FMOD mAb	Fibromodulin (FMOD)	Mertansine DM1	Sulfo-SMCC	ADC Info
Anti-EGFR-PEG4-Mal-DM1 ^[140]	Anti-EGFR mAb rat IgG2a	Epidermal growth factor receptor (EGFR)	Mertansine DM1	PEG4-Mal	ADC Info
Anti-EGFR-Sulfo-SMCC-DM1 ^[141]	Anti-EGFR mAb	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Sulfo-SMCC	ADC Info
Anti-CD47 mAb (IgG2b/kappa)-DM1 ^[142]	Anti-CD47 mAb (IgG2b/kappa)-	Leukocyte surface antigen CD47 (CD47)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-CD22-K149C-MPEO-DM1 ^[72]	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM1	MPEO	ADC Info
Anti-CD22-K149C-DM1 ^[72]	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
2G4-DM1 ^[143]	Anti-KIT mAb 2G4	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Undisclosed	ADC Info
Zt/g4-Maytansinoid ^[137]	Undisclosed	Macrophage-stimulating protein receptor (MST1R)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
APLP2/HER2 antibody-drug conjugate ^[144]	Undisclosed	Amyloid beta precursor like protein 2 (APLP2); Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info
PTM-001-ADC ^[145]	Undisclosed	Undisclosed	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuRH105-SMCC-DM1 ^[73]	Undisclosed	Endoglin (ENG)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IMB-101 ^[74]	Undisclosed	Cathepsin D (CTSD)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
CTAT-ADC ^[146]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info
Humanized Anti-HER2 Mab-Maytansine Conjugate ^[147]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info
ZV-0501 ^[148]	ZV05	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
CD70-MMAF-ADC ^[149]	Vorsetuzumab	CD70 antigen (CD70)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-TrkB DVD-ADC ^[46]	TrkB-DVD (h38C2)	BDNF/NT-3 growth factors receptor (NTRK2)	Monomethyl auristatin F	Hexapeptide linker ASTKGP	ADC Info
T-K-F (DAR 3.9) ^[150]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
T-C-F (DAR 3.7) ^[150]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
SG3-Val-Cit-MMAF8 ^[151]	SG3	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
SG2-Val-Cit-MMAF8 ^[151]	SG2	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
SG1-Val-Cit-MMAF8 ^[151]	SG1	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
LCB-ADC3 ^[152]	Isoprenylated trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Bridged PEG4-valine-alanine	ADC Info
LCB-ADC2 ^[152]	Isoprenylated trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Isoprene-PEG3,3,3-beta-Glu-PABC	ADC Info
LCB-ADC1 ^[152]	Isoprenylated trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Isoprene-PEG3-beta-Glu-PABC	ADC Info
DAR2-ARC-ADC ^[153]	Human hCLL-1 Anti-ody genetically fused with CD38	Collectin-10 (COLEC10)	Monomethyl auristatin F	NAD-based dinucleotide linker	ADC Info
EV20/MMAF ^[154]	EV20	Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-TrkB mAb 641 ADC ^[46]	Anti-TrkB mAb 641	BDNF/NT-3 growth factors receptor (NTRK2)	Monomethyl auristatin F	Hexapeptide linker ASTKGP	ADC Info
CD46-ADC ^[155]	Anti-CD46 mAb 23AG2	Membrane cofactor protein (CD46)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
MP-HER3-ADC ^[156]	Undisclosed	Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin F	Undisclosed	ADC Info
AVP10 ^[157]	Undisclosed	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin F	Undisclosed	ADC Info
DAR4-ARC-ADC ^[153]	Undisclosed	Collectin-10 (COLEC10)	Monomethyl auristatin F	NAD-based dinucleotide linker	ADC Info
NC-6201 ^[158]	NCAB001	Epidermal growth factor receptor (EGFR)	E7974	Undisclosed	ADC Info
An2-anti-HER2-Doxetaxel ^[159]	ANG4043	Receptor tyrosine-protein kinase erbB-2 (HER2)	Docetaxel	Undisclosed	ADC Info
APH-0912 ^[160]	Undisclosed	Undisclosed	Docetaxel	Hydrophilic linker containing sugar molecules	ADC Info
DAR8-alphaCD30-mDPR-GlucQ-AE ^[104]	Anti-CD30 DAR8-alphaCD30-mDPR-glucQ-AE mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin E	Quaternary ammonium linker GlucQ	ADC Info
T-N-F (DAR 3.2) ^[150]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Aldehyde-tagged MMAF	Undisclosed	ADC Info
T-N-F (DAR 1.6) ^[150]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Aldehyde-tagged MMAF	Undisclosed	ADC Info
1F6-Asn- (D)Lys-AF ^[36]	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Asn-D-Lys	ADC Info
Erbitux-MHT-71 ^[161]	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin F	MHT-71	ADC Info
4D5-AF (CUAAC) ^[162]	Anti-HER2/neu mAb 4D5	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin F	N6-(2-azidoethoxy)carbonyl-L-lysine	ADC Info
DAN-405 ^[163]	Undisclosed	Glutamate carboxypeptidase 2 (FOLH1)	Cabazitaxel	Undisclosed	ADC Info
Anti-HER2 scFv-Fc (Ser396Sec)-CN29 ^[164]	Anti-HER2 scFv-Fc (Ser396Sec)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F derivative peptide (CN29)	Lodoacetamido-caproyl	ADC Info
Trastuzumab-deBouganin ^[165]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	DeBouganin	Undisclosed	ADC Info
DAR8-alphaCD30-mDPR-Gluc-DMTub ^[104]	Anti-CD30 DAR8-alphaCD30-mDPR-gluc-DMTub mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	DMTub	Quaternary ammonium linker Gluc	ADC Info
Eribulin ADC (Jiangsu hengrui) ^[166]	Undisclosed	Undisclosed	Eribulin	Undisclosed	ADC Info
MET/MET-M114 ^[167]	Biparatopic METxMET Anti-ody	Hepatocyte growth factor receptor (MET); Hepatocyte growth factor receptor (MET)	Maytansine derivative M24	Succinate-Val-Cit-PABC	ADC Info
CBT-3112 ^[168]	Undisclosed	Serine/threonine-protein kinase DCLK1 (DCLK1)	Paclitaxel	Undisclosed	ADC Info
MI-130004 ^[169]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	PM050489	6-(2,5-dioxopyrrol-1-yl)-N-Propylhexanamide	ADC Info
MI-130110 ^[170]	Anti-CD13 TEA1/8 mAb	Aminopeptidase N (ANPEP)	PM050489	6-(2,5-dioxopyrrol-1-yl)-N-Propylhexanamide	ADC Info
Monoclonal antibody HB2-saporin conjugate ^[171]	Anti-CD7 mAb HB2	T-cell antigen CD7 (CD7)	Saporin	Undisclosed	ADC Info
Anti-CD30 monoclonal antibody-saporin conjugate ^[172]	Anti-CD30 mAb Ber-H2	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Saporin	Undisclosed	ADC Info
33B7-Saporin ^[173]	Anti-PTGFRN mAb 33B7	Prostaglandin F2 receptor negative regulator (PTGFRN)	Saporin	Undisclosed	ADC Info
Anti-CD38 IT OKT10-SAPORIN ^[174]	Undisclosed	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Saporin	Undisclosed	ADC Info
Anti-HER2 DVD-IgG1-Tiancimycin ^[175]	Anti-HER2 DVD-IgG1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tiancimycin	DVD-PEG4-Triazol	ADC Info
DAR8-alphaCD30-mDPR-GlucQ-Tub ^[104]	Anti-CD30 DAR8-alphaCD30-mDPR-glucQ-Tub mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin analogue 3	Quaternary ammonium linker GlucQ	ADC Info
LY3343544 ^[176]	Emibetuzumab	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
BB-1712 ^[177]	Anti-B7-H3 mAb	CD276 antigen (CD276)	Eribulin	A cleavable linker	ADC Info
Araris ADC ^[178]	Enfortumab	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Cathepsin B cleavable linker	ADC Info
MP-EV-20 ^[179]	EV20	Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin F	Undisclosed	ADC Info
GENA-111-AF ^[180]	GENA-111	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Undisclosed	ADC Info
AG 02 saporin conjugate ^[181]	Anti-CSP-1 mAb AG02	Cell surface protein 1 (CSP-1)	Saporin	Undisclosed	ADC Info
SC16.3-DL1 ^[182]	SC16.3	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.4-DL1 ^[182]	SC16.4	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.5-DL1 ^[182]	SC16.5	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.7-DL1 ^[182]	SC16.7	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.8-DL1 ^[182]	SC16.8	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.10-DL1 ^[182]	SC16.10	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.11-DL1 ^[182]	SC16.11	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.13-DL1 ^[182]	SC16.13	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.15-DL1 ^[182]	SC16.15	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.18-DL1 ^[182]	SC16.18	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.19-DL1 ^[182]	SC16.19	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.20-DL1 ^[182]	SC16.20	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.21-DL1 ^[182]	SC16.21	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.22-DL1 ^[182]	SC16.22	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.23-DL1 ^[182]	SC16.23	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.25-DL1 ^[182]	SC16.25	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.26-DL1 ^[182]	SC16.26	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.29-DL1 ^[182]	SC16.29	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.30-DL1 ^[182]	SC16.30	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.31-DL1 ^[182]	SC16.31	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.34-DL1 ^[182]	SC16.34	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.35-DL1 ^[182]	SC16.35	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.36-DL1 ^[182]	SC16.36	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.38-DL1 ^[182]	SC16.38	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.41-DL1 ^[182]	SC16.41	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.42-DL1 ^[182]	SC16.42	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.45-DL1 ^[182]	SC16.45	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.47-DL1 ^[182]	SC16.47	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.49-DL1 ^[182]	SC16.49	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.50-DL1 ^[182]	SC16.50	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.52-DL1 ^[182]	SC16.52	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.55-DL1 ^[182]	SC16.55	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.56-DL1 ^[182]	SC16.56	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.57-DL1 ^[182]	SC16.57	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.58-DL1 ^[182]	SC16.58	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.61-DL1 ^[182]	SC16.61	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.62-DL1 ^[182]	SC16.62	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.63-DL1 ^[182]	SC16.63	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.65-DL1 ^[182]	SC16.65	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.67-DL1 ^[182]	SC16.67	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.68-DL1 ^[182]	SC16.68	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.72-DL1 ^[182]	SC16.72	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.73-DL1 ^[182]	SC16.73	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.78-DL1 ^[182]	SC16.78	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.79-DL1 ^[182]	SC16.79	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.80-DL1 ^[182]	SC16.80	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.81-DL1 ^[182]	SC16.81	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.84-DL1 ^[182]	SC16.84	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.88-DL1 ^[182]	SC16.88	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.101-DL1 ^[182]	SC16.101	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.103-DL1 ^[182]	SC16.103	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.104-DL1 ^[182]	SC16.104	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.105-DL1 ^[182]	SC16.105	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.106-DL1 ^[182]	SC16.106	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.107-DL1 ^[182]	SC16.107	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.108-DL1 ^[182]	SC16.108	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.109-DL1 ^[182]	SC16.109	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.110-DL1 ^[182]	SC16.110	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.111-DL1 ^[182]	SC16.111	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.113-DL1 ^[182]	SC16.113	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.114-DL1 ^[182]	SC16.114	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.115-DL1 ^[182]	SC16.115	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.116-DL1 ^[182]	SC16.116	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.117-DL1 ^[182]	SC16.117	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.118-DL1 ^[182]	SC16.118	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.120-DL1 ^[182]	SC16.120	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.121-DL1 ^[182]	SC16.121	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.122-DL1 ^[182]	SC16.122	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.123-DL1 ^[182]	SC16.123	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.124-DL1 ^[182]	SC16.124	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.125-DL1 ^[182]	SC16.125	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.126-DL1 ^[182]	SC16.126	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.129-DL1 ^[182]	SC16.129	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.130-DL1 ^[182]	SC16.130	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.131-DL1 ^[182]	SC16.131	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.132-DL1 ^[182]	SC16.132	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.133-DL1 ^[182]	SC16.133	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.134-DL1 ^[182]	SC16.134	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.135-DL1 ^[182]	SC16.135	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.136-DL1 ^[182]	SC16.136	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.137-DL1 ^[182]	SC16.137	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.138-DL1 ^[182]	SC16.138	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.139-DL1 ^[182]	SC16.139	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.140-DL1 ^[182]	SC16.140	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.141-DL1 ^[182]	SC16.141	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.142-DL1 ^[182]	SC16.142	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.143-DL1 ^[182]	SC16.143	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.144-DL1 ^[182]	SC16.144	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.147-DL1 ^[182]	SC16.147	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.148-DL1 ^[182]	SC16.148	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.149-DL1 ^[182]	SC16.149	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
SC16.150-DL1 ^[182]	SC16.150	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	ADC Info
HuM25-vcMMAE-E2 ^[183]	HuM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuM25-vcMMAE-DAR4 ^[183]	HuM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuAD208.4.1-vcMMAE-DAR4 ^[183]	huAD208.4.1	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuAD208.14.1-vcMMAE-DAR4 ^[183]	huAD208.14.1	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuM25-mcMMAF-E2 ^[183]	HuM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
NS Cys-vc-MMAE ^[184]	Undisclosed	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cetux Cys-vc-MMAE ^[184]	Glyco-engineered cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Glyco-cetuximab Fab-vc-MMAE ^[184]	Glyco-engineered cetuximab Fab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cetux Fc/Fab-vc-MMAE ^[184]	Glyco-engineered cetuximab Fc/Fab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IC1-MMAE ^[185]	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IC1-MMAF ^[185]	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
IC1-DM4 ^[185]	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM4	Mal-EBE-Mal	ADC Info
IC1-DM1 ^[185]	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Mal-EBE-Mal	ADC Info
ADC Trast-7 ^[186]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
ADC Trast-10 ^[186]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Bis-BCN-modified Val-Cit-PABC linker 10	ADC Info
MMAE-IgG1 17 ^[187]	Anti-ENPP1 IgG1 17	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1)	Monomethyl auristatin E	Undisclosed	ADC Info
MMAE-IgG1 3G12 ^[187]	Anti-ENPP1 IgG1 3G12	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1)	Monomethyl auristatin E	Undisclosed	ADC Info
AB-3A4-Val-Cit-MMAE ^[188]	Anti-KAAG1 mAb AB-3A4	Kidney-associated antigen 1 (KAAG1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IGN-786 ^[189]	Anti-SAIL mAb	Translocator protein (TSPO)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
AVID-300 ^[190]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Undisclosed	ADC Info
1711 (scFv)-SNAP-AuriF ^[191]	1711/425 scFv-SNAP	Epidermal growth factor receptor (EGFR)	Auristatin F	BG based linker	ADC Info
MMAE.VC.SA.617 ^[192]	Undisclosed	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Undisclosed	ADC Info
CLDN1 ADC ^[193]	Anti-CLDN1 mAb 6F6	Claudin-1 (CLDN1)	Monomethyl auristatin E	Undisclosed	ADC Info
1959-sss/DM4 ^[194]	Undisclosed	Galectin-3-binding protein (LGALS3BP)	Mertansine DM4	Undisclosed	ADC Info
ZHER2-ABD-mcMMAF ^[195]	ZHER2-ABD	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
ZHER2-ABD-mcMMAE ^[195]	ZHER2-ABD	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleimido-caproyl	ADC Info
ITcetuximab ^[196]	Cetuximab	Epidermal growth factor receptor (EGFR)	Saporin	Undisclosed	ADC Info
Bevacizumab vedotin ^[197]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-DOG1-DM4-ADC ^[198]	Anti-DOG1 mAb	Anoctamin-1 (ANO1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
A5/158-vc-MMAE ^[199]	A5/158	C-type mannose receptor 2 (MRC2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
MesoADC ^[200]	Anti-GSDME mAb	Gasdermin-E (GSDME)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
3A5-mc-VC-PAB-MMAE ^[201]	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
3A5-55 ADC ^[201]	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Maytansine derivative 55	Mal-EBE-Mal	ADC Info
3A5-56 ADC ^[201]	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Maytansine derivative 56	Mal-EBE-Mal	ADC Info
3A5-57 ADC ^[201]	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Maytansine derivative 57	Maleimido-caproyl	ADC Info
MUC16-55 ADC ^[201]	Anti-MUC16 mAb	Mucin-16 (MUC16)	Maytansine derivative 55	Mal-EBE-Mal	ADC Info
MUC16-56 ADC ^[201]	Anti-MUC16 mAb	Mucin-16 (MUC16)	Maytansine derivative 56	Mal-EBE-Mal	ADC Info
Cys-linker-MMAE-based ADC 11 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Cys-11 ADC linker	ADC Info
Cys-linker-MMAE-based ADC 12 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Cys-12 ADC linker	ADC Info
Cys-linker-MMAE-based ADC 13 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Cys-13 ADC linker	ADC Info
Cys-linker-MMAE-based ADC 14 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Cys-14 ADC linker	ADC Info
Cys-linker-MMAE-based ADC 15 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-PABC	ADC Info
Cys-linker-MMAE-based ADC 16 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
P38B-DM1 ^[203]	P38B	Podoplanin (PDPN)	Mertansine DM1	Azide-modified dibenzocyclooctyne(DBCO)-albumin(HAS)	ADC Info
GPC-1-ADC ^[204]	Anti-GPC1 mAb clone 01a033	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
10D7-MMAE ^[205]	Anti-CDCP1 mAb 10D7	CUB domain-containing protein 1 (CDCP1)	Monomethyl auristatin E	Undisclosed	ADC Info
CD4-Val-Cit-MMAE ^[206]	Anti-CD4 mAb	T-cell surface glycoprotein CD4 (CD4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab-iCME ^[207]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Membrane-impermable colchinolmethyl ether (iCME) cytotoxin	Pacific blue fluorophore-SH based linker	ADC Info
2G10 RED-106 maytansine 2 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-106	ADC Info
2G10 RED-106 maytansine 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-106	ADC Info
2G10 RED-425 maytansine 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-425	ADC Info
2G10 RED-432 maytansine 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-432	ADC Info
2G10 RED-244 MMAE 2 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-244	ADC Info
2G10 RED-244 MMAE 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-244	ADC Info
2G10 RED-412 MMAE 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-412	ADC Info
2G10 RED-388 MMAE 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-388	ADC Info
2G10 RED-426 MMAE 4 ^[208]	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-426	ADC Info
IgG1 (trastuzumab)-vc-MMAE ^[209]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG1 (H32)-vc-MMAE ^[209]	Anti-HER2 IgG1(H32)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG1 (GH2-20)-vc-MMAE ^[209]	Anti-HER2 IgG1(GH2-20)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG1 (GH2-61)-vc-MMAE ^[209]	Anti-HER2 IgG1(GH2-61)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG1 (GH2-75)-vc-MMAE ^[209]	Anti-HER2 IgG1(GH2-75)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Ch735-Py-DM1 ^[210]	Chimeric human mAb ch735	Oncodevelopmental antigen polysialic acid (polySia)	Mertansine DM1	TCO-PEG3-Mal	ADC Info
T-Py-DM1 ^[210]	Trastuzumab	Oncodevelopmental antigen polysialic acid (polySia)	Mertansine DM1	TCO-PEG3-Mal	ADC Info
IgG1 (trastuzumab)-AL1-MMAE ^[209]	Trastuzumab-AL1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
IgG1 (H32)-AL1-MMAE ^[209]	Anti-HER2 IgG1(H32)-AL1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
IgG1 (GH2-20)-AL1-MMAE ^[209]	Anti-HER2 IgG1(GH2-20)-AL1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
IgG1 (GH2-61)-AL1-MMAE ^[209]	Anti-HER2 IgG1(GH2-61)-AL1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
IgG1 (GH2-75)-AL1-MMAE ^[209]	Anti-HER2 IgG1(GH2-75)-AL1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
SNS-622-DM1 ^[211]	SNS-622	Aspartyl/asparaginyl beta-hydroxylase (ASPH)	Mertansine DM1	Maleimido-caproyl	ADC Info
SNS-622-MMAE ^[211]	SNS-622	Aspartyl/asparaginyl beta-hydroxylase (ASPH)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
DAB4-DM1 ^[212]	DAB4	Lupus La protein (SSB)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
DAB4-DM4 ^[212]	DAB4	Lupus La protein (SSB)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Sal5-DM4 ^[212]	Sal5	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
DAB4-MMAE ^[212]	DAB4	Lupus La protein (SSB)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Sal5-MMAE ^[212]	Sal5	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
DAB4-MMAF ^[212]	DAB4	Lupus La protein (SSB)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
⁸⁹Zr-DFO-T-DM1 ^[213]	Zr-labeled trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info
Zt/g4-MMAE ^[214]	Anti-RON Zt/g4 (IgG1 kappa)	Macrophage-stimulating protein receptor (MST1R)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Promiximab-MMAE ^[215]	Promiximab	Neural cell adhesion molecule 1 (NCAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EGFRvIII-16 ^[216]	Anti-EGFRvIII mAb	Epidermal growth factor receptor variant III (EGFRvIII)	DM1 derivative 16	Mc-Val-Cit-PABC	ADC Info
EGFRvIII-MCC-DM1 ^[216]	Anti-EGFRvIII mAb	Epidermal growth factor receptor variant III (EGFRvIII)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
PSMA-15 ^[216]	Anti-PSMA mAb	Glutamate carboxypeptidase 2 (FOLH1)	DM1 derivative 15	Mc-Val-Cit-PABC	ADC Info
PSMA-16 ^[216]	Anti-PSMA mAb	Glutamate carboxypeptidase 2 (FOLH1)	DM1 derivative 16	Mc-Val-Cit-PABC	ADC Info
PRLR-16 ^[216]	Anti-PRLR mAb	Prolactin receptor (PRLR)	DM1 derivative 16	Mc-Val-Cit-PABC	ADC Info
Trastuzumab/nab-paclitaxel ^[217]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Paclitaxel	Undisclosed	ADC Info
GPC-1 ADC 1 ^[218]	Anti-GPC1 mAb 01a033	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 2 ^[218]	Anti-GPC1 mAb 01a002	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 3 ^[218]	Anti-GPC1 mAb 02a035	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 4 ^[218]	Anti-GPC1 mAb 02a034	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 5 ^[218]	Anti-GPC1 mAb 02a014	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 6 ^[218]	Anti-GPC1 mAb 02a002	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 7 ^[218]	Anti-GPC1 mAb 02a010	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 8 ^[218]	Anti-GPC1 mAb 01a016	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 9 ^[218]	Anti-GPC1 mAb 02b006	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 10 ^[218]	Anti-GPC1 mAb 01a021	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 11 ^[218]	Anti-GPC1 mAb 02a022	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 12 ^[218]	Anti-GPC1 mAb 01a009	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 13 ^[218]	Anti-GPC1 mAb 01a030	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 14 ^[218]	Anti-GPC1 mAb 01a017	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 15 ^[218]	Anti-GPC1 mAb 01a007	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 16 ^[218]	Anti-GPC1 mAb 01a042	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 17 ^[218]	Anti-GPC1 mAb 01a026	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
GPC-1 ADC 18 ^[218]	Anti-GPC1 mAb 02a006	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
Docetaxel-trastuzumab ^[219]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Docetaxel	Undisclosed	ADC Info
M9346A-CX-DM1 ^[220]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	triglycyl peptide linker CX	ADC Info
M9346A-4a-Cxxx-Mal-CX-DM1 ^[220]	Mirvetuximab (engineered cysteine LC-C205)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	ADC Info
M9346A-4b-Cxxx-Mal-CX-DM1 ^[220]	Mirvetuximab (engineered cysteine LC-C400)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	ADC Info
M9346A-4c-Cxxx-Mal-CX-DM1 ^[220]	Mirvetuximab (engineered cysteine HC-C118)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	ADC Info
M9346A-4d-Cxxx-Mal-CX-DM1 ^[220]	Mirvetuximab (engineered cysteine HC-C239)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	ADC Info
HBU12-mc-MMAF ^[221]	Anti-CD19 mAb hBU12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
CC2B-h15H3-gluc-MMAE ^[221]	Anti-ITGA5 mAb CC2B-h15H3	Integrin alpha-5 (ITGA5)	Monomethyl auristatin E	Quaternary ammonium linker Gluc	ADC Info
H15H3-gluc-MMAE ^[221]	Anti-ITGA5 mAb h15H3	Integrin alpha-5 (ITGA5)	Monomethyl auristatin E	Quaternary ammonium linker Gluc	ADC Info
HcHAb18-DM1 ^[222]	HcHAb18	Basigin (BSG)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
ChmAb-A B7-H3-ADC ^[223]	chmAb-A	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ChmAb-B B7-H3-ADC ^[223]	chmAb-B	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ChmAb-C B7-H3-ADC ^[223]	chmAb-C	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ChmAb-D B7-H3-ADC ^[223]	chmAb-D	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
QD6/B09-AZ1508 ^[224]	QD6/B09	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	QD6/B09-AZ1508	QD6/B09-AZ1508	ADC Info
RAA22/B09-AZ1508 ^[224]	RAA22/B09	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	RAA22/B09-AZ1508	RAA22/B09-AZ1508	ADC Info
MuDS6-DM1 ^[225]	Anti-CA6 mAb muDS6	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
MuDS6-SSNPP-MM1-202 ^[225]	Anti-CA6 mAb muDS6	Mucin-1 (MUC1)	Mertansine DM1	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
HuDS6v1.01-DM4 ^[225]	huDS6v1.01	Mucin-1 (MUC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuDS6v1.21-DM4 ^[225]	huDS6v1.21	Mucin-1 (MUC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
28E4-DM1 ^[225]	280000	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HAZcPB-DM1 ^[225]	HAZcPB	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
SSaPB-DM1 ^[225]	SSaPB	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
CNTO95-DM1 ^[226]	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
F105-DM1 ^[226]	F105	Integrin alpha-V (ITGAV)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
CNTO95-SPP-DM1 ^[226]	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
F105-SPP-DM1 ^[226]	F105	Integrin alpha-V (ITGAV)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
CNTO95-SSNPB-DM4 ^[226]	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	N-sulfosuccinimidyl-4-(5-nitro-2 pyridyldithio) butyrate (SSNPB)	ADC Info
F105-SSNPB-DM4 ^[226]	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	N-sulfosuccinimidyl-4-(5-nitro-2 pyridyldithio) butyrate (SSNPB)	ADC Info
CNTO95-SSNPP-DM4 ^[226]	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
F105-SSNPP-DM4 ^[226]	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
CNTO95-SPP-DM4 ^[226]	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
F105-SPP-DM4 ^[226]	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
CNTO95-SPDB-DM4 ^[226]	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
F105-SPDB-DM4 ^[226]	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
NBT062-SMCC-DM1 ^[1]	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
NBT062-SPP-DM1 ^[1]	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
B-B4-SPP-DM1 ^[1]	Anti-CD138 mAb B-B4	Syndecan-1 (SDC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
B-B4-SMCC-DM1 ^[1]	Anti-CD138 mAb B-B4	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
B-B4-SPDB-DM4 ^[1]	Anti-CD138 mAb B-B4	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuMov19-PEG4-Mal-DM1 ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
FR1-21-PEG4-Mal-DM1 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
Mov19-PEG4-Mal-DM1 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
Farletuzumab-PEG4-Mal-DM1 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
FR1-48-PEG4-Mal-DM1 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
FR1-49-PEG4-Mal-DM1 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
FR1-57-PEG4-Mal-DM1 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
FR1-65-PEG4-Mal-DM1 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
HuMOV19v1.6-PEG4-Mal-DM1 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
HuMOV19v1.0-PEG4-Mal-DM1 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
HuFR1-21-PEG4-Mal-DM1 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
MuFR1-21-PEG4-Mal-DM1 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
MuFR1-9-PEG4-Mal-DM1 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
MuFR1-13-PEG4-Mal-DM1 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
MuFR1-22-PEG4-Mal-DM1 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
MuFR1-23-PEG4-Mal-DM1 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
HuFR1-23-PEG4-Mal-DM1 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	ADC Info
HuMov19-SMCC-DM1 ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
FR1-21-SMCC-DM1 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Mov19-SMCC-DM1 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Farletuzumab-SMCC-DM1 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
FR1-48-SMCC-DM1 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
FR1-49-SMCC-DM1 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
FR1-57-SMCC-DM1 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
FR1-65-SMCC-DM1 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuMOV19v1.6-SMCC-DM1 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuMOV19v1.0-SMCC-DM1 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuFR1-21-SMCC-DM1 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MuFR1-21-SMCC-DM1 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MuFR1-9-SMCC-DM1 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MuFR1-13-SMCC-DM1 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MuFR1-22-SMCC-DM1 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MuFR1-23-SMCC-DM1 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuFR1-23-SMCC-DM1 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
HuMov19-SIA-DM1 ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
FR1-21-SIA-DM1 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
Mov19-SIA-DM1 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
Farletuzumab-SIA-DM1 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
FR1-48-SIA-DM1 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
FR1-49-SIA-DM1 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
FR1-57-SIA-DM1 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
FR1-65-SIA-DM1 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
HuMOV19v1.6-SIA-DM1 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
HuMOV19v1.0-SIA-DM1 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
HuFR1-21-SIA-DM1 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
MuFR1-21-SIA-DM1 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
MuFR1-9-SIA-DM1 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
MuFR1-13-SIA-DM1 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
MuFR1-22-SIA-DM1 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
MuFR1-23-SIA-DM1 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
HuFR1-23-SIA-DM1 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	ADC Info
HuMov19-SPP-DM1 ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
FR1-21-SPP-DM1 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Mov19-SPP-DM1 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Farletuzumab-SPP-DM1 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
FR1-48-SPP-DM1 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
FR1-49-SPP-DM1 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
FR1-57-SPP-DM1 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
FR1-65-SPP-DM1 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HuMOV19v1.6-SPP-DM1 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HuMOV19v1.0-SPP-DM1 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HuFR1-21-SPP-DM1 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
MuFR1-21-SPP-DM1 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
MuFR1-9-SPP-DM1 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
MuFR1-13-SPP-DM1 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
MuFR1-22-SPP-DM1 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
MuFR1-23-SPP-DM1 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HuFR1-23-SPP-DM1 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
HuMov19-sulfo-SPDB-DM4 (DAR3.8) ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
FR1-21-sulfo-SPDB-DM4 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
Mov19-sulfo-SPDB-DM4 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
Farletuzumab-sulfo-SPDB-DM4 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
FR1-48-sulfo-SPDB-DM4 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
FR1-49-sulfo-SPDB-DM4 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
FR1-57-sulfo-SPDB-DM4 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
FR1-65-sulfo-SPDB-DM4 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
HuMOV19v1.6-sulfo-SPDB-DM4 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
HuMOV19v1.0-sulfo-SPDB-DM4 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
HuFR1-21-sulfo-SPDB-DM4 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
MuFR1-21-sulfo-SPDB-DM4 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
MuFR1-9-sulfo-SPDB-DM4 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
MuFR1-13-sulfo-SPDB-DM4 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
MuFR1-22-sulfo-SPDB-DM4 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
MuFR1-23-sulfo-SPDB-DM4 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
HuFR1-23-sulfo-SPDB-DM4 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
HuMov19-SPDB-DM4 ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
FR1-21-SPDB-DM4 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Mov19-SPDB-DM4 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Farletuzumab-SPDB-DM4 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
FR1-48-SPDB-DM4 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
FR1-49-SPDB-DM4 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
FR1-57-SPDB-DM4 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
FR1-65-SPDB-DM4 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuMOV19v1.6-SPDB-DM4 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuMOV19v1.0-SPDB-DM4 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuFR1-21-SPDB-DM4 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
MuFR1-21-SPDB-DM4 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
MuFR1-9-SPDB-DM4 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
MuFR1-13-SPDB-DM4 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
MuFR1-22-SPDB-DM4 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
MuFR1-23-SPDB-DM4 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuFR1-23-SPDB-DM4 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
HuMov19-3-sulfo-Mal-DM4 (DAR 3.7) ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
FR1-21-3-sulfo-Mal-DM4 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
Mov19-3-sulfo-Mal-DM4 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
Farletuzumab-3-sulfo-Mal-DM4 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
FR1-48-3-sulfo-Mal-DM4 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
FR1-49-3-sulfo-Mal-DM4 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
FR1-57-3-sulfo-Mal-DM4 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
FR1-65-3-sulfo-Mal-DM4 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
HuMOV19v1.6-3-sulfo-Mal-DM4 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
HuMOV19v1.0-3-sulfo-Mal-DM4 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
HuFR1-21-3-sulfo-Mal-DM4 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
MuFR1-21-3-sulfo-Mal-DM4 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
MuFR1-9-3-sulfo-Mal-DM4 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
MuFR1-13-3-sulfo-Mal-DM4 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
MuFR1-22-3-sulfo-Mal-DM4 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
MuFR1-23-3-sulfo-Mal-DM4 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
HuFR1-23-3-sulfo-Mal-DM4 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
HuMov19-PEG4-Mal-DM4 ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
FR1-21-PEG4-Mal-DM4 ^[227]	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
Mov19-PEG4-Mal-DM4 ^[227]	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
Farletuzumab-PEG4-Mal-DM4 ^[227]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
FR1-48-PEG4-Mal-DM4 ^[227]	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
FR1-49-PEG4-Mal-DM4 ^[227]	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
FR1-57-PEG4-Mal-DM4 ^[227]	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
FR1-65-PEG4-Mal-DM4 ^[227]	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
HuMOV19v1.6-PEG4-Mal-DM4 ^[227]	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
HuMOV19v1.0-PEG4-Mal-DM4 ^[227]	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
HuFR1-21-PEG4-Mal-DM4 ^[227]	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
MuFR1-21-PEG4-Mal-DM4 ^[227]	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
MuFR1-9-PEG4-Mal-DM4 ^[227]	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
MuFR1-13-PEG4-Mal-DM4 ^[227]	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
MuFR1-22-PEG4-Mal-DM4 ^[227]	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
MuFR1-23-PEG4-Mal-DM4 ^[227]	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
HuFR1-23-PEG4-Mal-DM4 ^[227]	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	ADC Info
HuMov19-3-sulfo-Mal-DM4 (DAR 8.23) ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
HuMov19-sulfo-SPDB-DM4 (DAR6.8) ^[227]	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
M9346A-SMCC-DM1 ^[227]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
M9346A-SPP-DM1 ^[227]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
M9346A-sulfo-Mal-DM4 ^[227]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	ADC Info
M9346A-SPDB-DM4 ^[227]	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
1C1-mcMMAF ^[228]	Anti-EPHA2 mAb 1C1	Ephrin type-A receptor 2 (EPHA2)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
LCB14-0648 ^[229]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	LCB14-0648 linker	ADC Info
LCB14-0663 ^[229]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	LCB14-0663 linker	ADC Info
LCB14-0664 ^[229]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	LCB14-0664 linker	ADC Info
LCB14-6e ^[229]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	LCB14-6e linker	ADC Info
Anti-CD19(LC)-G7VIM-2i ^[229]	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Anti-CD19(LC)-G7VIM-2i linker	ADC Info
Blinatumomab-2i ^[229]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin F	Blinatumomab-2i linker	ADC Info
Inebilizumab-2i ^[229]	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Inebilizumab-2i linker	ADC Info
Tafasitamab-2i ^[229]	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Tafasitamab-2i linker	ADC Info
Obexelimab-2i ^[229]	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Obexelimab-2i linker	ADC Info
MDX-1342-2i ^[229]	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1342-2i linker	ADC Info
MDX-1435-2i ^[229]	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1435-2i linker	ADC Info
CHD37-2i ^[229]	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	cHD37-2i linker	ADC Info
AFM-11-2i ^[229]	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-11-2i linker	ADC Info
AFM-12-2i ^[229]	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-12-2i linker	ADC Info
GBR401-2i ^[229]	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	GBR401-2i linker	ADC Info
Denintuzumab-2i ^[229]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Denintuzumab-2i linker	ADC Info
Anti-CD19(LC)-G7VIM-4i ^[229]	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Anti-CD19(LC)-G7VIM-4i linker	ADC Info
Blinatumomab-4i ^[229]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin F	Blinatumomab-4i linker	ADC Info
Inebilizumab-4i ^[229]	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Inebilizumab-4i linker	ADC Info
Tafasitamab-4i ^[229]	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Tafasitamab-4i linker	ADC Info
Obexelimab-4i ^[229]	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Obexelimab-4i linker	ADC Info
MDX-1342-4i ^[229]	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1342-4i linker	ADC Info
MDX-1435-4i ^[229]	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1435-4i linker	ADC Info
CHD37-4i ^[229]	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	cHD37-4i linker	ADC Info
AFM-11-4i ^[229]	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-11-4i linker	ADC Info
AFM-12-4i ^[229]	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-12-4i linker	ADC Info
GBR401-4i ^[229]	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	GBR401-4i linker	ADC Info
Denintuzumab-4i ^[229]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Denintuzumab-4i linker	ADC Info
Anti-CD19(LC)-G7VIM-3i ^[229]	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Anti-CD19(LC)-G7VIM-3i linker	ADC Info
Blinatumomab-3i ^[229]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin F	Blinatumomab-3i linker	ADC Info
Inebilizumab-3i ^[229]	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Inebilizumab-3i linker	ADC Info
Tafasitamab-3i ^[229]	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Tafasitamab-3i linker	ADC Info
Obexelimab-3i ^[229]	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Obexelimab-3i linker	ADC Info
MDX-1342-3i ^[229]	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1342-3i linker	ADC Info
MDX-1435-3i ^[229]	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1435-3i linker	ADC Info
CHD37-3i ^[229]	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	cHD37-3i linker	ADC Info
AFM-11-3i ^[229]	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-11-3i linker	ADC Info
AFM-12-3i ^[229]	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-12-3i linker	ADC Info
GBR401-3i ^[229]	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	GBR401-3i linker	ADC Info
Denintuzumab-3i ^[229]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Denintuzumab-3i linker	ADC Info
Anti-CD19(LC)-G7VIM-6e ^[229]	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Anti-CD19(LC)-G7VIM-6e linker	ADC Info
Blinatumomab-6e ^[229]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-6e linker	ADC Info
Inebilizumab-6e ^[229]	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Inebilizumab-6e linker	ADC Info
Tafasitamab-6e ^[229]	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Tafasitamab-6e linker	ADC Info
Obexelimab-6e ^[229]	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Obexelimab-6e linker	ADC Info
MDX-1342-6e ^[229]	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	MDX-1342-6e linker	ADC Info
MDX-1435-6e ^[229]	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	MDX-1435-6e linker	ADC Info
CHD37-6e ^[229]	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	cHD37-6e linker	ADC Info
AFM-11-6e ^[229]	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	AFM-11-6e linker	ADC Info
AFM-12-6e ^[229]	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	AFM-12-6e linker	ADC Info
GBR401-6e ^[229]	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	GBR401-6e linker	ADC Info
Denintuzumab-6e ^[229]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Denintuzumab-6e linker	ADC Info
ADC14-0810 ^[230]	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	ADC14-0810 linker	ADC Info
LCB14-0645 ^[230]	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	LCB14-0645 linker	ADC Info
Cetuximab (LC)-2i ^[230]	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC)-2i linker	ADC Info
Cetuximab (LC) G7-CVIM-3i ^[230]	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC) G7-CVIM-3i linker	ADC Info
Cetuximab (LV) G7-CVIM-3i ^[230]	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LV) G7-CVIM-3i linker	ADC Info
Cetuximab (LC)-3i ^[230]	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC)-3i linker	ADC Info
Cetuximab (LC) G7-CVIM-4i ^[230]	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC) G7-CVIM-4i linker	ADC Info
Cetuximab (LV) G7-CVIM-4i ^[230]	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LV) G7-CVIM-4i linker	ADC Info
Cetuximab (LC)-4i ^[230]	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC)-4i linker	ADC Info
Cetuximab (LC) G7-CVIM-6e ^[230]	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab(LC) G7-CVIM-6e linker	ADC Info
Cetuximab (LV) G7-CVIM-6e ^[230]	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab(LV) G7-CVIM-6e linker	ADC Info
Cetuximab (LC)-6e ^[230]	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab(LC)-6e linker	ADC Info
MYK-3 ^[231]	BA03	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BA03-MC-MMAE ^[231]	BA03	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BA03-MCC-MMAE ^[231]	BA03	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-DM1 ^[232]	TF-mAb-SC1	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H29-DM1 ^[232]	TF-mAb-H29	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H30-DM1 ^[232]	TF-mAb-H30	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H31-DM1 ^[232]	TF-mAb-H31	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H32-DM1 ^[232]	TF-mAb-H32	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H33-DM1 ^[232]	TF-mAb-H33	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H34-DM1 ^[232]	TF-mAb-H34	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H35-DM1 ^[232]	TF-mAb-H35	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H36-DM1 ^[232]	TF-mAb-H36	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H37-DM1 ^[232]	TF-mAb-H37	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H38-DM1 ^[232]	TF-mAb-H38	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H39-DM1 ^[232]	TF-mAb-H39	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H40-DM1 ^[232]	TF-mAb-H40	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H41-DM1 ^[232]	TF-mAb-H41	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H42-DM1 ^[232]	TF-mAb-H42	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H43-DM1 ^[232]	TF-mAb-H43	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H44-DM1 ^[232]	TF-mAb-H44	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H45-DM1 ^[232]	TF-mAb-H45	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H46-DM1 ^[232]	TF-mAb-H46	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H47-DM1 ^[232]	TF-mAb-H47	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-H48-DM1 ^[232]	TF-mAb-H48	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TF-mAb-MMAE ^[232]	TF-mAb-SC1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H29-MMAE ^[232]	TF-mAb-H29	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H30-MMAE ^[232]	TF-mAb-H30	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H31-MMAE ^[232]	TF-mAb-H31	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H32-MMAE ^[232]	TF-mAb-H32	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H33-MMAE ^[232]	TF-mAb-H33	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H34-MMAE ^[232]	TF-mAb-H34	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H35-MMAE ^[232]	TF-mAb-H35	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H36-MMAE ^[232]	TF-mAb-H36	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H37-MMAE ^[232]	TF-mAb-H37	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H38-MMAE ^[232]	TF-mAb-H38	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H39-MMAE ^[232]	TF-mAb-H39	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H40-MMAE ^[232]	TF-mAb-H40	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H41-MMAE ^[232]	TF-mAb-H41	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H42-MMAE ^[232]	TF-mAb-H42	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H43-MMAE ^[232]	TF-mAb-H43	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H44-MMAE ^[232]	TF-mAb-H44	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H45-MMAE ^[232]	TF-mAb-H45	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H46-MMAE ^[232]	TF-mAb-H46	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H47-MMAE ^[232]	TF-mAb-H47	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TF-mAb-H48-MMAE ^[232]	TF-mAb-H48	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RGCLN18.2-MC-Val-Cit-PAB-MMAE ^[233]	RGCLN18.2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RGCLN18.2-D07-Val-Cit-PAB-MMAE ^[233]	RGCLN18.2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	D07-Val-Cit-PABC	ADC Info
RGCLN18.2-PY-Val-Cit-PAB-MMAE ^[233]	RGCLN18.2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	PY-VC-PABC	ADC Info
IMAB362-MC-Val-Cit-PAB-MMAE ^[233]	IMAB362	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2017089895A1 ADC1 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC1 linker	ADC Info
WO2017089895A1 ADC2 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC2 linker	ADC Info
WO2017089895A1 ADC3 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC3 linker	ADC Info
WO2017089895A1 ADC4 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC4 linker	ADC Info
WO2017089895A1 ADC5 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC5 linker	ADC Info
WO2017089895A1 ADC6 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC6 linker	ADC Info
WO2017089895A1 ADC7 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC7 linker	ADC Info
WO2017089895A1 ADC8 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC8 linker	ADC Info
WO2017089895A1 ADC9 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC9 linker	ADC Info
WO2017089895A1 ADC10 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC10 linker	ADC Info
WO2017089895A1 ADC11 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC11 linker	ADC Info
WO2017089895A1 ADC12 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC12 linker	ADC Info
WO2017089895A1 ADC13 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC13 linker	ADC Info
WO2017089895A1 ADC14 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC14 linker	ADC Info
WO2017089895A1 ADC15 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC15 linker	ADC Info
WO2017089895A1 ADC16 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC16 linker	ADC Info
WO2017089895A1 ADC17 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC17 linker	ADC Info
WO2017089895A1 ADC18 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC18 linker	ADC Info
WO2017089895A1 ADC19 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC19 linker	ADC Info
WO2017089895A1 ADC20 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC20 linker	ADC Info
WO2017089895A1 ADC86 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC86 linker	ADC Info
WO2017089895A1 ADC87 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC87 linker	ADC Info
WO2017089895A1 ADC23 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC23 linker	ADC Info
WO2017089895A1 ADC24 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC24 linker	ADC Info
WO2017089895A1 ADC25 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC25 linker	ADC Info
WO2017089895A1 ADC26 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC26 linker	ADC Info
WO2017089895A1 ADC27 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC27 linker	ADC Info
WO2017089895A1 ADC28 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC28 linker	ADC Info
WO2017089895A1 ADC29 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC29 linker	ADC Info
WO2017089895A1 ADC30 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC30 linker	ADC Info
WO2017089895A1 ADC31 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC31 linker	ADC Info
WO2017089895A1 ADC32 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC32 linker	ADC Info
WO2017089895A1 ADC33 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC33 linker	ADC Info
WO2017089895A1 ADC34 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC34 linker	ADC Info
WO2017089895A1 ADC35 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC35 linker	ADC Info
WO2017089895A1 ADC36 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC36 linker	ADC Info
WO2017089895A1 ADC37 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC37 linker	ADC Info
WO2017089895A1 ADC38 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC38 linker	ADC Info
WO2017089895A1 ADC39 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC39 linker	ADC Info
WO2017089895A1 ADC40 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC40 linker	ADC Info
WO2017089895A1 ADC41 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC41 linker	ADC Info
WO2017089895A1 ADC42 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC42 linker	ADC Info
WO2017089895A1 ADC43 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC43 linker	ADC Info
WO2017089895A1 ADC44 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC44 linker	ADC Info
WO2017089895A1 ADC45 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC45 linker	ADC Info
WO2017089895A1 ADC46 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC46 linker	ADC Info
WO2017089895A1 ADC47 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC47 linker	ADC Info
WO2017089895A1 ADC48 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC48 linker	ADC Info
WO2017089895A1 ADC49 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC49 linker	ADC Info
WO2017089895A1 ADC50 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC50 linker	ADC Info
WO2017089895A1 ADC51 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC51 linker	ADC Info
WO2017089895A1 ADC52 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC52 linker	ADC Info
WO2017089895A1 ADC53 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC53 linker	ADC Info
WO2017089895A1 ADC54 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC54 linker	ADC Info
WO2017089895A1 ADC55 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC55 linker	ADC Info
WO2017089895A1 ADC76 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC76 linker	ADC Info
WO2017089895A1 ADC88 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC88 linker	ADC Info
WO2017089895A1 ADC89 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC89 linker	ADC Info
WO2017089895A1 ADC90 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC90 linker	ADC Info
WO2017089895A1 ADC91 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC91 linker	ADC Info
WO2017089895A1 ADC60 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC60 linker	ADC Info
WO2017089895A1 ADC61 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC61 linker	ADC Info
WO2017089895A1 ADC62 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC62 linker	ADC Info
WO2017089895A1 ADC63 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089895A1_ADC63 linker	ADC Info
WO2017089895A1 ADC77 ^[234]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089895A1_ADC77 linker	ADC Info
WO2017089895A1 ADC64 ^[234]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089895A1_ADC64 linker	ADC Info
WO2017089895A1 ADC65 ^[234]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	WO2017089895A1_ADC65 linker	ADC Info
WO2017089895A1 ADC66 ^[234]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089895A1_ADC66 linker	ADC Info
WO2017089895A1 ADC67 ^[234]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089895A1_ADC67 linker	ADC Info
WO2017089895A1 ADC68 ^[234]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	WO2017089895A1_ADC68 linker	ADC Info
WO2017089895A1 ADC69 ^[234]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089895A1_ADC69 linker	ADC Info
WO2017089895A1 ADC70 ^[234]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089895A1_ADC70 linker	ADC Info
WO2017089895A1 ADC71 ^[234]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	WO2017089895A1_ADC71 linker	ADC Info
WO2017089895A1 ADC72 ^[234]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089895A1_ADC72 linker	ADC Info
WO2017089895A1 ADC73 ^[234]	Depatuxizumab	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin F	WO2017089895A1_ADC73 linker	ADC Info
WO2017089895A1 ADC74 ^[234]	Depatuxizumab	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	WO2017089895A1_ADC74 linker	ADC Info
WO2017089895A1 ADC75 ^[234]	Depatuxizumab	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin F	WO2017089895A1_ADC75 linker	ADC Info
WO2021044208A1 ADC2 ^[235]	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC2 linker	ADC Info
WO2021044208A1 ADC3 ^[235]	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC3 linker	ADC Info
WO2021044208A1 ADC4 ^[235]	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC4 linker	ADC Info
WO2021044208A1 ADC5 ^[235]	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC5 linker	ADC Info
WO2021044208A1 ADC9 ^[235]	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC9 linker	ADC Info
WO2021044208A1 ADC10 ^[235]	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC10 linker	ADC Info
WO2021044208A1 ADC 2A2-4 ^[235]	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC 2A2-4 linker	ADC Info
WO2021044208A1 ADC 2A2-5 ^[235]	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC 2A2-5 linker	ADC Info
WO2021044208A1 ADC AB4-2 ^[235]	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC AB4-2 linker	ADC Info
WO2021044208A1 ADC AB4-3 ^[235]	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC AB4-3 linker	ADC Info
WO2021044208A1 ADC AB4-4 ^[235]	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC AB4-4 linker	ADC Info
WO2021044208A1 ADC AB4-5 ^[235]	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC AB4-5 linker	ADC Info
WO2021044208A1 ADC A2F2-2 ^[235]	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC A2F2-2 linker	ADC Info
WO2021044208A1 ADC A2F2-3 ^[235]	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2-3 linker	ADC Info
WO2021044208A1 ADC A2F2-4 ^[235]	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2-4 linker	ADC Info
WO2021044208A1 ADC A2F2-5 ^[235]	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2-5 linker	ADC Info
WO2021044208A1 ADC A2F3-2 ^[235]	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC A2F3-2 linker	ADC Info
WO2021044208A1 ADC A2F3-3 ^[235]	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F3-3 linker	ADC Info
WO2021044208A1 ADC A2F3-4 ^[235]	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F3-4 linker	ADC Info
WO2021044208A1 ADC A2F3-5 ^[235]	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F3-5 linker	ADC Info
WO2021044208A1 ADC BA6-2 ^[235]	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC BA6-2 linker	ADC Info
WO2021044208A1 ADC BA6-3 ^[235]	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC BA6-3 linker	ADC Info
WO2021044208A1 ADC BA6-4 ^[235]	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC BA6-4 linker	ADC Info
WO2021044208A1 ADC BA6-5 ^[235]	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC BA6-5 linker	ADC Info
WO2021044208A1 ADC CC9-2 ^[235]	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC CC9-2 linker	ADC Info
WO2021044208A1 ADC CC9-3 ^[235]	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC CC9-3 linker	ADC Info
WO2021044208A1 ADC CC9-4 ^[235]	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC CC9-4 linker	ADC Info
WO2021044208A1 ADC CC9-5 ^[235]	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC CC9-5 linker	ADC Info
WO2021044208A1 ADC DG6-2 ^[235]	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC DG6-2 linker	ADC Info
WO2021044208A1 ADC DG6-3 ^[235]	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC DG6-3 linker	ADC Info
WO2021044208A1 ADC DG6-4 ^[235]	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC DG6-4 linker	ADC Info
WO2021044208A1 ADC DG6-5 ^[235]	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC DG6-5 linker	ADC Info
WO2021044208A1 ADC D2B12-2 ^[235]	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC D2B12-2 linker	ADC Info
WO2021044208A1 ADC D2B12-3 ^[235]	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC D2B12-3 linker	ADC Info
WO2021044208A1 ADC D2B12-4 ^[235]	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC D2B12-4 linker	ADC Info
WO2021044208A1 ADC D2B12-5 ^[235]	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC D2B12-5 linker	ADC Info
WO2021044208A1 ADC A2F2 M1-2 ^[235]	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC A2F2 M1-2 linker	ADC Info
WO2021044208A1 ADC A2F2 M1-3 ^[235]	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2 M1-3 linker	ADC Info
WO2021044208A1 ADC A2F2 M1-4 ^[235]	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2 M1-4 linker	ADC Info
WO2021044208A1 ADC A2F2 M1-5 ^[235]	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2 M1-5 linker	ADC Info
WO2007011968A2 cAC10-9a ^[236]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	WO2007011968A2_cAC10-9a linker	ADC Info
WO2007011968A2 c1F6-9a ^[236]	Anti-CD70 mAb c1F6	CD70 antigen (CD70)	Monomethyl auristatin E	WO2007011968A2_c1F6-9a linker	ADC Info
WO2007011968A2 cAC10-9b ^[236]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin F	WO2007011968A2_cAC10-9b linker	ADC Info
WO2007011968A2 c1F6-9b ^[236]	Anti-CD70 mAb c1F6	CD70 antigen (CD70)	Monomethyl auristatin F	WO2007011968A2_c1F6-9b linker	ADC Info
WO2015095755A1 h1F6-1.3 ^[237]	Anti-CD70 mAb h1F6	CD70 antigen (CD70)	Monomethyl auristatin E	WO2015095755A1_h1F6-1.3 linker	ADC Info
WO2015095755A1 cAC10-1.3 ^[237]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	WO2015095755A1_cAC10-1.3 linker	ADC Info
WO2015095755A1 h1F6-2.0 ^[237]	Anti-CD70 mAb h1F6	CD70 antigen (CD70)	Monomethyl auristatin E	WO2015095755A1_h1F6-2.0 linker	ADC Info
WO2015095755A1 cAC10-2.0 ^[237]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	WO2015095755A1_cAC10-2.0 linker	ADC Info
AAJ8D6-Mc-Val-Cit-MMAE ^[238]	AAJ8D6	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AAJ8D6-D07-Val-Cit-PAB-MMAE ^[238]	AAJ8D6	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AAJ8D6-PY-Val-Cit-MMAE ^[238]	AAJ8D6	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	PY-VC-PABC	ADC Info
ABT-700-Mc-Val-Cit-MMAE ^[238]	Telisotuzumab	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LgG1-Mc-Val-Cit-MMAE ^[238]	Anti-MET lgG1	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RC88-PY-MAA-Val-Cit-PAB-MMAE ^[239]	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RC88-PY-MAA-Val-Cit-PAB-MMAD ^[239]	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
RC88-Mc-Val-Cit-PAB-MMAE ^[239]	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RC88-Mc-Val-Cit-PAB-MMAD ^[239]	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
hBU12-mcMMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
hBU12-MC-vc-PABC-MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hBU12-MC-vc-PABC-MMAF DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hBU12-1 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Dpr-MA	ADC Info
hBU12-1 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Dpr-MA	ADC Info
hBU12-2 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MA	ADC Info
hBU12-2 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MA	ADC Info
hBU12-3 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Dpr-MA	ADC Info
hBU12-3 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Dpr-MA	ADC Info
hBU12-4 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MA	ADC Info
hBU12-4 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MA	ADC Info
hBU12-5 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MDpr	ADC Info
hBU12-5 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MDpr	ADC Info
hBU12-6 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MDpr	ADC Info
hBU12-6 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MDpr	ADC Info
hBU12-7 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Lys-MDpr	ADC Info
hBU12-7 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Lys-MDpr	ADC Info
hBU12-8 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thiazole-Glu-Lys-MDpr	ADC Info
hBU12-9 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-EDA-MDpr	ADC Info
hBU12-10 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-EDA-MDpr	ADC Info
hBU12-11 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Ile-EDA-MDpr	ADC Info
hBU12-12 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Ile-EDA-MDpr	ADC Info
hBU12-13 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thiazole-Glu-EDA-MDpr	ADC Info
hBU12-14 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asp-Ala-Lys-MDpr	ADC Info
hBU12-15 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Lys-MDpr	ADC Info
hBU12-16 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	PhosphoThr-Ala-Lys-MDpr	ADC Info
hBU12-17 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asn-AlaGlu-Dpr-MDpr	ADC Info
hBU12-18 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-19 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asp-AlaGlu-Dpr-MDpr	ADC Info
hBU12-20 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-21 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	hSer-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-22 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	ValoH-AlaGlu-Dpr-MDpr	ADC Info
hBU12-23 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	PhosphoThr-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-24 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Pyrazole-Glu-Dpr-MDpr	ADC Info
hBU12-25 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Triazole-Glu-Dpr-MDpr	ADC Info
hBU12-26 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asn-Glu-Dpr-MDpr	ADC Info
hBU12-27 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asp-Glu-Dpr-MDpr	ADC Info
hBU12-28 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Fur-Glu-Dpr-MDpr	ADC Info
hBU12-29 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	ValOH-Glu-Dpr-MDpr	ADC Info
hBU12-30 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Ser-Glu-Dpr-MDpr	ADC Info
hBU12-31 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	hSer-Glu-Dpr-MDpr	ADC Info
hBU12-32 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-IleLeu-Dpr-MDpr	ADC Info
hBU12-33 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Ile-Leu-Dpr-MDpr	ADC Info
hBU12-34 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Phe-Leu-Dpr-MDpr	ADC Info
hBU12-35 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-LeuPhe-Dpr-MDpr	ADC Info
hBU12-36 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Leu-Phe-Dpr-MDpr	ADC Info
hBU12-37 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Phe-Phe-Dpr-MDpr	ADC Info
hBU12-38 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-LysAla-Dpr-MDpr	ADC Info
hBU12-39 MMAE ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Lys-Dpr-MDpr	ADC Info
hBU12-1 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Dpr-MA	ADC Info
hBU12-2 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Glu-Dpr-MA	ADC Info
hBU12-3 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Dpr-MA	ADC Info
hBU12-4 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-Dpr-MA	ADC Info
hBU12-5 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Glu-Dpr-MDpr	ADC Info
hBU12-6 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-Dpr-MDpr	ADC Info
hBU12-7 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-Lys-MDpr	ADC Info
hBU12-8 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thiazole-Glu-Lys-MDpr	ADC Info
hBU12-9 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Glu-EDA-MDpr	ADC Info
hBU12-10 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-EDA-MDpr	ADC Info
hBU12-11 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Ile-EDA-MDpr	ADC Info
hBU12-12 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Ile-EDA-MDpr	ADC Info
hBU12-13 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thiazole-Glu-EDA-MDpr	ADC Info
hBU12-14 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asp-Ala-Lys-MDpr	ADC Info
hBU12-15 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Ala-Lys-MDpr	ADC Info
hBU12-16 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	PhosphoThr-Ala-Lys-MDpr	ADC Info
hBU12-17 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asn-AlaGlu-Dpr-MDpr	ADC Info
hBU12-18 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-19 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asp-AlaGlu-Dpr-MDpr	ADC Info
hBU12-20 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-21 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	hSer-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-22 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	ValoH-AlaGlu-Dpr-MDpr	ADC Info
hBU12-23 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	PhosphoThr-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-24 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Pyrazole-Glu-Dpr-MDpr	ADC Info
hBU12-25 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Triazole-Glu-Dpr-MDpr	ADC Info
hBU12-26 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asn-Glu-Dpr-MDpr	ADC Info
hBU12-27 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asp-Glu-Dpr-MDpr	ADC Info
hBU12-28 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Fur-Glu-Dpr-MDpr	ADC Info
hBU12-29 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	ValOH-Glu-Dpr-MDpr	ADC Info
hBU12-30 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Ser-Glu-Dpr-MDpr	ADC Info
hBU12-31 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	hSer-Glu-Dpr-MDpr	ADC Info
hBU12-32 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-IleLeu-Dpr-MDpr	ADC Info
hBU12-33 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Ile-Leu-Dpr-MDpr	ADC Info
hBU12-34 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Phe-Leu-Dpr-MDpr	ADC Info
hBU12-35 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-LeuPhe-Dpr-MDpr	ADC Info
hBU12-36 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Leu-Phe-Dpr-MDpr	ADC Info
hBU12-37 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Phe-Phe-Dpr-MDpr	ADC Info
hBU12-38 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-LysAla-Dpr-MDpr	ADC Info
hBU12-39 MMAF ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Lys-Dpr-MDpr	ADC Info
hBU12-MC-vc-PABC-MMAF DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hBU12-13 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thiazole-Glu-EDA-MDpr	ADC Info
hBU12-12 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Ile-EDA-MDpr	ADC Info
hBU12-11 MMAE DAR8 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Ile-EDA-MDpr	ADC Info
hBU12-17 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asn-AlaGlu-Dpr-MDpr	ADC Info
hBU12-20 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Glu-Dpr-MDpr	ADC Info
hBU12-24 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Pyrazole-Glu-Dpr-MDpr	ADC Info
hBU12-29 MMAE DAR4 ^[240]	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	ValOH-Glu-Dpr-MDpr	ADC Info
hL49-ADC ^[241]	Humanized Anti-CD228 SGN-CD228A mAb	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_27D_Ala-ADC ^[241]	hL49_27D_Ala	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_27D_Gln-ADC ^[241]	hL49_27D_Gln	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_27D_Tyr-ADC ^[241]	hL49_27D_Tyr	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_34_Ala-ADC ^[241]	hL49_34_Ala	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_34_Gln-ADC ^[241]	hL49_34_Gln	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_34_Tyr-ADC ^[241]	hL49_34_Tyr	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_3x_Ala-ADC ^[241]	hL49_3x_Ala	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_3x_Gln-ADC ^[241]	hL49_3x_Gln	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
hL49_3x_Tyr-ADC ^[241]	hL49_3x_Tyr	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	ADC Info
M69-MMAE ^[242]	Anti-Matriptase mAb M69	Suppressor of tumorigenicity 14 protein (ST14)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Zapadcine-1 ^[243]	Zaptuzumab	Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)	Monomethyl auristatin D	PY-VC-PABC	ADC Info
Wild type nBT062-DM4 ^[244]	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Half nBT062-DM4 ^[244]	Indatuximab (C226S + C229S)	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Stable nBT062-DM4 ^[244]	Indatuximab (S228P + R409K)	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Bispecific nBT062-natalizumab-DM4 ^[244]	Bispecific nBT062-natalizumab	Syndecan-1 (SDC1); Integrin alpha-4 (ITGA4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
ScFvF7-Fc-vcMMAE ^[245]	Anti-FGFR2 scFv ECD_FGFR2	Fibroblast growth factor receptor 2 (FGFR2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Alpha-CD30-7 ^[246]	Anti-CD30 mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin 7	Glucuronide quaternary ammonium linker 7	ADC Info
Alpha-CD30-8 ^[246]	Anti-CD30 mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin 8	Glucuronide quaternary ammonium linker 8	ADC Info
Alpha-CD30-9 ^[246]	Anti-CD30 mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin 9	Glucuronide quaternary ammonium linker 9	ADC Info
VCit ADC 3a ^[247]	Anti-HER2 mAb glutamine 295 (Q295)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	DBCO-PEG-VCit-PABC	ADC Info
EVCit ADC 3c ^[247]	Anti-HER2 mAb glutamine 295 (Q295)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	DBCO-PEG-EVCit-PABC	ADC Info
EGFR-MMAU ADC ^[248]	Cetuximab	Epidermal growth factor receptor (EGFR)	Glucuronyl-monomethyl-auristatin E (MMAU)	Mc-Val-Cit-PABC	ADC Info
HER2-MMAU ADC ^[248]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Glucuronyl-monomethyl-auristatin E (MMAU)	Mc-Val-Cit-PABC	ADC Info
GABRP Ab-DM1 ADC ^[249]	GABRP-Ab	Gamma-aminobutyric acid receptor subunit pi (GABRP)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-alpha10-SAP ^[250]	Anti-integrin alpha10 mAb	Integrin alpha-10 (ITGA10)	Saporin	Undisclosed	ADC Info
ADC Mil40-6 ^[251]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Silyl ether-based linker	ADC Info
Anti-CXCR4 ADC 513 ^[252]	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 518 ^[252]	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 510 ^[252]	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 519 ^[252]	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 381 ^[252]	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 553 ^[252]	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 554 ^[252]	Anti-CXCR4 mAb h17-NS	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 555 ^[252]	Anti-CXCR4 mAb h17-NQ	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 556 ^[252]	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	ADC Info
Anti-CXCR4 ADC 669 ^[252]	Anti-CXCR4 mAb h17-NQ	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 670 ^[252]	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 671 ^[252]	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 672 ^[252]	Anti-CXCR4 mAb h17-NS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 711 ^[252]	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 712 ^[252]	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 713 ^[252]	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Anti-CXCR4 ADC 714 ^[252]	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	ADC Info
Cetux Cys-vc-MMAE ^[184]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cetux Fab-vc-MMAE ^[184]	Cetuximab Fab (conjugate to glycan residues)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cetux Fc/Fab-vc-MMAE ^[184]	Cetuximab (Fc/Fab labeled with Neu5NAz)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ScFvGPIIb/IIIa-MMAE ^[253]	Anti-ITGA2B scFv	Integrin beta-3 (ITGB3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
MMAE-9F7-F11 ADC ^[254]	Anti-HER3 mAb 9F7-F11	Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RBGO1-mcF ^[255]	Anti-RAGE mAb RBGO1	Advanced glycosylation end product-specific receptor (AGER)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
TTZ-1-MMAE ^[256]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DSPh-Val-Ala-PABC	ADC Info
TTZ-2-MMAE ^[256]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DSPh-Val-Cit-PABC	ADC Info
TTZ-3-MMAE ^[256]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DSPh-PEG12-Val-Ala-PABC	ADC Info
TTZ-4-MMAE ^[256]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DSPh-PEG12-Val-Cit-PABC	ADC Info
Trastuzumab-DVP-linker-MMAE 1 ^[257]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DVP-based linker 1f	ADC Info
Trastuzumab-Val-Cit linker-MMAE 2 ^[257]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Val-Cit linker 2e	ADC Info
Trastuzumab-DVP-linker-MMAE 3 ^[257]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DVP-based linker 3	ADC Info
Trastuzumab-DVP-linker-MMAE 4 ^[257]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DVP-based linker 4	ADC Info
B10v5 225-M-vc-MMAE ^[258]	B10v5 225-M	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B10v5 225-H-vc-MMAE ^[258]	B10v5 225-H	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B10 225-M-vc-MMAE ^[258]	B10 225-M	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Cetuximab-vc-MMAE ^[258]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Mil40-15 ^[202]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-PABC	ADC Info
M25ADCMMAF ^[259]	Anti-ALPPL2 mAb M25	Alkaline phosphatase, germ cell type (ALPG)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
M25ADCMMAE ^[259]	Anti-ALPPL2 mAb M25	Alkaline phosphatase, germ cell type (ALPG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FOLR1-Mal-PEG2-Val-Cit-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2-Val-Cit-PABC	ADC Info
FOLR1-Mal-PEG8-Val-Cit-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG8-Val-Cit-PABC	ADC Info
FOLR1-Mal-Caproyl-Val-Cit-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Maleimide-Caproyl-Val-Cit-PABC	ADC Info
FOLR1-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2-Ala-Ala-Asn-PABC	ADC Info
FOLR1-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC	ADC Info
FOLR1-Mal-PEG4-tria-PEG3-Sulfo-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG4-triazole-PEG3-Sulfonamide	ADC Info
FOLR1-Mal-PEG2-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2	ADC Info
FOLR1-Mal-PEG4-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG4	ADC Info
FOLR1-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG4-Val-Cit-PABC	ADC Info
FOLR1-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC	ADC Info
FOLR1-Suc/SPAAC-PEG3-Sulfonamide-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG3-Sulfonamide	ADC Info
FOLR1-Suc/SPAAC-PEG2-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG2	ADC Info
FOLR1-Suc/SPAAC-PEG4-Eribulin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG4	ADC Info
FOLR1-Mal-PEG-Val-Cit-PABC-Cryptophycin ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Cryptophycin	Mal-PEG-Val-Cit-PABC	ADC Info
FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAE ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Monomethyl auristatin E	Maleimide-Caproyl-Val-Cit-PABC	ADC Info
FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAF ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Monomethyl auristatin F	Maleimide-Caproyl-Val-Cit-PABC	ADC Info
MSLN-Mal-PEG2-Val-Cit-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG2-Val-Cit-PABC	ADC Info
MSLN-Mal-PEG8-Val-Cit-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG8-Val-Cit-PABC	ADC Info
MSLN-Mal-Caproyl-Val-Cit-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Maleimide-Caproyl-Val-Cit-PABC	ADC Info
MSLN-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG2-Ala-Ala-Asn-PABC	ADC Info
MSLN-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC	ADC Info
MSLN-Mal-PEG4-tria-PEG3-Sulfo-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG4-triazole-PEG3-Sulfonamide	ADC Info
MSLN-Mal-PEG2-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG2	ADC Info
MSLN-Mal-PEG4-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG4	ADC Info
MSLN-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG4-Val-Cit-PABC	ADC Info
MSLN-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC	ADC Info
MSLN-Suc/SPAAC-PEG3-Sulfonamide-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG3-Sulfonamide	ADC Info
MSLN-Suc/SPAAC-PEG2-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG2	ADC Info
MSLN-Suc/SPAAC-PEG4-Eribulin ^[260]	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG4	ADC Info
MSLN-Mal-PEG-Val-Cit-PABC-Cryptophycin ^[260]	Amatuximab	Mesothelin (MSLN)	Cryptophycin	Mal-PEG-Val-Cit-PABC	ADC Info
MSLN-Mal-Caproyl-Val-Cit-PABC-MMAE ^[260]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Maleimide-Caproyl-Val-Cit-PABC	ADC Info
MSLN-Mal-Caproyl-Val-Cit-PABC-MMAF ^[260]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin F	Maleimide-Caproyl-Val-Cit-PABC	ADC Info
Farletuzumab-sulfo SPDB-DM4 ^[260]	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	ADC Info
Crown Ether ADC 4a ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	6-Amino-alpha-cyclodextrin-Val-Cit-PABC	ADC Info
Crown Ether ADC 4b ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	6-Amino-beta-cyclodextrin-Val-Cit-PABC	ADC Info
Crown Ether ADC 4c ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	6-Amino-gama-cyclodextrin-Val-Cit-PABC	ADC Info
Crown Ether ADC 4d ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	3-Amino-alpha-cyclodextrin-Val-Cit-PABC	ADC Info
Crown Ether ADC 4e ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	3-Amino-beta-cyclodextrin-Val-Cit-PABC	ADC Info
Crown Ether ADC 4f ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	3-Amino-gama-cyclodextrin-Val-Cit-PABC	ADC Info
Crown Ether ADC 5a ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	1-Aza-24-crown-8-Val-Cit-PABC	ADC Info
Crown Ether ADC 5b ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	1-Aza-42-crown-14-Val-Cit-PABC	ADC Info
Crown Ether ADC 6a ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	PEG(8u)-Val-Cit-PABC	ADC Info
Crown Ether ADC 6b ^[261]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	PEG(24u)-Val-Cit-PABC	ADC Info
Ch14.18-MMAE ^[262]	Anti-GD2 mAb ch14.18	Ganglioside GD2 (GD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Ch14.18-MMAF ^[262]	Anti-GD2 mAb ch14.18	Ganglioside GD2 (GD2)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
HER2-acetal-ADC 11 ^[263]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Clravable-acetal based linker 11	ADC Info
HER2-acetal-ADC 12 ^[263]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Clravable-TAMRA-acetal based linker 12	ADC Info
HER2-azide-alkyne MMAE conjugate ^[264]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Azide-alkyne based linker 10a	ADC Info
HER2-cyclopropene-tetrazine MMAE conjugate ^[264]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Cyclopropene-tetrazine based linker 10b	ADC Info
HER2-norbornene-tetrazine MMAE conjugate ^[264]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Norbornene-tetrazine based linker 10c	ADC Info
5E3-Saporin ADC ^[265]	Anti-SEMA4A mAb 5E3	Semaphorin-4A (SEMA4A)	Saporin	Undisclosed	ADC Info
5E3-vedotin ^[265]	Anti-SEMA4A mAb 5E3	Semaphorin-4A (SEMA4A)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
5E3-emtansine ^[265]	Anti-SEMA4A mAb 5E3	Semaphorin-4A (SEMA4A)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Trastuzumab biosimilar mil40 12a ^[266]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleamic methyl ester-based Val-Ala-PABC linker 12a	ADC Info
Trastuzumab biosimilar mil40 12b ^[266]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleamic methyl ester-based Val-Ala-PABC linker 12b	ADC Info
Trastuzumab biosimilar mil40 12c ^[266]	Mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleamic methyl ester-based Val-Cit-PABC linker 12c	ADC Info
T-FcBP-DM1 ^[267]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	N-terminal norbornene group pFcBP linker	ADC Info
T-D8-1508 ^[268]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	AZ-1508	Cysteine D8	ADC Info
T-D6-1508 ^[268]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	AZ-1508	Cysteine D6	ADC Info
T-D4-1508 ^[268]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	AZ-1508	Cysteine D4	ADC Info
T-D2-1508 ^[268]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	AZ-1508	Cysteine D2	ADC Info
N-D8-1508 ^[268]	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	AZ-1508	Cysteine D8	ADC Info
N-D6-1508 ^[268]	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	AZ-1508	Cysteine D6	ADC Info
N-D4-1508 ^[268]	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	AZ-1508	Cysteine D4	ADC Info
N-D2-1508 ^[268]	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)	AZ-1508	Cysteine D2	ADC Info
THL4-mpeoDM1 ^[269]	Anti-DLL4 mAb THL4 (V207C, A121C)	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	ADC Info
TH2-mpeoDM1 ^[269]	Anti-DLL4 mAb TH2 (A121C)	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	ADC Info
TL2-mpeoDM1 ^[269]	Anti-DLL4 mAb TL2 (V207C)	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	ADC Info
THL4-vcMMAE ^[269]	Anti-DLL4 mAb THL4 (V207C, A121C)	Delta-like protein 4 (DLL4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H3L2-mpeoDM1 ^[269]	Anti-DLL4 mAb H3L2	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	ADC Info
CTX-MMAE ^[270]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	PD-Val-Cit-PABC	ADC Info
H32-DM1_3.0 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
H32-DM1_3.3 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
H32-DM1_3.7 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
H32-DM1_3.8 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
H32-VCMMAE_2.1 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H32-VCMMAE_3.2 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H32-VCMMAE_3.8 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H32-VCMMAE_6.6 ^[271]	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HER2 ADC-18 ^[272]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Vinylsulfonamide based linker 15	ADC Info
HER2 ADC-19 ^[272]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Vinylsulfonamide based linker 16	ADC Info
HER2 ADC-20 ^[272]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Vinylsulfonamide based linker 17	ADC Info
EGFR ADC-21 ^[272]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Vinylsulfonamide based linker 15	ADC Info
EGFR ADC-22 ^[272]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Vinylsulfonamide based linker 16	ADC Info
EGFR ADC-23 ^[272]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Vinylsulfonamide based linker 17	ADC Info
T-DM1-IR700 ^[273]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1 plus IRDye700DX	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Trastuzumab I253Q-MMAE ^[274]	Trastuzumab I253Q	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Dansylcadaverine-BCN based linker	ADC Info
Trastuzumab deglycosylated WT-MMAE ^[274]	Trastuzumab I253Q	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Dansylcadaverine deglycosylated-BCN based linker	ADC Info
HER2-gsADC-1 ^[275]	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	ThioPz linker 6a	ADC Info
HER2-gsADC-2 ^[275]	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	2-Aminobenzamide oxime	ADC Info
HER2-gsADC-3 ^[275]	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Hydroxylamine derivative 6c	ADC Info
HER2-gsADC-4 ^[275]	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6n	ADC Info
HER2-gsADC-5 ^[275]	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Azadibenzocylooctyne-amine derivative 6d	ADC Info
HER2-gsADC-6 ^[275]	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Bicyclononyne derivative 6e	ADC Info
HER2-gsADC-7 ^[275]	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6m	ADC Info
HER2-gsADC-8 ^[275]	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6r	ADC Info
HER2-gsADC-9 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Linear alkyne 6f	ADC Info
HER2-gsADC-10 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6g	ADC Info
HER2-gsADC-11 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6h	ADC Info
HER2-gsADC-12 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6i	ADC Info
HER2-gsADC-13 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6j	ADC Info
HER2-gsADC-14 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6k	ADC Info
HER2-gsADC-15 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6l	ADC Info
HER2-gsADC-16 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6m	ADC Info
HER2-gsADC-17 ^[275]	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Noncleavable linker 6t	ADC Info
HER2-gsADC-18 ^[275]	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	ThioPz linker 6a	ADC Info
HER2-gsADC-19 ^[275]	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	2-Aminobenzamide oxime	ADC Info
HER2-gsADC-20 ^[275]	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Hydroxylamine derivative 6c	ADC Info
HER2-gsADC-21 ^[275]	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6n	ADC Info
HER2-gsADC-22 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Linear alkyne 6f	ADC Info
HER2-gsADC-23 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6g	ADC Info
HER2-gsADC-24 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6h	ADC Info
HER2-gsADC-25 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6i	ADC Info
HER2-gsADC-26 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6j	ADC Info
HER2-gsADC-27 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6k	ADC Info
HER2-gsADC-28 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6l	ADC Info
HER2-gsADC-29 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6m	ADC Info
HER2-gsADC-30 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6o	ADC Info
HER2-gsADC-31 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6p	ADC Info
HER2-gsADC-32 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6q	ADC Info
HER2-gsADC-33 ^[275]	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6r	ADC Info
HER2-gsADC-34 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Linear alkyne 6f	ADC Info
HER2-gsADC-35 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6g	ADC Info
HER2-gsADC-36 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6h	ADC Info
HER2-gsADC-37 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6i	ADC Info
HER2-gsADC-38 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6j	ADC Info
HER2-gsADC-39 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6k	ADC Info
HER2-gsADC-40 ^[275]	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6l	ADC Info
HER2-gsADC-41 ^[275]	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Bicyclononyne derivative 6e	ADC Info
HER2-gsADC-42 ^[275]	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6l	ADC Info
HER2-gsADC-43 ^[275]	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEGylation linker 6m	ADC Info
HER2-gsADC-44 ^[275]	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Noncleavable linker 6s	ADC Info
HER2-gsADC-45 ^[275]	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Noncleavable linker 6t	ADC Info
HER2-gsADC-46 ^[275]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	ThioPz linker 6a	ADC Info
HER2-gsADC-47 ^[275]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Hydroxylamine derivative 6c	ADC Info
HER2-gsADC-48 ^[275]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	2-Aminobenzamide oxime	ADC Info
HER2-gsADC-49 ^[275]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Azadibenzocylooctyne-amine derivative 6d	ADC Info
HER2-gsADC-50 ^[275]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	2-Aminobenzamidoxime without core-fucosylation	ADC Info
T-DM1-2.6 ^[275]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
AXL02-MMAE ^[276]	Anti-AXL mAb AXL02	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NOV0712-DM4 ^[277]	Anti-CDH6 mAb NOV0712	Cadherin-6 (CDH6)	Mertansine DM4	Sulfo-SPDB	ADC Info
H01L02-DM4 ^[277]	Anti-CDH6 mAb H01L02	Cadherin-6 (CDH6)	Mertansine DM4	Sulfo-SPDB	ADC Info
hu4DFabv7-BMPEO-DM1 ^[278]	hu4DFabv7	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv7-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (A121C)-BMPEO-DM1 ^[278]	hu4DFabv8 (A121C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (A121C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (V110C)-BMPEO-DM1 ^[278]	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (V110C)-BMPEO-DM1 linker	ADC Info
Thio-Tr (A121C)-BMPEO-DM1 ^[278]	Thio-Tr (A121C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	Thio-Tr (A121C)-BMPEO-DM1 linker	ADC Info
2H9-A121C-BMPEO-DM1 ^[278]	Anti-HER2 antibody 2H9-A121C	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	2H9-A121C-BMPEO-DM1 linker	ADC Info
Thio-3A5 (A121C)-BMPEO-DM1 ^[278]	Thio-3A5 (A121C)	Mucin-16 (MUC16)	Maytansinoid DM1	Thio-3A5 (A121C)-BMPEO-DM1 linker	ADC Info
Anti-MUC16 antibody 3A5-BMPEO-DM1 ^[278]	Anti-MUC16 antibody 3A5	Mucin-16 (MUC16)	Maytansinoid DM1	Anti-MUC16 antibody 3A5-BMPEO-DM1 linker	ADC Info
Thio-Tmab-BMPEO-DM1 ^[278]	Thio-Tmab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	Thio-Tmab-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (V110C)-MC-MMAF ^[278]	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
hu4DFabv8 (V110C)-MC-MMAE ^[278]	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleimido-caproyl	ADC Info
hu4DFabv8 (V110C)-MC-Val-Cit-PAB-MMAF ^[278]	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
hu4DFabv8 (V110C)-MC-Val-Cit-PAB-MMAE ^[278]	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hu4DFabv8 (L-V15C)-BMPEO-DM1 ^[278]	hu4DFabv8 (L-V15C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (L-V15C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (L-A43C)-BMPEO-DM1 ^[278]	hu4DFabv8 (L-A43C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (L-A43C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (L-A144C)-BMPEO-DM1 ^[278]	hu4DFabv8 (L-A144C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (L-A144C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (L-S168C)-BMPEO-DM1 ^[278]	hu4DFabv8 (L-S168C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (L-S168C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (H-A40C)-BMPEO-DM1 ^[278]	hu4DFabv8 (H-A40C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (H-A40C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (H-A88C)-BMPEO-DM1 ^[278]	hu4DFabv8 (H-A88C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (H-A88C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (H-S119C)-BMPEO-DM1 ^[278]	hu4DFabv8 (H-S119C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (H-S119C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (H-S122C)-BMPEO-DM1 ^[278]	hu4DFabv8 (H-S122C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (H-S122C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (H-A175C)-BMPEO-DM1 ^[278]	hu4DFabv8 (H-A175C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (H-A175C)-BMPEO-DM1 linker	ADC Info
hu4DFabv8 (H-S179C)-BMPEO-DM1 ^[278]	hu4DFabv8 (H-S179C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Maytansinoid DM1	hu4DFabv8 (H-S179C)-BMPEO-DM1 linker	ADC Info
WO2017089890A1 ADC1 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC1 linker	ADC Info
WO2017089890A1 ADC2 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC2 linker	ADC Info
WO2017089890A1 ADC3 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC3 linker	ADC Info
WO2017089890A1 ADC4 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC4 linker	ADC Info
WO2017089890A1 ADC5 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC5 linker	ADC Info
WO2017089890A1 ADC6 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC6 linker	ADC Info
WO2017089890A1 ADC7 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC7 linker	ADC Info
WO2017089890A1 ADC8 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC8 linker	ADC Info
WO2017089890A1 ADC9 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC9 linker	ADC Info
WO2017089890A1 ADC10 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC10 linker	ADC Info
WO2017089890A1 ADC11 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC11 linker	ADC Info
WO2017089890A1 ADC12 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC12 linker	ADC Info
WO2017089890A1 ADC13 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC13 linker	ADC Info
WO2017089890A1 ADC14 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC14 linker	ADC Info
WO2017089890A1 ADC15 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC15 linker	ADC Info
WO2017089890A1 ADC16 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC16 linker	ADC Info
WO2017089890A1 ADC17 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC17 linker	ADC Info
WO2017089890A1 ADC18 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC18 linker	ADC Info
WO2017089890A1 ADC19 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC19 linker	ADC Info
WO2017089890A1 ADC20 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC20 linker	ADC Info
WO2017089890A1 ADC86 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC86 linker	ADC Info
WO2017089890A1 ADC87 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC87 linker	ADC Info
WO2017089890A1 ADC23 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC23 linker	ADC Info
WO2017089890A1 ADC24 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC24 linker	ADC Info
WO2017089890A1 ADC25 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC25 linker	ADC Info
WO2017089890A1 ADC26 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC26 linker	ADC Info
WO2017089890A1 ADC27 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC27 linker	ADC Info
WO2017089890A1 ADC28 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC28 linker	ADC Info
WO2017089890A1 ADC29 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC29 linker	ADC Info
WO2017089890A1 ADC30 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC30 linker	ADC Info
WO2017089890A1 ADC31 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC31 linker	ADC Info
WO2017089890A1 ADC32 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC32 linker	ADC Info
WO2017089890A1 ADC33 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC33 linker	ADC Info
WO2017089890A1 ADC34 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC34 linker	ADC Info
WO2017089890A1 ADC35 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC35 linker	ADC Info
WO2017089890A1 ADC36 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC36 linker	ADC Info
WO2017089890A1 ADC37 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC37 linker	ADC Info
WO2017089890A1 ADC38 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC38 linker	ADC Info
WO2017089890A1 ADC39 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC39 linker	ADC Info
WO2017089890A1 ADC40 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC40 linker	ADC Info
WO2017089890A1 ADC41 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC41 linker	ADC Info
WO2017089890A1 ADC42 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC42 linker	ADC Info
WO2017089890A1 ADC43 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC43 linker	ADC Info
WO2017089890A1 ADC44 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC44 linker	ADC Info
WO2017089890A1 ADC45 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC45 linker	ADC Info
WO2017089890A1 ADC46 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC46 linker	ADC Info
WO2017089890A1 ADC47 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC47 linker	ADC Info
WO2017089890A1 ADC48 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC48 linker	ADC Info
WO2017089890A1 ADC49 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC49 linker	ADC Info
WO2017089890A1 ADC50 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC50 linker	ADC Info
WO2017089890A1 ADC51 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC51 linker	ADC Info
WO2017089890A1 ADC52 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC52 linker	ADC Info
WO2017089890A1 ADC53 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC53 linker	ADC Info
WO2017089890A1 ADC54 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC54 linker	ADC Info
WO2017089890A1 ADC55 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC55 linker	ADC Info
WO2017089890A1 ADC76 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC76 linker	ADC Info
WO2017089890A1 ADC88 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC88 linker	ADC Info
WO2017089890A1 ADC89 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC89 linker	ADC Info
WO2017089890A1 ADC90 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC90 linker	ADC Info
WO2017089890A1 ADC91 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC91 linker	ADC Info
WO2017089890A1 ADC60 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC60 linker	ADC Info
WO2017089890A1 ADC61 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC61 linker	ADC Info
WO2017089890A1 ADC62 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC62 linker	ADC Info
WO2017089890A1 ADC63 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	WO2017089890A1_ADC63 linker	ADC Info
WO2017089890A1 ADC77 ^[279]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	WO2017089890A1_ADC77 linker	ADC Info
WO2017089890A1 ADC64 ^[279]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC64 linker	ADC Info
WO2017089890A1 ADC65 ^[279]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	WO2017089890A1_ADC65 linker	ADC Info
WO2017089890A1 ADC66 ^[279]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC66 linker	ADC Info
WO2017089890A1 ADC67 ^[279]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089890A1_ADC67 linker	ADC Info
WO2017089890A1 ADC68 ^[279]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	WO2017089890A1_ADC68 linker	ADC Info
WO2017089890A1 ADC69 ^[279]	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089890A1_ADC69 linker	ADC Info
WO2017089890A1 ADC70 ^[279]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089890A1_ADC70 linker	ADC Info
WO2017089890A1 ADC71 ^[279]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	WO2017089890A1_ADC71 linker	ADC Info
WO2017089890A1 ADC72 ^[279]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089890A1_ADC72 linker	ADC Info
WO2017089890A1 ADC73 ^[279]	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC73 linker	ADC Info
WO2017089890A1 ADC74 ^[279]	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	WO2017089890A1_ADC74 linker	ADC Info
WO2017089890A1 ADC75 ^[279]	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC75 linker	ADC Info
Anti-BCMA 15B2GL-mcMMAF ^[280]	Anti-BCMA antibody 15B2GL	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA 15B2WT-mcMMAF ^[280]	Anti-BCMA antibody 15B2WT	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA I09-mcMMAF ^[280]	Anti-BCMA antibody I09	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA L15-mcMMAF ^[280]	Anti-BCMA antibody L15	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA M02-mcMMAF ^[280]	Anti-BCMA antibody M02	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA N22-mcMMAF ^[280]	Anti-BCMA antibody N22	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA P10-mcMMAF ^[280]	Anti-BCMA antibody P10	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Anti-BCMA J6M0-mcMMAF ^[280]	Anti-BCMA antibody J6M0	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
2C3 WT-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 WT	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2C3 A114N-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 A114N	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2C3 Y436S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 Y436S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2C3 S440N-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 S440N	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2C3 S442N-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 S442N	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2C3 NGT-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 NGT	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2C3 S298N Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 2C3 S298N Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TEM1 Clone 187 WT-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-TEM1 mAb Clone 187 WT	Endosialin (CD248)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
TEM1 Clone 187 A114N-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-TEM1 mAb Clone 187 A114N	Endosialin (CD248)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HER2 WT-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-HER2 mAb WT	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
A114N-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-HER2 mAb A114N	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NNAS-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-HER2 mAb NNAS	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
A114N NNAS-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-HER2 mAb A114N NNAS	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HER2 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-HER2 mAb S298N/T299A/Y300S	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H66-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-TRAC mAb H66	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H66 S298N/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-TRAC mAb H66 S298N/Y300S	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H66 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-TRAC mAb H66 S298N/T299A/Y300S	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H66 N297Q/S298N/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-TRAC mAb H66 N297Q/S298N/Y300S	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
12G6 WT-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 12G6 WT	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
12G6 S298N/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 12G6 S298N/Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
12G6 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 12G6 S298N/T299A/Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
12G6 N297Q/S298N/Y300S-Mc-Val-Cit-PABC-MMAE ^[281]	Anti-CD52 mAb 12G6 N297Q/S298N/Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-HER-AO-Cys-MC-VC-PABC-MMAE ^[281]	Anti-HER2 mAb WT	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER-AO-Cys-MC-VC-PABC-MMAE linker	ADC Info
Anti-FAP B11-MC-VC-PABC-MMAE ^[281]	Anti-FAP mAb B11	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	Anti-FAP B11-MC-VC-PABC-MMAE linker	ADC Info
Anti-FAP B11-AO-Cys-MC-VC-PABC-MMAE ^[281]	Anti-FAP mAb B11	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	Anti-FAP B11-AO-Cys-MC-VC-PABC-MMAE linker	ADC Info
huPr1-vcMMAE ^[282]	Anti-TMEFF2 mAb huPr1	Tomoregulin-2 (TMEFF2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2015177360A1 ADC-wt-vcMMAE ^[283]	Anti-PSMA mAb wt	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2015177360A1 ADC-HC41-vcMMAE ^[283]	Anti-PSMA mAb wt HC S41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2015177360A1 ADC-LC40-vcMMAE ^[283]	Anti-PSMA mAb wt LC P40C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2015177360A1 ADC-LC41-vcMMAE ^[283]	Anti-PSMA mAb wt LC G41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2015177360A1 ADC-H8-HC40-vcMMAE ^[283]	Anti-5T4 mAb H8 S40C	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2015177360A1 ADC-wt-mcMMAF ^[283]	Anti-PSMA mAb wt	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
WO2015177360A1 ADC-HC41-mcMMAF ^[283]	Anti-PSMA mAb wt HC S41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
WO2015177360A1 ADC-LC40-mcMMAF ^[283]	Anti-PSMA mAb wt LC P40C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
WO2015177360A1 ADC-LC41-mcMMAF ^[283]	Anti-PSMA mAb wt LC G41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
WO2015177360A1 ADC-H8-wt-mcMMAF ^[283]	Anti-5T4 mAb H8 wt	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
WO2015177360A1 ADC-H8-HC40-mcMMAF ^[283]	Anti-5T4 mAb H8 S40C	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
h3G10.A57-h3G10 vcMMAD ^[284]	h3G10.A57-h3G10	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
h3G10.A57-h3G10 vc0101 ^[284]	h3G10.A57-h3G10	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
h3G10.A57-h3G10.2.72 vcMMAD ^[284]	h3G10.A57-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
h3G10.A57-h3G10.2.72 vc0101 ^[284]	h3G10.A57-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
h3G10.1.91-h3G10.2.72 vcMMAD ^[284]	h3G10.1.91-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
h3G10.1.91-h3G10.2.72 vc0101 ^[284]	h3G10.1.91-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
h3G10.2.37-h3G10.2.72 vcMMAD ^[284]	h3G10.2.37-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
h3G10.2.37-h3G10.2.72 vc0101 ^[284]	h3G10.2.37-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
H3G10.A57-h3G10.A58 vcMMAD ^[284]	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
H3G10.A57-h3G10.A58 vc0101 ^[284]	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
H3G10.1.91-h3G10.A58 vcMMAD ^[284]	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
H3G10.1.91-h3G10.A58 vc0101 ^[284]	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
H3G10.2.37-h3G10.A58 vcMMAD ^[284]	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
H3G10.2.37-h3G10.A58 vc0101 ^[284]	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
H3G10.A57-h3G10.A58 vcMMAD ^[284]	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
H3G10.A57-h3G10.A58 vc0101 ^[284]	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
H3G10.1.91-h3G10.A58 vcMMAD ^[284]	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
H3G10.1.91-h3G10.A58 vc0101 ^[284]	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
H3G10.2.37-h3G10.A58 vcMMAD ^[284]	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
H3G10.2.37-h3G10.A58 vc0101 ^[284]	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
3G10-TG6-vcMMAD ^[284]	3G10-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
6B6-TG6-vcMMAD ^[284]	6B6-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
12A11-TG6-vcMMAD ^[284]	12A11-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	ADC Info
3G10-TG6-vc0101 ^[284]	3G10-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
6B6-TG6-vc0101 ^[284]	6B6-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
Trastuzumab-Compound 9 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Trastuzumab-Compound 9 linker	ADC Info
Pertuzumab-Compound 9 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Pertuzumab-Compound 9 linker	ADC Info
Rituximab-Compound 9 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Rituximab-Compound 9 linker	ADC Info
Alemtuzumab-Compound 9 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM1	Alemtuzumab-Compound 9 linker	ADC Info
Bevacizumab-Compound 9 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM1	Bevacizumab-Compound 9 linker	ADC Info
Adalimumab-Compound 9 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Adalimumab-Compound 9 linker	ADC Info
Cetuximab-Compound 9 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Cetuximab-Compound 9 linker	ADC Info
Amatuximab-Compound 9 ^[285]	Amatuximab	Mesothelin (MSLN)	Mertansine DM1	Amatuximab-Compound 9 linker	ADC Info
Blinatumomab-Compound 9 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Mertansine DM1	Blinatumomab-Compound 9 linker	ADC Info
Brentuximab-Compound 9 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Brentuximab-Compound 9 linker	ADC Info
Sacituzumab-Compound 9 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Sacituzumab-Compound 9 linker	ADC Info
Panitumumab-Compound 9 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Panitumumab-Compound 9 linker	ADC Info
Nimotuzumab-Compound 9 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Nimotuzumab-Compound 9 linker	ADC Info
Gemtuzumab-Compound 9 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM1	Gemtuzumab-Compound 9 linker	ADC Info
Golimumab-Compound 9 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Golimumab-Compound 9 linker	ADC Info
Ibritumomab-Compound 9 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ibritumomab-Compound 9 linker	ADC Info
Infliximab-Compound 9 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM1	Infliximab-Compound 9 linker	ADC Info
Ipilimumab-Compound 9 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Ipilimumab-Compound 9 linker	ADC Info
Ofatumumab-Compound 9 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ofatumumab-Compound 9 linker	ADC Info
Tositumomab-Compound 9 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Tositumomab-Compound 9 linker	ADC Info
Trastuzumab-Compound 17 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Trastuzumab-Compound 17 linker	ADC Info
Pertuzumab-Compound 17 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Pertuzumab-Compound 17 linker	ADC Info
Rituximab-Compound 17 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Rituximab-Compound 17 linker	ADC Info
Alemtuzumab-Compound 17 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM4	Alemtuzumab-Compound 17 linker	ADC Info
Bevacizumab-Compound 17 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM4	Bevacizumab-Compound 17 linker	ADC Info
Adalimumab-Compound 17 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Adalimumab-Compound 17 linker	ADC Info
Cetuximab-Compound 17 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Cetuximab-Compound 17 linker	ADC Info
Amatuximab-Compound 17 ^[285]	Amatuximab	Mesothelin (MSLN)	Mertansine DM4	Amatuximab-Compound 17 linker	ADC Info
Blinatumomab-Compound 17 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Mertansine DM4	Blinatumomab-Compound 17 linker	ADC Info
Brentuximab-Compound 17 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM4	Brentuximab-Compound 17 linker	ADC Info
Sacituzumab-Compound 17 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM4	Sacituzumab-Compound 17 linker	ADC Info
Panitumumab-Compound 17 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Panitumumab-Compound 17 linker	ADC Info
Nimotuzumab-Compound 17 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Nimotuzumab-Compound 17 linker	ADC Info
Gemtuzumab-Compound 17 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM4	Gemtuzumab-Compound 17 linker	ADC Info
Golimumab-Compound 17 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Golimumab-Compound 17 linker	ADC Info
Ibritumomab-Compound 17 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ibritumomab-Compound 17 linker	ADC Info
Infliximab-Compound 17 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM4	Infliximab-Compound 17 linker	ADC Info
Ipilimumab-Compound 17 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM4	Ipilimumab-Compound 17 linker	ADC Info
Ofatumumab-Compound 17 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ofatumumab-Compound 17 linker	ADC Info
Tositumomab-Compound 17 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Tositumomab-Compound 17 linker	ADC Info
Trastuzumab-Compound 25 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Trastuzumab-Compound 25 linker	ADC Info
Pertuzumab-Compound 25 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pertuzumab-Compound 25 linker	ADC Info
Rituximab-Compound 25 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 25 linker	ADC Info
Alemtuzumab-Compound 25 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 25 linker	ADC Info
Bevacizumab-Compound 25 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 25 linker	ADC Info
Adalimumab-Compound 25 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 25 linker	ADC Info
Cetuximab-Compound 25 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 25 linker	ADC Info
Amatuximab-Compound 25 ^[285]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 25 linker	ADC Info
Blinatumomab-Compound 25 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-Compound 25 linker	ADC Info
Brentuximab-Compound 25 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 25 linker	ADC Info
Sacituzumab-Compound 25 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 25 linker	ADC Info
Panitumumab-Compound 25 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 25 linker	ADC Info
Nimotuzumab-Compound 25 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 25 linker	ADC Info
Gemtuzumab-Compound 25 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 25 linker	ADC Info
Golimumab-Compound 25 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 25 linker	ADC Info
Ibritumomab-Compound 25 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 25 linker	ADC Info
Infliximab-Compound 25 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 25 linker	ADC Info
Ipilimumab-Compound 25 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 25 linker	ADC Info
Ofatumumab-Compound 25 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 25 linker	ADC Info
Tositumomab-Compound 25 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 25 linker	ADC Info
Trastuzumab-Compound 31 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Trastuzumab-Compound 31 linker	ADC Info
Pertuzumab-Compound 31 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Pertuzumab-Compound 31 linker	ADC Info
Rituximab-Compound 31 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Rituximab-Compound 31 linker	ADC Info
Alemtuzumab-Compound 31 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Auristatin 0101	Alemtuzumab-Compound 31 linker	ADC Info
Bevacizumab-Compound 31 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Auristatin 0101	Bevacizumab-Compound 31 linker	ADC Info
Adalimumab-Compound 31 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Adalimumab-Compound 31 linker	ADC Info
Cetuximab-Compound 31 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Cetuximab-Compound 31 linker	ADC Info
Amatuximab-Compound 31 ^[285]	Amatuximab	Mesothelin (MSLN)	Auristatin 0101	Amatuximab-Compound 31 linker	ADC Info
Blinatumomab-Compound 31 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Auristatin 0101	Blinatumomab-Compound 31 linker	ADC Info
Brentuximab-Compound 31 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin 0101	Brentuximab-Compound 31 linker	ADC Info
Sacituzumab-Compound 31 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	Sacituzumab-Compound 31 linker	ADC Info
Panitumumab-Compound 31 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Panitumumab-Compound 31 linker	ADC Info
Nimotuzumab-Compound 31 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Nimotuzumab-Compound 31 linker	ADC Info
Gemtuzumab-Compound 31 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Auristatin 0101	Gemtuzumab-Compound 31 linker	ADC Info
Golimumab-Compound 31 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Golimumab-Compound 31 linker	ADC Info
Ibritumomab-Compound 31 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ibritumomab-Compound 31 linker	ADC Info
Infliximab-Compound 31 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Auristatin 0101	Infliximab-Compound 31 linker	ADC Info
Ipilimumab-Compound 31 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Auristatin 0101	Ipilimumab-Compound 31 linker	ADC Info
Ofatumumab-Compound 31 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ofatumumab-Compound 31 linker	ADC Info
Tositumomab-Compound 31 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Tositumomab-Compound 31 linker	ADC Info
Trastuzumab-Compound 36 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Trastuzumab-Compound 36 linker	ADC Info
Pertuzumab-Compound 36 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pertuzumab-Compound 36 linker	ADC Info
Rituximab-Compound 36 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 36 linker	ADC Info
Alemtuzumab-Compound 36 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 36 linker	ADC Info
Bevacizumab-Compound 36 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 36 linker	ADC Info
Adalimumab-Compound 36 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 36 linker	ADC Info
Cetuximab-Compound 36 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 36 linker	ADC Info
Amatuximab-Compound 36 ^[285]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 36 linker	ADC Info
Blinatumomab-Compound 36 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-Compound 36 linker	ADC Info
Brentuximab-Compound 36 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 36 linker	ADC Info
Sacituzumab-Compound 36 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 36 linker	ADC Info
Panitumumab-Compound 36 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 36 linker	ADC Info
Nimotuzumab-Compound 36 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 36 linker	ADC Info
Gemtuzumab-Compound 36 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 36 linker	ADC Info
Golimumab-Compound 36 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 36 linker	ADC Info
Ibritumomab-Compound 36 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 36 linker	ADC Info
Infliximab-Compound 36 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 36 linker	ADC Info
Ipilimumab-Compound 36 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 36 linker	ADC Info
Ofatumumab-Compound 36 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 36 linker	ADC Info
Tositumomab-Compound 36 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 36 linker	ADC Info
Trastuzumab-Compound 55 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Trastuzumab-Compound 55 linker	ADC Info
Pertuzumab-Compound 55 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Pertuzumab-Compound 55 linker	ADC Info
Rituximab-Compound 55 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Rituximab-Compound 55 linker	ADC Info
Alemtuzumab-Compound 55 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM1	Alemtuzumab-Compound 55 linker	ADC Info
Bevacizumab-Compound 55 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM1	Bevacizumab-Compound 55 linker	ADC Info
Adalimumab-Compound 55 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Adalimumab-Compound 55 linker	ADC Info
Cetuximab-Compound 55 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Cetuximab-Compound 55 linker	ADC Info
Amatuximab-Compound 55 ^[285]	Amatuximab	Mesothelin (MSLN)	Mertansine DM1	Amatuximab-Compound 55 linker	ADC Info
Blinatumomab-Compound 55 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Mertansine DM1	Blinatumomab-Compound 55 linker	ADC Info
Brentuximab-Compound 55 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Brentuximab-Compound 55 linker	ADC Info
Sacituzumab-Compound 55 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Sacituzumab-Compound 55 linker	ADC Info
Panitumumab-Compound 55 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Panitumumab-Compound 55 linker	ADC Info
Nimotuzumab-Compound 55 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Nimotuzumab-Compound 55 linker	ADC Info
Gemtuzumab-Compound 55 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM1	Gemtuzumab-Compound 55 linker	ADC Info
Golimumab-Compound 55 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Golimumab-Compound 55 linker	ADC Info
Ibritumomab-Compound 55 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ibritumomab-Compound 55 linker	ADC Info
Infliximab-Compound 55 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM1	Infliximab-Compound 55 linker	ADC Info
Ipilimumab-Compound 55 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Ipilimumab-Compound 55 linker	ADC Info
Ofatumumab-Compound 55 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ofatumumab-Compound 55 linker	ADC Info
Tositumomab-Compound 55 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Tositumomab-Compound 55 linker	ADC Info
Trastuzumab-Compound 59 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Trastuzumab-Compound 59 linker	ADC Info
Pertuzumab-Compound 59 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Pertuzumab-Compound 59 linker	ADC Info
Rituximab-Compound 59 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Rituximab-Compound 59 linker	ADC Info
Alemtuzumab-Compound 59 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM4	Alemtuzumab-Compound 59 linker	ADC Info
Bevacizumab-Compound 59 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM4	Bevacizumab-Compound 59 linker	ADC Info
Adalimumab-Compound 59 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Adalimumab-Compound 59 linker	ADC Info
Cetuximab-Compound 59 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Cetuximab-Compound 59 linker	ADC Info
Amatuximab-Compound 59 ^[285]	Amatuximab	Mesothelin (MSLN)	Mertansine DM4	Amatuximab-Compound 59 linker	ADC Info
Blinatumomab-Compound 59 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Mertansine DM4	Blinatumomab-Compound 59 linker	ADC Info
Brentuximab-Compound 59 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM4	Brentuximab-Compound 59 linker	ADC Info
Sacituzumab-Compound 59 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM4	Sacituzumab-Compound 59 linker	ADC Info
Panitumumab-Compound 59 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Panitumumab-Compound 59 linker	ADC Info
Nimotuzumab-Compound 59 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Nimotuzumab-Compound 59 linker	ADC Info
Gemtuzumab-Compound 59 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM4	Gemtuzumab-Compound 59 linker	ADC Info
Golimumab-Compound 59 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Golimumab-Compound 59 linker	ADC Info
Ibritumomab-Compound 59 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ibritumomab-Compound 59 linker	ADC Info
Infliximab-Compound 59 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM4	Infliximab-Compound 59 linker	ADC Info
Ipilimumab-Compound 59 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM4	Ipilimumab-Compound 59 linker	ADC Info
Ofatumumab-Compound 59 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ofatumumab-Compound 59 linker	ADC Info
Tositumomab-Compound 59 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Tositumomab-Compound 59 linker	ADC Info
Trastuzumab-Compound 64 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Trastuzumab-Compound 64 linker	ADC Info
Pertuzumab-Compound 64 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pertuzumab-Compound 64 linker	ADC Info
Rituximab-Compound 64 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 64 linker	ADC Info
Alemtuzumab-Compound 64 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 64 linker	ADC Info
Bevacizumab-Compound 64 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 64 linker	ADC Info
Adalimumab-Compound 64 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 64 linker	ADC Info
Cetuximab-Compound 64 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 64 linker	ADC Info
Amatuximab-Compound 64 ^[285]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 64 linker	ADC Info
Blinatumomab-Compound 64 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-Compound 64 linker	ADC Info
Brentuximab-Compound 64 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 64 linker	ADC Info
Sacituzumab-Compound 64 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 64 linker	ADC Info
Panitumumab-Compound 64 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 64 linker	ADC Info
Nimotuzumab-Compound 64 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 64 linker	ADC Info
Gemtuzumab-Compound 64 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 64 linker	ADC Info
Golimumab-Compound 64 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 64 linker	ADC Info
Ibritumomab-Compound 64 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 64 linker	ADC Info
Infliximab-Compound 64 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 64 linker	ADC Info
Ipilimumab-Compound 64 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 64 linker	ADC Info
Ofatumumab-Compound 64 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 64 linker	ADC Info
Tositumomab-Compound 64 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 64 linker	ADC Info
Trastuzumab-Compound 69 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Trastuzumab-Compound 69 linker	ADC Info
Pertuzumab-Compound 69 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pertuzumab-Compound 69 linker	ADC Info
Rituximab-Compound 69 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 69 linker	ADC Info
Alemtuzumab-Compound 69 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 69 linker	ADC Info
Bevacizumab-Compound 69 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 69 linker	ADC Info
Adalimumab-Compound 69 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 69 linker	ADC Info
Cetuximab-Compound 69 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 69 linker	ADC Info
Amatuximab-Compound 69 ^[285]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 69 linker	ADC Info
Blinatumomab-Compound 69 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-Compound 69 linker	ADC Info
Brentuximab-Compound 69 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 69 linker	ADC Info
Sacituzumab-Compound 69 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 69 linker	ADC Info
Panitumumab-Compound 69 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 69 linker	ADC Info
Nimotuzumab-Compound 69 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 69 linker	ADC Info
Gemtuzumab-Compound 69 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 69 linker	ADC Info
Golimumab-Compound 69 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 69 linker	ADC Info
Ibritumomab-Compound 69 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 69 linker	ADC Info
Infliximab-Compound 69 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 69 linker	ADC Info
Ipilimumab-Compound 69 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 69 linker	ADC Info
Ofatumumab-Compound 69 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 69 linker	ADC Info
Tositumomab-Compound 69 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 69 linker	ADC Info
Trastuzumab-Compound 75 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Trastuzumab-Compound 75 linker	ADC Info
Pertuzumab-Compound 75 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pertuzumab-Compound 75 linker	ADC Info
Rituximab-Compound 75 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 75 linker	ADC Info
Alemtuzumab-Compound 75 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 75 linker	ADC Info
Bevacizumab-Compound 75 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 75 linker	ADC Info
Adalimumab-Compound 75 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 75 linker	ADC Info
Cetuximab-Compound 75 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 75 linker	ADC Info
Amatuximab-Compound 75 ^[285]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 75 linker	ADC Info
Blinatumomab-Compound 75 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-Compound 75 linker	ADC Info
Brentuximab-Compound 75 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 75 linker	ADC Info
Sacituzumab-Compound 75 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 75 linker	ADC Info
Panitumumab-Compound 75 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 75 linker	ADC Info
Nimotuzumab-Compound 75 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 75 linker	ADC Info
Gemtuzumab-Compound 75 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 75 linker	ADC Info
Golimumab-Compound 75 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 75 linker	ADC Info
Ibritumomab-Compound 75 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 75 linker	ADC Info
Infliximab-Compound 75 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 75 linker	ADC Info
Ipilimumab-Compound 75 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 75 linker	ADC Info
Ofatumumab-Compound 75 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 75 linker	ADC Info
Tositumomab-Compound 75 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 75 linker	ADC Info
Trastuzumab-Compound 76 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Trastuzumab-Compound 76 linker	ADC Info
Pertuzumab-Compound 76 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Pertuzumab-Compound 76 linker	ADC Info
Rituximab-Compound 76 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 76 linker	ADC Info
Alemtuzumab-Compound 76 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 76 linker	ADC Info
Bevacizumab-Compound 76 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 76 linker	ADC Info
Adalimumab-Compound 76 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 76 linker	ADC Info
Cetuximab-Compound 76 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 76 linker	ADC Info
Amatuximab-Compound 76 ^[285]	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 76 linker	ADC Info
Blinatumomab-Compound 76 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-Compound 76 linker	ADC Info
Brentuximab-Compound 76 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 76 linker	ADC Info
Sacituzumab-Compound 76 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 76 linker	ADC Info
Panitumumab-Compound 76 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 76 linker	ADC Info
Nimotuzumab-Compound 76 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 76 linker	ADC Info
Gemtuzumab-Compound 76 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 76 linker	ADC Info
Golimumab-Compound 76 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 76 linker	ADC Info
Ibritumomab-Compound 76 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 76 linker	ADC Info
Infliximab-Compound 76 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 76 linker	ADC Info
Ipilimumab-Compound 76 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 76 linker	ADC Info
Ofatumumab-Compound 76 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 76 linker	ADC Info
Tositumomab-Compound 76 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 76 linker	ADC Info
Trastuzumab-Compound 77 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Trastuzumab-Compound 77 linker	ADC Info
Pertuzumab-Compound 77 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Pertuzumab-Compound 77 linker	ADC Info
Rituximab-Compound 77 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Rituximab-Compound 77 linker	ADC Info
Alemtuzumab-Compound 77 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM1	Alemtuzumab-Compound 77 linker	ADC Info
Bevacizumab-Compound 77 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM1	Bevacizumab-Compound 77 linker	ADC Info
Adalimumab-Compound 77 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Adalimumab-Compound 77 linker	ADC Info
Cetuximab-Compound 77 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Cetuximab-Compound 77 linker	ADC Info
Amatuximab-Compound 77 ^[285]	Amatuximab	Mesothelin (MSLN)	Mertansine DM1	Amatuximab-Compound 77 linker	ADC Info
Blinatumomab-Compound 77 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Mertansine DM1	Blinatumomab-Compound 77 linker	ADC Info
Brentuximab-Compound 77 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Brentuximab-Compound 77 linker	ADC Info
Sacituzumab-Compound 77 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Sacituzumab-Compound 77 linker	ADC Info
Panitumumab-Compound 77 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Panitumumab-Compound 77 linker	ADC Info
Nimotuzumab-Compound 77 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Nimotuzumab-Compound 77 linker	ADC Info
Gemtuzumab-Compound 77 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM1	Gemtuzumab-Compound 77 linker	ADC Info
Golimumab-Compound 77 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Golimumab-Compound 77 linker	ADC Info
Ibritumomab-Compound 77 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ibritumomab-Compound 77 linker	ADC Info
Infliximab-Compound 77 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM1	Infliximab-Compound 77 linker	ADC Info
Ipilimumab-Compound 77 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Ipilimumab-Compound 77 linker	ADC Info
Ofatumumab-Compound 77 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ofatumumab-Compound 77 linker	ADC Info
Tositumomab-Compound 77 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Tositumomab-Compound 77 linker	ADC Info
Trastuzumab-Compound 78 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Trastuzumab-Compound 78 linker	ADC Info
Pertuzumab-Compound 78 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Pertuzumab-Compound 78 linker	ADC Info
Rituximab-Compound 78 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Rituximab-Compound 78 linker	ADC Info
Alemtuzumab-Compound 78 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Auristatin 0101	Alemtuzumab-Compound 78 linker	ADC Info
Bevacizumab-Compound 78 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Auristatin 0101	Bevacizumab-Compound 78 linker	ADC Info
Adalimumab-Compound 78 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Adalimumab-Compound 78 linker	ADC Info
Cetuximab-Compound 78 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Cetuximab-Compound 78 linker	ADC Info
Amatuximab-Compound 78 ^[285]	Amatuximab	Mesothelin (MSLN)	Auristatin 0101	Amatuximab-Compound 78 linker	ADC Info
Blinatumomab-Compound 78 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Auristatin 0101	Blinatumomab-Compound 78 linker	ADC Info
Brentuximab-Compound 78 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin 0101	Brentuximab-Compound 78 linker	ADC Info
Sacituzumab-Compound 78 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	Sacituzumab-Compound 78 linker	ADC Info
Panitumumab-Compound 78 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Panitumumab-Compound 78 linker	ADC Info
Nimotuzumab-Compound 78 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Nimotuzumab-Compound 78 linker	ADC Info
Gemtuzumab-Compound 78 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Auristatin 0101	Gemtuzumab-Compound 78 linker	ADC Info
Golimumab-Compound 78 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Golimumab-Compound 78 linker	ADC Info
Ibritumomab-Compound 78 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ibritumomab-Compound 78 linker	ADC Info
Infliximab-Compound 78 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Auristatin 0101	Infliximab-Compound 78 linker	ADC Info
Ipilimumab-Compound 78 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Auristatin 0101	Ipilimumab-Compound 78 linker	ADC Info
Ofatumumab-Compound 78 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ofatumumab-Compound 78 linker	ADC Info
Tositumomab-Compound 78 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Tositumomab-Compound 78 linker	ADC Info
Trastuzumab-Compound 79 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Trastuzumab-Compound 79 linker	ADC Info
Pertuzumab-Compound 79 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Pertuzumab-Compound 79 linker	ADC Info
Rituximab-Compound 79 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Rituximab-Compound 79 linker	ADC Info
Alemtuzumab-Compound 79 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Auristatin 0101	Alemtuzumab-Compound 79 linker	ADC Info
Bevacizumab-Compound 79 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Auristatin 0101	Bevacizumab-Compound 79 linker	ADC Info
Adalimumab-Compound 79 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Adalimumab-Compound 79 linker	ADC Info
Cetuximab-Compound 79 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Cetuximab-Compound 79 linker	ADC Info
Amatuximab-Compound 79 ^[285]	Amatuximab	Mesothelin (MSLN)	Auristatin 0101	Amatuximab-Compound 79 linker	ADC Info
Blinatumomab-Compound 79 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Auristatin 0101	Blinatumomab-Compound 79 linker	ADC Info
Brentuximab-Compound 79 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin 0101	Brentuximab-Compound 79 linker	ADC Info
Sacituzumab-Compound 79 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	Sacituzumab-Compound 79 linker	ADC Info
Panitumumab-Compound 79 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Panitumumab-Compound 79 linker	ADC Info
Nimotuzumab-Compound 79 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Nimotuzumab-Compound 79 linker	ADC Info
Gemtuzumab-Compound 79 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Auristatin 0101	Gemtuzumab-Compound 79 linker	ADC Info
Golimumab-Compound 79 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Golimumab-Compound 79 linker	ADC Info
Ibritumomab-Compound 79 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ibritumomab-Compound 79 linker	ADC Info
Infliximab-Compound 79 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Auristatin 0101	Infliximab-Compound 79 linker	ADC Info
Ipilimumab-Compound 79 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Auristatin 0101	Ipilimumab-Compound 79 linker	ADC Info
Ofatumumab-Compound 79 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ofatumumab-Compound 79 linker	ADC Info
Tositumomab-Compound 79 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Tositumomab-Compound 79 linker	ADC Info
Trastuzumab-Compound 80 ^[285]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Trastuzumab-Compound 80 linker	ADC Info
Pertuzumab-Compound 80 ^[285]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Pertuzumab-Compound 80 linker	ADC Info
Rituximab-Compound 80 ^[285]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Rituximab-Compound 80 linker	ADC Info
Alemtuzumab-Compound 80 ^[285]	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM4	Alemtuzumab-Compound 80 linker	ADC Info
Bevacizumab-Compound 80 ^[285]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM4	Bevacizumab-Compound 80 linker	ADC Info
Adalimumab-Compound 80 ^[285]	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Adalimumab-Compound 80 linker	ADC Info
Cetuximab-Compound 80 ^[285]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Cetuximab-Compound 80 linker	ADC Info
Amatuximab-Compound 80 ^[285]	Amatuximab	Mesothelin (MSLN)	Mertansine DM4	Amatuximab-Compound 80 linker	ADC Info
Blinatumomab-Compound 80 ^[285]	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Mertansine DM4	Blinatumomab-Compound 80 linker	ADC Info
Brentuximab-Compound 80 ^[285]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM4	Brentuximab-Compound 80 linker	ADC Info
Sacituzumab-Compound 80 ^[285]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM4	Sacituzumab-Compound 80 linker	ADC Info
Panitumumab-Compound 80 ^[285]	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Panitumumab-Compound 80 linker	ADC Info
Nimotuzumab-Compound 80 ^[285]	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Nimotuzumab-Compound 80 linker	ADC Info
Gemtuzumab-Compound 80 ^[285]	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM4	Gemtuzumab-Compound 80 linker	ADC Info
Golimumab-Compound 80 ^[285]	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Golimumab-Compound 80 linker	ADC Info
Ibritumomab-Compound 80 ^[285]	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ibritumomab-Compound 80 linker	ADC Info
Infliximab-Compound 80 ^[285]	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM4	Infliximab-Compound 80 linker	ADC Info
Ipilimumab-Compound 80 ^[285]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM4	Ipilimumab-Compound 80 linker	ADC Info
Ofatumumab-Compound 80 ^[285]	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ofatumumab-Compound 80 linker	ADC Info
Tositumomab-Compound 80 ^[285]	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Tositumomab-Compound 80 linker	ADC Info
Anti-MSL1 mAb-Compound 9 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM1	Anti-MSL1 mAb-Compound 9 linker	ADC Info
Anti-CD59 mAb-Compound 9 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM1	Anti-CD59 mAb-Compound 9 linker	ADC Info
Anti-HER2 mAb-Compound 9 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Anti-HER2 mAb-Compound 9 linker	ADC Info
Anti-MSL1 mAb-Compound 17 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM4	Anti-MSL1 mAb-Compound 17 linker	ADC Info
Anti-CD59 mAb-Compound 17 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM4	Anti-CD59 mAb-Compound 17 linker	ADC Info
Anti-HER2 mAb-Compound 17 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Anti-HER2 mAb-Compound 17 linker	ADC Info
Anti-MSL1 mAb-Compound 25 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 25 linker	ADC Info
Anti-CD59 mAb-Compound 25 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 25 linker	ADC Info
Anti-HER2 mAb-Compound 25 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 25 linker	ADC Info
Anti-MSL1 mAb-Compound 31 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Auristatin 0101	Anti-MSL1 mAb-Compound 31 linker	ADC Info
Anti-CD59 mAb-Compound 31 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Auristatin 0101	Anti-CD59 mAb-Compound 31 linker	ADC Info
Anti-HER2 mAb-Compound 31 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Anti-HER2 mAb-Compound 31 linker	ADC Info
Anti-MSL1 mAb-Compound 36 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 36 linker	ADC Info
Anti-CD59 mAb-Compound 36 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 36 linker	ADC Info
Anti-HER2 mAb-Compound 36 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 36 linker	ADC Info
Anti-MSL1 mAb-Compound 55 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM1	Anti-MSL1 mAb-Compound 55 linker	ADC Info
Anti-CD59 mAb-Compound 55 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM1	Anti-CD59 mAb-Compound 55 linker	ADC Info
Anti-HER2 mAb-Compound 55 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Anti-HER2 mAb-Compound 55 linker	ADC Info
Anti-MSL1 mAb-Compound 59 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM4	Anti-MSL1 mAb-Compound 59 linker	ADC Info
Anti-CD59 mAb-Compound 59 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM4	Anti-CD59 mAb-Compound 59 linker	ADC Info
Anti-HER2 mAb-Compound 59 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Anti-HER2 mAb-Compound 59 linker	ADC Info
Anti-MSL1 mAb-Compound 64 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 64 linker	ADC Info
Anti-CD59 mAb-Compound 64 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 64 linker	ADC Info
Anti-HER2 mAb-Compound 64 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 64 linker	ADC Info
Anti-MSL1 mAb-Compound 69 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 69 linker	ADC Info
Anti-CD59 mAb-Compound 69 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 69 linker	ADC Info
Anti-HER2 mAb-Compound 69 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 69 linker	ADC Info
Anti-MSL1 mAb-Compound 75 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 75 linker	ADC Info
Anti-CD59 mAb-Compound 75 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 75 linker	ADC Info
Anti-HER2 mAb-Compound 75 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 75 linker	ADC Info
Anti-MSL1 mAb-Compound 76 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 76 linker	ADC Info
Anti-CD59 mAb-Compound 76 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 76 linker	ADC Info
Anti-HER2 mAb-Compound 76 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 76 linker	ADC Info
Anti-MSL1 mAb-Compound 77 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM1	Anti-MSL1 mAb-Compound 77 linker	ADC Info
Anti-CD59 mAb-Compound 77 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM1	Anti-CD59 mAb-Compound 77 linker	ADC Info
Anti-HER2 mAb-Compound 77 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Anti-HER2 mAb-Compound 77 linker	ADC Info
Anti-MSL1 mAb-Compound 78 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Auristatin 0101	Anti-MSL1 mAb-Compound 78 linker	ADC Info
Anti-CD59 mAb-Compound 78 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Auristatin 0101	Anti-CD59 mAb-Compound 78 linker	ADC Info
Anti-HER2 mAb-Compound 78 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Anti-HER2 mAb-Compound 78 linker	ADC Info
Anti-MSL1 mAb-Compound 79 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Auristatin 0101	Anti-MSL1 mAb-Compound 79 linker	ADC Info
Anti-CD59 mAb-Compound 79 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Auristatin 0101	Anti-CD59 mAb-Compound 79 linker	ADC Info
Anti-HER2 mAb-Compound 79 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Anti-HER2 mAb-Compound 79 linker	ADC Info
Anti-MSL1 mAb-Compound 80 ^[285]	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM4	Anti-MSL1 mAb-Compound 80 linker	ADC Info
Anti-CD59 mAb-Compound 80 ^[285]	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM4	Anti-CD59 mAb-Compound 80 linker	ADC Info
Anti-HER2 mAb-Compound 80 ^[285]	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM4	Anti-HER2 mAb-Compound 80 linker	ADC Info
H-1-vcMMAE ^[286]	Anti-HER2 mAb H-1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H-3-vcMMAE ^[286]	Anti-HER2 mAb H-3	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
H-4-vcMMAE ^[286]	Anti-HER2 mAb H-4	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-KIT 9P3-SMCC-DM1 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT NEG024-SMCC-DM1 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT NEG026-SMCC-DM1 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT NEG027-SMCC-DM1 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT NEG085-SMCC-DM1 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT NEG086-SMCC-DM1 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT NEG087-SMCC-DM1 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT 20376-SMCC-DM1 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-KIT 9P3-SPDB-DM4 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT NEG024-SPDB-DM4 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT NEG026-SPDB-DM4 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT NEG027-SPDB-DM4 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT NEG085-SPDB-DM4 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT NEG086-SPDB-DM4 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT NEG087-SPDB-DM4 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT 20376-SPDB-DM4 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-KIT 9P3-CX1-1-DM1 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT NEG024-CX1-1-DM1 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT NEG026-CX1-1-DM1 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT NEG027-CX1-1-DM1 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT NEG085-CX1-1-DM1 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT NEG086-CX1-1-DM1 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT NEG087-CX1-1-DM1 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT 20376-CX1-1-DM1 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-KIT 9P3-SSNPP-DM3 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT NEG024-SSNPP-DM3 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT NEG026-SSNPP-DM3 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT NEG027-SSNPP-DM3 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT NEG085-SSNPP-DM3 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT NEG086-SSNPP-DM3 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT NEG087-SSNPP-DM3 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT 20376-SSNPP-DM3 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-KIT 9P3-SPP-DM1 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT NEG024-SPP-DM1 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT NEG026-SPP-DM1 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT NEG027-SPP-DM1 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT NEG085-SPP-DM1 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT NEG086-SPP-DM1 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT NEG087-SPP-DM1 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT 20376-SPP-DM1 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-KIT 9P3-SPDP-DM1 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT NEG024-SPDP-DM1 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT NEG026-SPDP-DM1 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT NEG027-SPDP-DM1 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT NEG085-SPDP-DM1 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT NEG086-SPDP-DM1 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT NEG087-SPDP-DM1 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT 20376-SPDP-DM1 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-KIT 9P3 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT NEG024 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT NEG026 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT NEG027 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT NEG085 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT NEG086 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT NEG087 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-KIT 20376 Sulfo-SPDB-DM4 ^[287]	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-12425 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-14629 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-20562 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-20811 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-12422 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-12439 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-10164 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-10220 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-10846 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-10918 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-10923 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-11722 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-11723 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-11725 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-12433 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-12931 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-12944 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2 mAb-12947 SMCC-DM1 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-10553 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-10554 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-10925 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-10729 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-12435 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-12438 SMCC-DM1 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Anti-FGFR2/4 mAb-12425 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-14629 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-20562 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-20811 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-12422 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-12439 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-10164 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-10220 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-10846 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-10918 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-10923 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-11722 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-11723 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-11725 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-12433 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-12931 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-12944 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2 mAb-12947 SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-10553 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-10554 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-10925 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-10729 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-12435 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-12438 SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	ADC Info
Anti-FGFR2/4 mAb-12425 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-14629 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-20562 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-20811 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-12422 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-12439 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-10164 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-10220 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-10846 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-10918 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-10923 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-11722 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-11723 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-11725 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-12433 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-12931 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-12944 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2 mAb-12947 CX1-1-DM1 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-10553 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-10554 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-10925 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-10729 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-12435 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-12438 CX1-1-DM1 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	ADC Info
Anti-FGFR2/4 mAb-12425 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-14629 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-20562 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-20811 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-12422 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-12439 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-10164 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-10220 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-10846 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-10918 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-10923 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-11722 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-11723 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-11725 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-12433 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-12931 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-12944 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2 mAb-12947 SSNPP-DM3 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-10553 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-10554 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-10925 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-10729 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-12435 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-12438 SSNPP-DM3 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	ADC Info
Anti-FGFR2/4 mAb-12425 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-14629 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-20562 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-20811 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-12422 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-12439 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-10164 SPP-DM1 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-10220 SPP-DM1 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-10846 SPP-DM1 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-10918 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-10923 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-11722 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-11723 SPP-DM1 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-11725 SPP-DM1 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-12433 SPP-DM1 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-12931 SPP-DM1 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-12944 SPP-DM1 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2 mAb-12947 SPP-DM1 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-10553 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-10554 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-10925 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-10729 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-12435 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-12438 SPP-DM1 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	ADC Info
Anti-FGFR2/4 mAb-12425 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-14629 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-20562 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-20811 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-12422 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-12439 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-10164 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-10220 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-10846 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-10918 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-10923 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-11722 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-11723 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-11725 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-12433 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-12931 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-12944 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2 mAb-12947 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-10553 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-10554 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-10925 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-10729 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-12435 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-12438 Sulfo-SPDB-DM4 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	ADC Info
Anti-FGFR2/4 mAb-12425 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-14629 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-20562 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-20811 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-12422 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-12439 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-10164 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-10220 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-10846 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-10918 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-10923 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-11722 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-11723 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-11725 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-12433 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-12931 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-12944 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2 mAb-12947 SPDP-DM1 ^[288]	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-10553 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-10554 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-10925 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-10729 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-12435 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
Anti-FGFR2/4 mAb-12438 SPDP-DM1 ^[288]	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	ADC Info
AbA-vcMMAE ^[289]	Anti-EGFR AbA	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Ab1-mcMMAF ^[289]	Anti-EGFR Ab1	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
Ab3-mcMMAF ^[289]	Anti-EGFR Ab3	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
AbA-mcMMAE ^[289]	Anti-EGFR AbA	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Maleimido-caproyl	ADC Info

Investigative(Terminated)

Click To Hide/Show 12 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
Alpha-CD70-Mc-MMAF ^[290]	Chimeric Anti-CD70 Anti-ody	CD70 antigen (CD70)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CD30-BTG-ADC ^[291]	Anti-CD30 mAb cAC10Q	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	PEG3-benzotriazole-PEG-Val-Cit-PABC	ADC Info
Anti-TenB2 antibody drug conjugate ^[292]	Anti-TENB2 monoclonal Anti-ody (mAb)	Tomoregulin-2 (TMEFF2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Alpha-CD30-Val-Cit-MMAE ^[293]	Anti-CD30 alphaCD30-vcMMAE mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B-1453 ^[294]	Undisclosed	Tumor necrosis factor ligand superfamily member 10 (TNFSF10)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B-1452 ^[294]	Undisclosed	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EGFRvIII/MMAE antibody drug conjugate ^[295]	Undisclosed	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Undisclosed	ADC Info
C-met monoclonal antibody-drug conjugate ^[296]	STI-D0606	Hepatocyte growth factor receptor (MET)	Mertansine DM1	Undisclosed	ADC Info
Cetuximab based antibody-drug conjugate ^[297]	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
FGFR2/FGFR4 dual targeting antibody-drug conjugate ^[298]	Undisclosed	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Trastuzumab-dTSPEG-MMAF ^[299]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	dTSPEG	ADC Info
Fluorescent Antibody-Drug Conjugate ^[300]	Anti-CEA mAb MIC0101	Pregnancy-specific beta-1-glycoprotein 2 (PSG2)	Paclitaxel	Undisclosed	ADC Info

Investigative

Click To Hide/Show 900 ADC Related to This Stage

ADC Name	Antibody	Antigen	Payload	Linker	ADC Info
ZA202500202A D04-Y180F404/K42/E161-LP23 ^[301]	D04-Y180F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-6,4 nnAA-B-Glucuronide-PEG12	ADC Info
ZA202500202A D04-Y180F404/K42/E161-LP22 ^[301]	D04-Y180F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-nnAA-PEG13-AAN	ADC Info
ZA202500202A D04-Y180F404/K42/E161-LP21 ^[301]	D04-Y180F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-nnAA-PEG13-VKG	ADC Info
FS-1502	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
CBP-1008 ^[302]	Undisclosed	Folate receptor alpha (FOLR1); Transient receptor potential cation channel subfamily V member 6 (TRPV6)	Monomethyl auristatin E	Undisclosed	ADC Info
DXC004 ^[303]	Nimotuzumab derivative	Epidermal growth factor receptor (EGFR)	Tubulysin B analog	Undisclosed	ADC Info
ADC2122 ^[304]	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Duostatin 5	Pip-Val-Cit linker	ADC Info
CPO-102 ^[305]	Undisclosed	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Undisclosed	ADC Info
16A5-MCC-DM1 ^[306]	MBH-1309	Lymphocyte antigen 75 (LY75)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
RG-7600 ^[307]	Humanized IgG1 Anti-MSLN mAb h7D9.v3	Mesothelin (MSLN)	Monomethyl auristatin E	Protease-labile valine-citrulline linker	ADC Info
Trastuzumab botidotin ^[308]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Duostatin 5	K-lock-Val-Cit-PABC	ADC Info
HS630 ^[309]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info
BsADC ^[310]	anti PD-L1 with B7-H3 scFv	Programmed cell death 1 ligand 1 (PD-L1); CD276 antigen (CD276)	Monomethyl auristatin E	Undisclosed	ADC Info
pCAD x CDH17 bispecific MMAE ADC ^[311]	pCAD x CDH17 bispecific antibody bsAb 10	Cadherin-3 (CDH3); Cadherin-17 (CDH17)	Monomethyl auristatin E	Undisclosed	ADC Info
CD276 mAb-MMAF ^[312]	Hu276 mAb	CD276 antigen (CD276)	Monomethyl auristatin F	DBM linker	ADC Info
HER2 × HER3 BsADC ^[313]	23V	Receptor tyrosine-protein kinase erbB-2 (HER2); Receptor tyrosine-protein kinase erbB-3 (HER3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-Her2_ (Q295)_AsnAsnPABC_MMAE ^[314]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	AsnAsnPABC	ADC Info
Anti-Her2_ (Q295)_AsnAlaPABC_MMAE ^[314]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	AsnAlaPABC	ADC Info
Antl-Her2_ (0295)_ValAlaPABC_MMAE ^[314]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
Anti-Her2_AsnAsnPABC_MMAE ^[314]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	AsnAsnPABC	ADC Info
Anti-Her2_AsnAlaPABC_MMAE ^[314]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	AsnAlaPABC	ADC Info
Anti-Her2_ValCitPABC_MMAE ^[314]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-Trop2_AsnAsnPABC_MMAE 7.6 ^[314]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	AsnAsnPABC	ADC Info
Antl-Trop2_AsnAlaPABC_MMAE ^[314]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	AsnAlaPABC	ADC Info
Antl-Trop2_ValAlaPABC_MMAE ^[314]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
Anti-Trop2_AsnAsnPABC_MMAE 4.5 ^[314]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	AsnAsnPABC	ADC Info
Anti-Trop2_ValCitPABC_MMAE ^[314]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-0079b_AsnAsnPABC_MMAE ^[314]	Undisclosed	Undisclosed	Monomethyl auristatin E	AsnAsnPABC	ADC Info
Anti.CD79b_ValCitPABC_MMAE ^[314]	Undisclosed	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
37917882 CD6-ADC ^[315]	UMCD6	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Nonbinding control-ADC ^[315]	control mouse IgG	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
37235999 ADC 401-4 ^[316]	B7-H3 mAb 401	CD276 antigen (CD276)	Monomethyl auristatin E	Fmoc-Val-Cit-PAB-PNP	ADC Info
huNb26/Nb26-Nbh-MMAE ^[317]	huNb26/Nb26-Nbh	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
37493255 7E7-DM4 ADC ^[318]	Undisclosed	Interleukin-3 receptor subunit alpha (IL3RA)	Mertansine DM4	Undisclosed	ADC Info
FG-ADC (DAR 4) ^[319]	Undisclosed	Undisclosed	Mertansine DM1	MA-FG-P12	ADC Info
FG-ADC (DAR 8) ^[319]	Undisclosed	Undisclosed	Mertansine DM1	MA-FG-P12	ADC Info
VAG-ADC (DAR 4) ^[319]	Undisclosed	Undisclosed	Mertansine DM1	MA-VAG-P12	ADC Info
VAG-ADC (DAR 8) ^[319]	Undisclosed	Undisclosed	Mertansine DM1	MA-VAG-P12	ADC Info
38139459 8D302-MMAE ^[320]	8D302	Sortilin (SORT1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Control to 8D302-MMAE ^[320]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Mehozumab-DM1 ^[321]	Undisclosed	Basigin (BSG)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
GsADC 3b ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
GsADC 5d ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
KsADC 7a ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
38981219 ADC 10a ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
38981219 ADC 10b ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
38981219 ADC 12a ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	NHS-VC-PAB	ADC Info
38981219 ADC 12b ^[322]	SAC 1	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	NHS-VC-PAB	ADC Info
H1D8-DC ^[323]	H1D8	CD44 antigen (CD44)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Actuximab-MMAE ^[324]	Actuximab	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG-MMAE 8 ^[324]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
37146146 IC1-MMAE ^[325]	Chimeric ICAM1 Antibody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
37146146 IC1-MMAF ^[325]	Chimeric ICAM1 Antibody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	Undisclosed	ADC Info
37146146 IC1-DM1 ^[325]	Chimeric ICAM1 Antibody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Mal-EBE-Mal	ADC Info
37146146 IC1-DM4 ^[325]	Chimeric ICAM1 Antibody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM4	Mal-EBE-Mal	ADC Info
Control-MMAE-DAR3 ^[326]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hu1084-MMAE-DAR3 ^[326]	Hu1084	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hu1084-MMAE-DAR8 ^[326]	Hu1084	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab-MMAU (DAR4) ^[327]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Glucuronyl-monomethyl-auristatin E (MMAU)	Val-Ser (beta-Glc) cleavable linker	ADC Info
Trastuzumab-MMAU (DAR8) ^[327]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Glucuronyl-monomethyl-auristatin E (MMAU)	Val-Ser (beta-Glc) cleavable linker	ADC Info
AGCM-22 ^[328]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
38850783 ADC 1 ^[329]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Dimaleimide linker 1	ADC Info
38850783 ADC 2 ^[329]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Dimaleimide linker 2	ADC Info
38850783 ADC 3 ^[329]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Dimaleimide linker 3	ADC Info
38850783 ADC 4 ^[329]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Dimaleimide linker 4	ADC Info
38850783 ADC 5 ^[329]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Dimaleimide linker 5	ADC Info
RS7-DL 1 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RS7-DL 2 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG4-Val-Cit-PABC	ADC Info
RS7-DL 3 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG8-Val-Cit-PAB	ADC Info
RS7-DL 4 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG24-Val-Cit-PAB	ADC Info
RS7-DL 5 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG8-Val-Cit-PEG8-PAB	ADC Info
RS7-DL 6 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG4-Lys (PEG24)-Cit-PAB	ADC Info
RS7-DL 7 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG8-Val-Lys (PEG8)-Cit-PAB	ADC Info
RS7-DL 8 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG4-Val-Lys (PEG12)-Cit-PAB	ADC Info
RS7-DL 9 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG4-Val-Lys (PEG16)-Cit-PAB	ADC Info
RS7-DL 10 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG4-Val-Lys (PEG24)-Cit-PAB	ADC Info
RS7-DL 11 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-Val-Lys (PEG24)-Cit-PAB	ADC Info
RS7-DL 12 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-Val-Lys-PAB	ADC Info
RS7-DL 13 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-PEG4-Lys (PEG24)-Cit-PAB	ADC Info
RS7-DL 14 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-Gly (glucose)-Val-Cit-PAB	ADC Info
RS7-DL 15 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-Val-Lys (Ser-PEG4-glucose)-PAB	ADC Info
RS7-DL 16 ^[330]	hRS7	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mal-Val-Lys (Ser-PEG4-glucose)-PAB	ADC Info
Anti-CD276 mAb-MMAF ^[331]	Anti-CD276 mAb	CD276 antigen (CD276)	Monomethyl auristatin F	Undisclosed	ADC Info
39410752 ADC (5) ^[332]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mal-Exo-EVC	ADC Info
39410752 ADC (6) ^[332]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mal-Exo-EEVC	ADC Info
39410752 ADC (8) ^[332]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mal-Exo-EEVC	ADC Info
39410752 ADC (10) ^[332]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
39410752 ADC (11) ^[332]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
39410752 ADC (12) ^[332]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-EVC-PAB	ADC Info
37834445 15cl12 L328C MMAE ^[333]	15cl12 L328C	Immunoglobulin E (IgE)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
37492000 ADC 6a (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1a	ADC Info
37492000 ADC 6b (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1b	ADC Info
37492000 ADC 6c (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1c	ADC Info
37492000 ADC 6d (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1d	ADC Info
37492000 ADC 7a (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2a	ADC Info
37492000 ADC 7b (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2b	ADC Info
37492000 ADC 7c (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2c	ADC Info
37492000 ADC 7d (4h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2d	ADC Info
37492000 ADC 6a (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1a	ADC Info
37492000 ADC 6b (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1b	ADC Info
37492000 ADC 6c (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1c	ADC Info
37492000 ADC 6d (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 1d	ADC Info
37492000 ADC 7a (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2a	ADC Info
37492000 ADC 7b (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2b	ADC Info
37492000 ADC 7c (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2c	ADC Info
37492000 ADC 7d (24h) ^[334]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TetraDVP based linker 2d	ADC Info
T4H11-DM4 ^[335]	T4H11	Epithelial discoidin domain-containing receptor 1 (DDR1)	Mertansine DM4	N-succinimidyl 3- (2-pyridyldithio) propionate (SPDP)	ADC Info
hSD5-vedotin ^[336]	hSD5	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG-vedotin ^[336]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
39143910 ADC 40 ^[337]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	1- (4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl (Dde) based linker	ADC Info
S1 Trastuzumab glycovariants ADC ^[338]	S1 Trastuzumab glycovariants	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit	ADC Info
S4 Trastuzumab glycovariants ADC ^[338]	S4 Trastuzumab glycovariants	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit	ADC Info
S6 Trastuzumab glycovariants ADC ^[338]	S6 Trastuzumab glycovariants	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit	ADC Info
F12-MMAE ^[339]	F12	Prostate stem cell antigen (PSCA)	Monomethyl auristatin E	NHS-VC-PAB	ADC Info
Ab1-MMAE ^[339]	Ab1	Nectin-4 (NECTIN4)	Monomethyl auristatin E	NHS-VC-PAB	ADC Info
37573404 CD6-ADC ^[340]	UMCD6	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Non-binding IgG -ADC ^[340]	Control mouse IgG	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
humanized CD6-ADC ^[340]	Humanized UMCD6	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
algM ADC ^[341]	Masked chicken-derived anti-IgM (aIgM) antibody	Undisclosed	Monomethyl auristatin E	DBCO-PEG4-Val-Cit-PABC	ADC Info
Masked Protease-activated CH2-aIgM ADC ^[341]	Protease-activated chicken-derived anti-IgM (aIgM) antibody	Undisclosed	Monomethyl auristatin E	DBCO-PEG4-Val-Cit-PABC	ADC Info
Nectin-4-MMAE ^[342]	MW282 mAb	Nectin-4 (NECTIN4)	Monomethyl auristatin E	IDconnect linker	ADC Info
36924655 ADC 28 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 29 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 30 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 31 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 5 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 6 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 7 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 8 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 9 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 10 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 11 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 12 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 13 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 14 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 15 ^[343]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 32 ^[343]	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Undisclosed	ADC Info
36924655 ADC 33 ^[343]	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Undisclosed	ADC Info
B2C4-MMAE ^[344]	B2C4	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B2-MMAE ^[344]	B2	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
C4-MMAE ^[344]	C4	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab-LplA-MMAE ^[345]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DBCO-Val-Cit-PABC	ADC Info
Rituximab-LplA-MMAE ^[345]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	DBCO-Val-Cit-PABC	ADC Info
B9-MMAE ^[346]	B9	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
alpha-cMET FDC-MMAE_C ^[347]	cMET A1-8 IgG Fab	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
alpha-RSV FDC-MMAE_C ^[347]	anti-RSV IgG Fab	Respiratory syncytial virus (RSV)	Monomethyl auristatin E	Undisclosed	ADC Info
hIMB1636-MMAE ^[348]	hIMB1636	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CA1-vedotin ^[349]	CA1	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-CD79b-RKAA-MMAE ADC ^[350]	Undisclosed	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	RKAA-PABC	ADC Info
LA-057-MMAE ^[351]	LA-057	Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
38679234 ADC1-MMAE ^[352]	Undisclosed	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
38679234 ADC1-DM1 ^[352]	Undisclosed	Undisclosed	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
Trastuzumab- (VC-PABC-MMAE)2 ^[353]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HAV ADC ^[354]	HAV	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
LAV ADC ^[354]	LAV	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
Tras (C8)-MMAE ^[355]	Trastuzumab (C8)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
aCSPG4 (scFv)-SNAP-AURIF ^[356]	aCSPG4 (scFv)-SNAP	Chondroitin sulfate proteoglycan 4 (CSPG4)	Monomethyl auristatin F	Undisclosed	ADC Info
Trastuzumab-DM1 (K248) ^[357]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Undisclosed	ADC Info
Trastuzumab-MMAE (K248) ^[357]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
Trastuzumab-MMAE (K288) ^[357]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
Rituximab-DM1 (K248) ^[357]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Undisclosed	ADC Info
Rituximab-MMAE (K248) ^[357]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Undisclosed	ADC Info
CD79b-MMAE ^[358]	Undisclosed	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
39837982 ADC PCMdt-MMAE ^[359]	PCMbs-MR	Hepatocyte growth factor receptor (MET); Macrophage-stimulating protein receptor (MST1R)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CD22 Nanobody DM1 ^[360]	CD22 Nanobody	B-cell receptor CD22 (CD22)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
38888299 ADC 1 ^[361]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Tuneable thiol exchange linker 1	ADC Info
38888299 ADC 2 ^[361]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Tuneable thiol exchange linker 2	ADC Info
38888299 ADC 3 ^[361]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Tuneable thiol exchange linker 3	ADC Info
Trastu-AzaNIRII-MMAE ^[362]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	azaNIRII-BCN-PEG4-VAC-PAB	ADC Info
Site-sepcific ADC 1 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 2 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 3 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 4 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 5 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 6 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 7 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 8 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 9 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 10 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 11 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Site-sepcific ADC 12 ^[363]	Zilovertamab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
40151029 ADC 1 ^[363]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
40151029 ADC 2 ^[363]	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	TE-VC-PAB	ADC Info
Trz-LC:p67-MMAE ^[364]	Trz-LC:p67	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
Trz-HC:p67-MMAE ^[364]	Trz-HC:p67	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
40187444 7DC2-DM1 ^[365]	7DC2	Leukocyte surface antigen CD47 (CD47)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
40187444 7DC4-DM1 ^[365]	7DC4	Leukocyte surface antigen CD47 (CD47)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
39914224 Ate-36 ^[366]	Atezolizumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Phenoxy silyl linker 36	ADC Info
39914224 Ate-37 ^[366]	Atezolizumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Phenoxy silyl linker 37	ADC Info
39914224 Ate-38 ^[366]	Atezolizumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Phenoxy silyl linker 38	ADC Info
39914224 Ate-39 ^[366]	Atezolizumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Phenoxy silyl linker 39	ADC Info
39757732 ADC1 ^[367]	Ab-2	Undisclosed	Monomethyl auristatin E	D1 Linker	ADC Info
39757732 ADC3 ^[367]	Ab-2	Undisclosed	Monomethyl auristatin E	D3 Linker	ADC Info
Ptz-SA vedotin ^[368]	Ptz-SA	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
40410803 16B10-DM1 ^[369]	16B10	Transforming growth factor alpha (TGFA)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
40410803 16B10-MMAF ^[369]	16B10	Transforming growth factor alpha (TGFA)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
40410803 5F1-DM1 ^[369]	5F1	Transforming growth factor alpha (TGFA)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
40410803 5F1-MMAF ^[369]	5F1	Transforming growth factor alpha (TGFA)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
Anti-CD64 (scFv)-SNAP-Auristatin F ^[370]	H22 (scFv)-SNAP	High affinity immunoglobulin gamma Fc receptor I (Fcgr1)	Monomethyl auristatin F	Undisclosed	ADC Info
alphaTROP2-MMAE ^[371]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
Mouse IgG2a-Val-Cit-Pab-MMAE ^[372]	Mouse IgG2a	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
Mouse IgG2a-PEG8-MMAE ^[372]	Mouse IgG2a	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
hIgG1-MMAE (gylcan conjugation) ^[372]	hIgG1	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
Isotype-MMAE (gylcan conjugation) ^[372]	Undisclosed	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
hIgG1-MMAE (Lysine conjugation) ^[372]	hIgG1	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
Isotype-MMAE (Lysine conjugation) ^[372]	Undisclosed	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
Ipi-DM1 38127423 ^[373]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Undisclosed	ADC Info
hIgGFc-DM1 (38127423) ^[373]	Undisclosed	Undisclosed	Mertansine DM1	Undisclosed	ADC Info
39812376 84-MMAE ^[374]	#84.7	Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)	Monomethyl auristatin E	Undisclosed	ADC Info
anti CAD-ADC ^[375]	h3E1	Cell adhesion molecule 1 (CADM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
OncoFAP-GlyPro-MMAE ^[376]	OncoFAP	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	Maleimido Caproyl-GlyPro-PAB linker	ADC Info
HuNb (TROP2-HSA)-MMAE ^[377]	HuNb (TROP2-HSA)	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
39870768 20D9h3-MMAF ^[378]	20D9h3	Receptor-type tyrosine-protein kinase FLT3 (FLT3)	Monomethyl auristatin F	Undisclosed	ADC Info
39860260 2Rs15d-H3KH6-MMAE ^[379]	2Rs15d	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit-PABC	ADC Info
Tras-VC-MMAE ^[380]	Tras-N3	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti TRBC1-MMAE ^[381]	Undisclosed	T cell receptor beta-chain constant region 1 (TRBC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Tra-CAST-MMAE ^[382]	Tra-CAST	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Styrylboronic acid-Val-Cit-PAB	ADC Info
AXL02-MMAE ^[383]	AXL02	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Undisclosed	ADC Info
AXL02-vc-MMAE ^[383]	AXL02	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
huB12-MMAE ^[384]	huB12	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
huB12-MMAF ^[384]	huB12	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
huB12-DM1 ^[384]	huB12	Prolyl endopeptidase FAP (FAP)	Mertansine DM1	Mc-Val-Cit-PABC	ADC Info
h3E1-MMAE ^[385]	h3E1	Cell adhesion molecule 1 (CADM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hIgG-MMAE ^[385]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
GLK-33 ^[386]	Lintuzumab	Myeloid cell surface antigen CD33 (CD33)	Glucuronyl-monomethyl-auristatin E (MMAU)	Undisclosed	ADC Info
chMC-813-70-VC-PAB-MMAE ^[387]	chMC-813-70	Stage-specific embryonic antigen-4 (SSEA4)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit-PABC	ADC Info
chMC-813-70-PAB-MMAE ^[387]	chMC-813-70	Stage-specific embryonic antigen-4 (SSEA4)	Monomethyl auristatin E	DBCO-PEG4-PAB	ADC Info
HC-A118C-1a ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A118C-1b ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A118C-2 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A118C-3 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A118C-4 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A140C-1a ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A140C-1b ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A140C-2 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A140C-3 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-A140C-4 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-E258C-1a ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-E258C-1b ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-E258C-2 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-E258C-3 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-E258C-4 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-S400C-1a ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-S400C-1b ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-S400C-2 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-S400C-3 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
HC-S400C-4 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-K149C-1a ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-K149C-1b ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-K149C-2 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-K149C-3 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-K149C-4 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-V205C-1a ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-V205C-1b ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-V205C-2 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-V205C-3 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
LC-V205C-4 ^[388]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
38501590 Anti-HER2 ARC-FDC (1) ^[389]	Trastuzumab-Fab-cd38	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	2'-Cl-araNAD linker	ADC Info
38501590 Anti-HER2 ARC-FDC (2) ^[389]	Trastuzumab-Fab-cd38	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	2'-Cl-araNAD linker	ADC Info
Positively Charged ADC ^[390]	Trastuzumab (Positively Charged)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WT ADC ^[390]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CD98hc-ADC ^[391]	Undisclosed	Solute carrier family 3 member 2 (SLC3A2)	Mertansine DM1	Undisclosed	ADC Info
38703658 19G4-MMAE ^[392]	19G4	Solute carrier family 3 member 2 (SLC3A2)	Monomethyl auristatin E	Undisclosed	ADC Info
aTCRA6 DAR2 ^[393]	aTCRA6S1	Transcriptional regulatory protein TcrA (TCRA6)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit-PABC	ADC Info
aTCRA6 DAR2-8 ^[393]	aTCRA6S1	Transcriptional regulatory protein TcrA (TCRA6)	Monomethyl auristatin E	DBCO-PEG4-Val-Cit-PABC	ADC Info
Enfortumab-MMAE ^[394]	Enfortumab	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Undisclosed	ADC Info
37520726 I1-MMAE ^[395]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
n501-MMAE ^[396]	n501	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
n501-alphaHSA-MMAE ^[396]	n501-alphaHSA	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-TAG-72 ADC ^[397]	Undisclosed	Tumor-associated glycoprotein 72 (TAG-72)	Monomethyl auristatin E	Undisclosed	ADC Info
Trastuzumab-Qtag2-MMAE ^[398]	Trastuzumab-Qtag2	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEG4-VC-PAB	ADC Info
Trastuzumabk453del-Qtag2-MMAE ^[398]	Trastuzumabk453del-Qtag2	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEG4-VC-PAB	ADC Info
Trastuzumab-Qtag2-DM1 ^[398]	Trastuzumab-Qtag2	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	PEG4-SMCC	ADC Info
Ipi-DM1 36909522 ^[399]	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Undisclosed	ADC Info
hIgGFc-DM1 (36909522) ^[399]	Undisclosed	Undisclosed	Mertansine DM1	Undisclosed	ADC Info
scFv-PEG4-DM1 ^[400]	Undisclosed	Undisclosed	Mertansine DM1	Undisclosed	ADC Info
scFv-PEG4-DM4 ^[400]	Undisclosed	Undisclosed	Mertansine DM4	Undisclosed	ADC Info
h3E1-MMAE ADC ^[401]	h3E1	Cell adhesion molecule 1 (CADM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
alphaCLDN18.2-MMAE ^[402]	Undisclosed	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Undisclosed	ADC Info
XiRB49 MMAE ^[403]	xiRB49	Endothelin-1 (EDN1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
40287441 3D1 MMAE ^[404]	MUC1 3D1	Mucin-1 (MUC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
PF-08046032 ^[405]	A detuned-affinity anti-CD25 mAb	Interleukin-2 receptor subunit alpha (IL2RA)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
YB-800 MMAF ^[406]	YB-800	Neuronal pentraxin receptor (NPTXR)	Monomethyl auristatin F	Undisclosed	ADC Info
TDC MMAE ^[407]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CD318-MMAE ^[408]	Undisclosed	CUB domain-containing protein 1 (CDCP1)	Monomethyl auristatin E	Undisclosed	ADC Info
TGW101 ^[409]	Anti-TAG-72 antibody	Tumor-associated glycoprotein 72 (TAG-72)	Monomethyl auristatin E	A cleavable linker	ADC Info
Non-pH-B7-H3 Ab-MMAE ^[410]	Non-pH-B7-H3 Ab	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
pH-B7-H3 Ab-MMAE ^[410]	pH-B7-H3 Ab	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IDP-001 ^[411]	Undisclosed	CUB domain-containing protein 1 (CDCP1); Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Undisclosed	ADC Info
SDV2102 ^[412]	D10	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Undisclosed	ADC Info
AT2604 ^[413]	Undisclosed	Alkaline phosphatase, germ cell type (ALPG); Alkaline phosphatase, placental type (ALPP)	Monomethyl auristatin E	Undisclosed	ADC Info
BSI-721 ^[414]	Fully humanized anti-CDH17 monoclonal antibody	Cadherin-17 (CDH17)	Monomethyl auristatin E	Undisclosed	ADC Info
PB-MMAE-2 ^[415]	PB-223	Truncated Core-2 O-glycans	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
PB-MMAE-5 ^[415]	PB-223	Truncated Core-2 O-glycans	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
PB-MMAE-6 ^[415]	PB-223	Truncated Core-2 O-glycans	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB-205 ^[416]	bispecific anti-c-Met/EGFR antibody	Receptor tyrosine-protein kinase erbB-2 (HER2); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
GPC1-ADC ^[417]	humanized anti-GPC1 monoclonal antibody	Glypican-1 (GPC1)	Monomethyl auristatin E	Undisclosed	ADC Info
PLB-002 ^[418]	PLB-002-ab7	Claudin-6 (CLDN6)	Eribulin	A cleavable linker	ADC Info
Anti-hEGFR (IgG4)-ABNO-DM-1: E4-AD ^[419]	anti-EGFR IgG4 antibody	Epidermal growth factor receptor (EGFR)	Mertansine DM1	ABNO Linker	ADC Info
PF-08046031 ^[420]	HL49	Melanotransferrin (MELTF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BR111 ^[421]	Anti-ROR1 mAb	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Eribulin	Undisclosed	ADC Info
3A11-MMAE ^[422]	3A11	Fibroblast growth factor receptor 4 (FGFR4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ADRX-0134 ^[423]	Undisclosed	Sodium-dependent phosphate transport protein 2B (SLC34A2)	AP052	Undisclosed	ADC Info
KY-0301	EGFR/c-Met bispecific nanobody	Hepatocyte growth factor receptor (MET); Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	A cleavable linker	ADC Info
CN119343152A 1C1-Example 1 ^[424]	1C1	Ephrin type-A receptor 2 (EPHA2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example1 Linker	ADC Info
CN119343152A 1C1-Example 2 ^[424]	1C1	Ephrin type-A receptor 2 (EPHA2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example2 Linker	ADC Info
Trastuzumab-Example 1 ^[424]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example1 Linker	ADC Info
Trastuzumab-Example 2 ^[424]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example2 Linker	ADC Info
NOV169N31Q-Example 1 ^[424]	NOV169N31Q	Cadherin-3 (CDH3)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example1 Linker	ADC Info
NOV169N31Q-Example 2 ^[424]	NOV169N31Q	Cadherin-3 (CDH3)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example2 Linker	ADC Info
Trastuzumab-Example 5 ^[424]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	CN119343152A Trastuzumab-Example5 Payload	CN119343152A 1C1-Example1 Linker	ADC Info
BR112024020733A2ADC1 ^[425]	2G10-5	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	BR112024020733A2 ADC1 Linker	ADC Info
FS002-A1-vc-MMAE ^[426]	FS002-A1	Integrin alpha 2 (ITGA2)	Monomethyl auristatin E	Undisclosed	ADC Info
FS002-A15-vc-MMAE ^[426]	FS002-A15	Integrin alpha 2 (ITGA2)	Monomethyl auristatin E	Undisclosed	ADC Info
FS002-A36-vc-MMAE ^[426]	FS002-A36	Integrin alpha 2 (ITGA2)	Monomethyl auristatin E	Undisclosed	ADC Info
Vatelizumab-vc-MMAE ^[426]	Vatelizumab	Integrin alpha 2 (ITGA2)	Monomethyl auristatin E	Undisclosed	ADC Info
CN110997009BADC#42 ^[427]	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	CN110997009B ADC#42 Payload	CN110997009B ADC#42 Linker	ADC Info
CN110997009BADC#43 ^[427]	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	CN110997009B ADC#43 Payload	CN110997009B ADC#42 Linker	ADC Info
CN110997009BADC#44 ^[427]	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duo5	CN110997009B ADC#40 Linker	ADC Info
CN110997009BADC#45 ^[427]	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duo5	CN110997009B ADC#45 Linker	ADC Info
CN110997009BADC#46 ^[427]	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duo5	CN110997009B ADC#46 Linker	ADC Info
HIS092-vc-MMAE ^[428]	HIS029	CD44 antigen (CD44)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
MORAb-003 ADC5 ^[429]	MORAb-003	Folate receptor alpha (FOLR1)	Eribulin	VCP linker	ADC Info
MORAb-003 ADC8 ^[429]	MORAb-003	Folate receptor alpha (FOLR1)	Mertansine DM1	6-Maleimidocaproic acid	ADC Info
MORAb-003 ADC9 ^[429]	MORAb-003	Folate receptor alpha (FOLR1)	Monomethyl auristatin E	Maleimidyl- (CH2)5-Val-Cit-pAB linker	ADC Info
MORAb-003 ADC10 ^[429]	MORAb-003	Folate receptor alpha (FOLR1)	Auristatin F	NHS-PEG2 linker	ADC Info
MORAb-003 ADC11 ^[429]	MORAb-003	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
MORAb-003 ADC13 ^[429]	MORAb-003	Folate receptor alpha (FOLR1)	Dolicatatin 5	Asn-Ala linker	ADC Info
MORAb-003 ADC33 ^[430]	MORAb-003	Folate receptor alpha (FOLR1)	Dolicatatin 5	PEG-pAB linker	ADC Info
NY920-DAPA-VC-MMAE ^[431]	NY920-DAPA	CD48 antigen (CD48)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NY920-CysMab-VC-MMAE ^[431]	NY920-CysMab	CD48 antigen (CD48)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NY938-DAPA-VC-MMAE ^[431]	NY938-DAPA	CD48 antigen (CD48)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
NY938-CysMab-VC-MMAE ^[431]	NY938-CysMab	CD48 antigen (CD48)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC1 S-49-8 ^[432]	S-49-8	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC1 S-60-6 ^[432]	S-60-6	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC2 S-49-8 ^[432]	S-49-8	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC2 S-60-6 ^[432]	S-60-6	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC3 S-49-8 ^[432]	S-49-8	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC3 S-60-6 ^[432]	S-60-6	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC4 S-49-8 ^[432]	S-49-8	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119019562A ADC4 S-60-6 ^[432]	S-60-6	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4461318A2 anti-PSMA ADC1 ^[433]	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Undisclosed	ADC Info
EP4461318A2 anti-PSMA ADC2 ^[433]	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Undisclosed	ADC Info
EP4461318A2 anti-PSMA ADC3 ^[433]	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	CLeavable (Val-Citruline-PEG1) linker	ADC Info
EP4461318A2 anti-PSMA ADC4 ^[433]	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Short Cleavable (Valine-Citruline-Acetyl)	ADC Info
EP4461318A2 anti-PSMA ADC5 ^[433]	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Short Cleavable (Valine-Citruline-Acetyl)	ADC Info
EP4461318A2 anti-PSMA ADC6 ^[433]	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Undisclosed	ADC Info
EP4461318A2 anti-PSMA ADC7 ^[433]	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Undisclosed	ADC Info
EP4461318A2 anti-PSMA ADC8 ^[433]	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	CLeavable (Val-Citruline-PEG1) linker	ADC Info
EP4461318A2 anti-PSMA ADC9 ^[433]	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Short Cleavable (Valine-Citruline-Acetyl)	ADC Info
EP4461318A2 anti-PSMA ADC10 ^[433]	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Short Cleavable (Valine-Citruline-Acetyl)	ADC Info
EP4461318A2 anti-PSMA ADC11 ^[433]	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Undisclosed	ADC Info
EP4461318A2 anti-PSMA ADC12 ^[433]	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Undisclosed	ADC Info
EP4461318A2 anti-PSMA ADC13 ^[433]	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	CLeavable (Val-Citruline-PEG1) linker	ADC Info
EP4461318A2 anti-PSMA ADC14 ^[433]	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Short Cleavable (Valine-Citruline-Acetyl)	ADC Info
EP4461318A2 anti-PSMA ADC15 ^[433]	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Short Cleavable (Valine-Citruline-Acetyl)	ADC Info
CN118401256A ADC 1 ^[434]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Allenamide-Amcap-Val-Cit-PABC	ADC Info
CN118401256A ADC 2 ^[434]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maleimido-caproyl-Val-Cit-PABC	ADC Info
CN118401256A ADC 3 ^[434]	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Allenamide-Amcap-Val-Cit-PABC	ADC Info
CAT-10-106 ^[435]	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Maytansine	Undisclosed	ADC Info
CAB-Axl-ADCm ^[436]	BA3011	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Undisclosed	ADC Info
CAB-Axl-ADCf ^[436]	BA3011	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin F	Undisclosed	ADC Info
2A1-LC-Cys110ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys110ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys111ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys111ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys142ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys142ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys272ins-mc-vc-PAB-MMAE TDC (1.74) ^[437]	2A1-LC-Cys271ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys272ins-mc-vc-PAB-MMAE TDC (1.77) ^[437]	2A1-LC-Cys272ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys275ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys275ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys276ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys276ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys381ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys381ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys382ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys382ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys384ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys384	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys407ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys407ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys408ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys408ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys418ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys418ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys419ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys419ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
2A1-LC-Cys445ins-mc-vc-PAB-MMAE TDC ^[437]	2A1-LC-Cys445ins	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ICAM1-MMAE 3.92 ^[438]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ICAM1-MMAF 4.09 ^[438]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
ICAM1-DM1 3.96 ^[438]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Mal-EBE-Mal	ADC Info
ICAM1-DM4 ^[438]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM4	Mal-EBE-Mal	ADC Info
KR1020240043161A 3G7-Sec-DM1 ^[439]	3G7	Endoplasmin homolog (LPG3)	Mertansine DM1	Undisclosed	ADC Info
US20230109312A1 ADC with 4 MMAF ^[440]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	US20230109312A1 ADC with 4 MMAF Linker	ADC Info
CX-2009 ADC ^[441]	CX-2009	CD166 antigen (ALCAM)	Mertansine DM4	SPDB	ADC Info
HuMab-CD74-005-vcMMAE ^[442]	HuMab-CD74-005	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuMab-CD74-006-vcMMAE ^[442]	HuMab-CD74-006	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuMab-CD74-011-vcMMAE ^[442]	HuMab-CD74-011	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
HuMab-CD74-005-mcMMAF ^[442]	HuMab-CD74-005	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin F	Undisclosed	ADC Info
HuMab-CD74-006-mcMMAF ^[442]	HuMab-CD74-006	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin F	Undisclosed	ADC Info
US20230256114A1 ADC (DAR4) 1 ^[443]	Anti-Trop	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
US20230256114A1 ADC (DAR4) 2 ^[443]	Anti-Trop	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CM311-18D10-VH3/VL2-ADC ^[444]	CM311-18D10-VH3/VL2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CM311-18D10-VH6/VL1-ADC ^[444]	CM311-18D10-VH6/VL1	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CM311-18D10-VH6/VL2-ADC ^[444]	CM311-18D10-VH6/VL2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CM311-18A9-VH7/VL2-ADC ^[444]	CM311-18A9-VH7/VL2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
B62-H3L3-MMAE ^[445]	B62-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119371541A B31-H3L3-MMAE ^[445]	B31-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN119371541A 99961.1-MMAE ^[445]	99961.1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AU2023226367A1-3 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin E	RU20241285-3-linker	ADC Info
AU2023226367A1-3b ^[446]	CD20-A antibody	B-lymphocyte antigen CD20 (MS4A1)	Auristatin E	RU20241285-3-linker	ADC Info
AU2023226367A1-3c ^[446]	Imgatuzumab	Epidermal growth factor receptor (EGFR)	Auristatin E	RU20241285-3-linker	ADC Info
AU2023226367A1-7 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	RU20241285-7-linker	ADC Info
AU2023226367A1-8 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	RU20241285-8-linker	ADC Info
AU2023226367A1-14 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	RU20241285-8-linker	ADC Info
AU2023226367A1-16 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	EP4487874A1-18linker	ADC Info
AU2023226367A1-17 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	RU20241285-17-linker	ADC Info
AU2023226367A1-18 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	RU20241285-18-linker	ADC Info
AU2023226367A1-19 ^[446]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin E	RU20241285-19-linker	ADC Info
ZA202500202A 2188-D04-Y180/F404-LP1 ^[301]	2188-D04-Y180/F404	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500202A 2188-D04-Y180/F404/K42-LP1 ^[301]	2188-D04-Y180/F404/K42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500202A D04-Y180/F404/K42/E161-LP12 ^[301]	D04-Y180/F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO sidechain PEG12 ValLys-pAB	ADC Info
ZA202500202A D04-Y180/F404/K42/E161-LP13 ^[301]	D04-Y180/F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO sidechain PEG12 ValGlu-pAB	ADC Info
ZA202500202A D04-Y180/F404/K42/E161-LP1 7.99 ^[301]	D04-Y180/F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500202A D04-Y180/F404/K42/E161-LP1 7.95 ^[301]	D04-Y180/F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500202A D04-Y180/F404-LP11 ^[301]	D04-Y180/F404	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500202A D04-Y180/F404-LP1 ^[301]	D04-Y180/F404	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500202A D04-Y180F404/K42/E161-LP1 ^[301]	D04-Y180F404/K42/E161	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
ZA202500114A-ADC-1 ^[447]	ZA202500114A-mAb-1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
ZA202500114A-ADC-4 ^[447]	Anti-TROP2 mAb	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
ZA202500114A-ADC-5 ^[447]	Anti-TROP2 mAb	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
mL49-MDpr-PEG (12)gluc-MMAE ^[448]	mouse L49	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
cL49-MDpr-PEG (12)-gluc-MMAE ^[448]	Chimeric L49	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
mL235-MDpr-PEG (12)-gluc-MMAE ^[448]	mouse L235	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
Santa Cruz (#271633)-MDpr-PEG (12)gluc-MMAE ^[448]	Santa Cruz (#271633)	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
R&D (#893416)-MDpr-PEG (12)-gluc-MMAE ^[448]	R&D (#893416)	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
Biolegend (#363101)-MDpr-PEG (12)-gluc-MMAE ^[448]	Biolegend (#363101)	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
hIgG-MDpr-PEG (12)-gluc-MMAE ^[448]	humanIgG	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
hL49-HALC-MDpr-PEG (12)-gluc-MMAE ^[448]	hL49-HALC	Melanotransferrin (MELTF)	Monomethyl auristatin E	MDpr-PEG (12)gluc	ADC Info
hL49-HALC-MC-VC-MMAE ^[448]	hL49-HALC	Melanotransferrin (MELTF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Trastuzumab N221 (WT)-MMAF #1 ^[449]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Trastuzumab N221 (WT)-MMAF #2 ^[449]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Trastuzumab N221 (GDLN)-MMAF ^[449]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Tras-LN-MMAF ^[449]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Tras.D221N-MMAF (HEK GDLN) ^[449]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Tras.D221N-MMAF (HEK WT) ^[449]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
MER-M6 ^[450]	M6	Tyrosine-protein kinase Mer (MERTK)	Monomethyl auristatin F	Undisclosed	ADC Info
AbA-vcMMAE ^[451]	AbA	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BAP048.7-mc-VC-PAB-MMAE ^[452]	BAP048.7	Tyrosine-protein kinase transmembrane receptor ROR2 (ROR2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BAP048.7-mc-PEG8-vC-PAB-MMAE ^[452]	BAP048.7	Tyrosine-protein kinase transmembrane receptor ROR2 (ROR2)	Monomethyl auristatin E	Mal-PEG8-Val-Cit-PAB	ADC Info
FS001-VH4-VL1-VC-MMAE ^[453]	FS001-huVH4-huVL1	Glypican-3 (GPC3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FS001-VH3-VL2-Vc-MMAE ^[453]	FS001-huVH3-huVL2	Glypican-3 (GPC3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FS001-VH4-VL2-vc-MMAE ^[453]	FS001-huVH4-huVL2	Glypican-3 (GPC3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FS001-VH4-VL3-VC-MMAE ^[453]	FS001-huVH4-huVL3	Glypican-3 (GPC3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-Trop2- (Q295-mcValCitPABC-A6)- (mcMMAF) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Her2- (Q295-mcValCitPABC-A6)- (mcMMAF) ^[454]	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Trop2- (Q295-mcA6)- (mcMMMAF) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Her2- (0295-mcA6)- (mcMMAF) ^[454]	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Trop2- (Q295-mcMMAF)- (mcValCitPABC-A6) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Her2- (0295-mcMMAF)- (mcValCitPABC-A6) ^[454]	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Trop2- (0295-mcMMAF)- (mc-A6) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Her2- (0295-mcMMAF)- (mc-A6) ^[454]	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Anti-Trop2- (Q295-mcMMAE)- (mc-A6) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Undisclosed	ADC Info
Trop2-Saci- (mc-MMAF)- (McAsnAsn-A6) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	ADC Info
Trop2-Saci- (mc-MMAF)- (mc-A6) ^[454]	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	ADC Info
Her2-Saci- (mc-MMAF)- (McAsnAsn-A6) ^[454]	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
Her2-Saci- (mc-MMAF)- (mc-A6) ^[454]	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Undisclosed	ADC Info
hlgG-MMAE ^[455]	Undisclosed	Seizure 6-like protein 2 (SEZ6L2)	Monomethyl auristatin E	Undisclosed	ADC Info
MOJ008268C 3E2-MMAE ^[455]	300	Seizure 6-like protein 2 (SEZ6L2)	Monomethyl auristatin E	Undisclosed	ADC Info
MOJ008268C 3A1-MMAE ^[455]	3A1	Seizure 6-like protein 2 (SEZ6L2)	Monomethyl auristatin E	Undisclosed	ADC Info
ISO-ADC ^[456]	Undisclosed	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
WO2024193682A1 32G1-2F11-ADC ^[456]	Undisclosed	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
WO2024193682A1 32G1-8H10-ADC ^[456]	Undisclosed	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
WO2024193682A1 32G1-8D9-ADC ^[456]	Undisclosed	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
Telisotuzumab-ADC ^[456]	Undisclosed	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
PF06263507-ADC ^[456]	Undisclosed	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
WO2024193682A1 32G1-ADC ^[456]	32G1	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
WO2024193682A1 8H10-ADC ^[456]	8H10	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
WO2024193682A1 8D9-ADC ^[456]	8D9	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	ADC Info
FM2b-S-D2 ^[457]	FM2b-S	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FM2b-F-D2 ^[457]	FM2b-F	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FM2b-K-D2 ^[457]	FM2b-K	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
FM2b-Y-D2 ^[457]	FM2b-Y	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB02E-MMAE ^[458]	BB02E	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB03E-MMAE ^[458]	BB03E	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB03E-A-MMAE ^[458]	BB03E-A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB04E-MMAE ^[458]	BB04E	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
BB05E-MMAE ^[458]	BB05E	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Degly-ISOmAb-1-mc-vc-PAB-MMAE ^[459]	degly-ISOmAb	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Degly-mAb1-1-mc-vc-PAB-MMAE ^[459]	degly-mAb1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb1-mc-vc-PAB-MMAE ^[459]	mAb1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IN202317039249 ACD6-ADC ^[460]	Undisclosed	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mIgG-ADC ^[460]	Undisclosed	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
W3195-1.53.1-p1-ulgG11-MMAE ^[461]	W3195-1.53.1-p1-ulgG11	Cadherin-3 (CDH3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WBP319-BMK4.uIgG1k-DM1 ^[461]	WBP319-BMK4.uIgG1k	Cadherin-3 (CDH3)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
TWI852077B-J1 ^[462]	Anti-cKIT Fab'1	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J2 ^[462]	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J3 ^[462]	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J4 ^[462]	Anti-cKIT Fab'4	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J5 ^[462]	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J6 ^[462]	Anti-Her2Fab'	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J9 ^[462]	Anti-cKIT F (ab'4)₂	Mast/stem cell growth factor receptor Kit (KIT)	TWI852077B-C4-payload	TWI852077B-C4-linker	ADC Info
TWI852077B-J11 ^[462]	Anti-cKIT Fab3	Mast/stem cell growth factor receptor Kit (KIT)	TWI852077B-C4-payload	TWI852077B-C4-linker	ADC Info
TWI852077B-J12 ^[462]	Anti-cKIT F (ab')₂	Mast/stem cell growth factor receptor Kit (KIT)	TWI852077B-C4-payload	TWI852077B-C4-linker	ADC Info
TWI852077B-J14 ^[462]	Anti-cKIT Fab'1	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
TWI852077B-J16 ^[462]	Anti-cKIT Fab'1	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J17 ^[462]	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
TWI852077B-J19 ^[462]	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J20 ^[462]	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
TWI852077B-J22 ^[462]	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J23 ^[462]	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J24 ^[462]	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852077B-J25 ^[462]	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
TWI852077B-JW ^[462]	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852078B-JX ^[462]	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
TWI852079B-JY ^[462]	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	ADC Info
TWI852080B-JZ ^[462]	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
P015004-vc-PAB-MMAE ^[463]	P015004	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
P015042-vc-PAB-MMAE ^[463]	P015042	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
P015043-vc-PAB-MMAE ^[463]	P015043	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
P015044-vc-PAB-MMAE ^[463]	P015044	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
UC961-vc-PAB-MMAE ^[463]	UC961	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LC0HC0-VC-MMAE ^[464]	LC0HC0	C-type mannose receptor 2 (MRC2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LC4HC3-VC-MMAE ^[464]	LC4HC3	C-type mannose receptor 2 (MRC2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RKAAR-PABC-MMAE ^[465]	RKAAR	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RRKAY-PABC-MMAE ^[465]	RRKAY	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RRK-PABC-MMAE ^[465]	RRK	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ARKRA-PABC-MMAE ^[465]	ARKRA	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
RKAA-PABC-MMAE ^[465]	RKAA	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
KAR-PABC-MMAE ^[465]	KAR	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP3838893B1-ADC-I ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C3-Val-Ala-PAB	ADC Info
EP3838893B1-ADC-II ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-Val-Ala-PAB	ADC Info
EP3838893B1-ADC-III ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-Val-Cit-PAB	ADC Info
EP3838893B1-ADC-A ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-PEG4-Val-Ala-PAB	ADC Info
EP3838893B1-ADC-B ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-PEG8-Val-Ala-PAB	ADC Info
EP3838893B1-ADC-C ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-PEG8'-Val-Ala-PAB	ADC Info
Su-C6-Val-Cit-PAB ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Maa-C6-Val-Ala-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maa-C6-Val-Ala-PAB	ADC Info
Maa-C6-Val-Cit-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Maa-C6-Val-Cit-PAB	ADC Info
Mf-C6-Val-Ala-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-Val-Ala-PAB	ADC Info
Mf-C3-Val-Ala-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C3-Val-Ala-PAB	ADC Info
Mf-C6-Val-Cit-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mf-C6-Val-Cit-PAB	ADC Info
Mm-C6-Val-Ala-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-Val-Ala-PAB	ADC Info
Mm-C3-Val-Ala-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C3-Val-Ala-PAB	ADC Info
Mm-C6-Val-Cit-PAB-MMAE ^[466]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-Val-Cit-PAB	ADC Info
Mm-C6-PEG4-Val-Ala-PAB-MMAE ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-PEG4-Val-Ala-PAB	ADC Info
Mm-C6-PEG8-Val-Ala-PAB-MMAE ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-PEG8-Val-Ala-PAB	ADC Info
Mm-C6-PEG8'-Val-Ala-PAB-MMAE ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mm-C6-PEG8'-Val-Ala-PAB	ADC Info
Su-C3-VA ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	PEG2-Val-Cit-PABC	ADC Info
Su-C6-VC ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Su-C6-VA ^[466]	mil40	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
WO2024140927A1-ADC-A (DAR4) ^[467]	mAb-A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024140927A1-ADC-B (DAR4) ^[467]	mAb-B	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024140927A1-ADC-C (DAR2) ^[467]	mAb-C	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024140927A1-ADC-C (DAR4) ^[467]	mAb-C	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024140927A1-ADC-C (DAR7) ^[467]	mAb-C	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024140927A1-ADC-A (DAR6) ^[467]	mAb-A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024140927A1-ADC-A (DAR2) ^[467]	mAb-A	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
T (kK183C+K290C)-VC0101 ADC ^[468]	T (kK183C+K290C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
WO2023047090A1-MMAE ADC ^[468]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
AU2022395626A1 ADC-H1-P1 ^[469]	Trastuzumab-K249	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	ADC Info
AU2022395626A1 ADC-H1-P2 ^[469]	Trastuzumab-K249	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H2-P1 ^[469]	Trastuzumab-K251	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	ADC Info
AU2022395626A1 ADC-H3-P1 ^[469]	Trastuzumab-K291	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	ADC Info
AU2022395626A1 ADC-H4-P1 ^[469]	Trastuzumab-K320	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	ADC Info
AU2022395626A1 ADC-H4-P2 ^[469]	Trastuzumab-K320	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H5-P1 ^[469]	Trastuzumab-K343	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	ADC Info
AU2022395626A1 ADC-H6-P2 ^[469]	Trastuzumab-P41	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H7-P2 ^[469]	Trastuzumab-G42	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-L1-P2 ^[469]	Trastuzumab-A51	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-L2-P2 ^[469]	Trastuzumab-A111	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-L3-P2 ^[469]	Trastuzumab-K169	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-L4-P2 ^[469]	Trastuzumab-G41	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-L5-P2 ^[469]	Trastuzumab-P59	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H1H4-P2 ^[469]	Trastuzumab-K249&K320	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H1H5-P2 ^[469]	Trastuzumab-K249&K343	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H1L3-P2 ^[469]	Trastuzumab-K249&K169	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H1L4-P2 ^[469]	Trastuzumab-K249&G41	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H4L3-P2 ^[469]	Trastuzumab-K320&K169	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H4L4-P2 ^[469]	Trastuzumab-K320&G41	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
AU2022395626A1 ADC-H6L4-P2 ^[469]	Trastuzumab-P41&G41	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
GlyADC-H1-P2 ^[469]	Trastuzumab-K249	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
GlyADC-H4-P2 ^[469]	Trastuzumab-K320	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	H-Tet-Glucuronide	ADC Info
LN474-63 ^[470]	STI-1260	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin E	CN118079014A-linker-1	ADC Info
LN437-99 ^[470]	BY016	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	CN118079014A-linker-2	ADC Info
LN474-64 ^[470]	STI-1260	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin E	CN118079014A-linker-3	ADC Info
Hu001-2-MMAE ^[471]	Hu001-2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Hu001-3-MMAE ^[471]	Hu001-3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Hu005-44-MMAE ^[471]	Hu005-44	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Hu005-46-MMAE ^[471]	Hu005-46	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
UC961-MMAE ^[471]	UC961	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb001c-vc-MMAE ^[471]	mAb001c	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024092067A1 2E7-vedotin ^[472]	20000000	CD70 antigen (CD70)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hz26A12C1H4L3-MMAE ^[473]	hz26A12C1H4L3	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hz46F1D5H4L3-MMAE ^[473]	hz46F1D5H4L3	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hz49E10H1H5L6-MMAE ^[473]	hz49E10H1H5L6	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hz49E10H1H5L7-MMAE ^[473]	hz49E10H1H5L7	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hz103E9B3H5L5-MMAE ^[473]	hz103E9B3H5L5	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
hz103E9B3H6L5-MMAE ^[473]	hz103E9B3H6L5	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EDB-L19-vc-0101 ^[474]	EDB-L19	Vesicle-associated membrane protein 8 (VAMP8)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
EDB- (κK183C-K290C)-vc-0101 ^[474]	EDB- (kK183C-K290C)	Vesicle-associated membrane protein 8 (VAMP8)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
EDB- (K94R)-vc-0101 ^[474]	EDB- (K94R)	Vesicle-associated membrane protein 8 (VAMP8)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
EDB- (κK183C-K94R-K290C)-vc-0101 ^[474]	EDB- (kK183C-K94R-K290C)	Vesicle-associated membrane protein 8 (VAMP8)	Auristatin 0101	Mc-Val-Cit-PABC	ADC Info
EDB-L19-diS-DM1 ^[474]	EDB-L19	Vesicle-associated membrane protein 8 (VAMP8)	Mertansine DM1	Dis linker	ADC Info
IN202417103159A 2188-D04-Yl80/F404-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-Val-Cit-PABC	ADC Info
IN202417103159A 2188-D04-Yl80/F404/K42-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-Val-Cit-PABC	ADC Info
IN202417103159A 2188-D04-Yl80/F404/K42/E161-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-Val-Cit-PABC	ADC Info
IN202417103159A D04-Y180/F404/K42/E161-LP12 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO sidechain PEG12 ValLys-pAB	ADC Info
IN202417103159A D04-Y180/F404/K42/E161-LP13 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO sidechain PEG12 ValGlu-pAB	ADC Info
IN202417103159A D04-Y180/F404/K42/E161-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	Undisclosed	ADC Info
IN202417103159A D04-Yl80/F404/K42/E161-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
IN202417103159A D04-Yl80/F404-LP11 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
IN202417103159A D04-Yl80/F404-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
IN202417103159A D04-Yl80F404/K42/E161-LP23 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	Undisclosed	ADC Info
IN202417103159A D04-Yl80F404/K42/E161-LP22 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-nnAA-PEG13-AAN	ADC Info
IN202417103159A D04-Yl80F404/K42/E161-LP1 ^[475]	Undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
RC88-Py-MAA-Val-Cit-PAB-MMAE ^[476]	RC88	Mesothelin (MSLN)	Monomethyl auristatin E	PY-MAA-Val-Cit-PABC	ADC Info
RC88-Mc-Val-Cit-PAB-MMAE ^[476]	RC88	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IN202417078684A+ADC1 ^[477]	IN202417078684A+Ab1	Undisclosed	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IN202417078684A+ADC2 ^[477]	IN202417078684A+Ab2	Undisclosed	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IN202417078684A+ADC3 ^[477]	IN202417078684A+Ab3	Undisclosed	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IN202417078684A+ADC4 ^[477]	IN202417078684A+Ab4	Undisclosed	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IN202417078684A+ADC5 ^[477]	IN202417078684A+Ab4	Undisclosed	Mertansine DM4	SPDB	ADC Info
IN202417078684A+ADC6 ^[477]	IN202417078684A+Ab4	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IN202417078684A+ADC9 ^[477]	IN202417078684A+Ab4	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
HG4K IgG4-Linker-DM1 (2) ^[478]	HG4K IgG4	Basal cell adhesion molecule (BCAM)	Mertansine DM1	Undisclosed	ADC Info
Abl-Linker-DM1 ^[478]	Ab1	Nectin-4 (NECTIN4)	Mertansine DM1	Undisclosed	ADC Info
Abl-Linker-MMAF ^[478]	Ab1	Nectin-4 (NECTIN4)	Monomethyl auristatin F	Undisclosed	ADC Info
WO2024107014A1 Ab3-Linker-MMAF ^[478]	Ab3	Nectin-4 (NECTIN4)	Monomethyl auristatin F	Undisclosed	ADC Info
HG4K IgG4-Linker-MMAF (3) ^[478]	HG4K IgG4	Basal cell adhesion molecule (BCAM)	Monomethyl auristatin F	Undisclosed	ADC Info
CO20240013452A2 ADC1 ^[479]	B62-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CO20240013452A2 ADC1 (2) ^[479]	B31-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CO20240013452A2 99961-MMAE ^[479]	99961.1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 1F-MMAE ^[480]	1F	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 25A-MMAE ^[480]	25A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 25A3-MMAE ^[480]	25A3	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 25G1-MMAE ^[480]	25G1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 29E-MMAE ^[480]	29E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 39A-MMAE ^[480]	39A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 43B1-MMAE ^[480]	43B1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 43D7-MMAE ^[480]	43D7	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 43Ea-MMAE ^[480]	43Ea	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4495597A2 54E-MMAE ^[480]	54E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-EGFR Ab No.1 (L328C)-vcMMAE ^[481]	EGFR No.1 (L328C)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-HER2 Ab (L328C)-vcMMAE ^[481]	HER2 (L328C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-TROP2 Ab (L328C)-vcMMAE ^[481]	TROP2 (L328C)	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-EGFR Ab No.1 (L234A, L235A, L328C)-vcMMAE ^[481]	EGFR No.1 (L234A, L235A, L328C)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-EGFR Ab No.3 (L234A, L235A, L328C)-vcMMAE ^[481]	EGFR No.3 (L234A, L235A, L328C)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
LOL1-anti-HER2 Ab (L234A, L235A, L328C) ^[481]	LOL1-HER2 (L234A, L235A, L328C)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
anti-TROP2 Ab (L234A, L235A, L328C)-vcMMAE ^[481]	TROP2 Ab (L234A, L235A, L328C)	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4470568A1 ADC-3 ^[482]	hAb017-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4470568A1 ADC-5 ^[482]	hAb015-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4470568A1 ADC-6 ^[482]	hAb015-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4470568A1 ADC-7 ^[482]	hAb015-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
EP4470568A1 ADC-8 ^[482]	SN8	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024110905A1 ADC1-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-2	ADC Info
WO2024110905A1 ADC1-4 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-4	ADC Info
WO2024110905A1 ADC1-11 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-11	ADC Info
WO2024110905A1 ADC2-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-2	ADC Info
WO2024110905A1 ADC2-4 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-4	ADC Info
WO2024110905A1 ADC2-9-1 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-9-1	ADC Info
WO2024110905A1 ADC2-9-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-9-1	ADC Info
WO2024110905A1 ADC2-11 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-11	ADC Info
WO2024110905A1 ADC2-36-1 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-36-1	ADC Info
WO2024110905A1 ADC2-36-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-36-1	ADC Info
WO2024110905A1 ADC2-43 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-43	ADC Info
WO2024110905A1 ADC2-62-1 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-62-1 Linker	ADC Info
WO2024110905A1 ADC2-62-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-62-1 Linker	ADC Info
WO2024110905A1 ADC2-63-1 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-63-1 Linker	ADC Info
WO2024110905A1 ADC2-63-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-63-1 Linker	ADC Info
WO2024110905A1 ADC2-64-1 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-64-1 Linker	ADC Info
WO2024110905A1 ADC2-64-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-64-1 Linker	ADC Info
WO2024110905A1 ADC2-65-1 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-62-1 Linker	ADC Info
WO2024110905A1 ADC2-65-2 ^[483]	Undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-64-1 Linker	ADC Info
YC1605 ^[484]	J591	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024105206A1 33i-5657 2 ^[485]	TPP-5657	Undisclosed	Monomethyl auristatin E	22i-5657 Linker	ADC Info
WO2024105206A1 34p-Avelu 2 ^[485]	TPP-Avelumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	22i-5657 Linker	ADC Info
anti-TRBC1-MMAE ^[486]	Undisclosed	T cell receptor beta-chain constant region 1 (TRBC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AU2023281032A1 ADC-1 ^[487]	Undisclosed	Undisclosed	Monomethyl auristatin E	AU2023281032A1 ADC-1 linker	ADC Info
AU2023281032A1 ADC-5 ^[487]	anti-TROP2 antibody	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	AU2023281032A1 ADC-1 linker	ADC Info
C1.18 DBM- (C6)-MMAF ^[488]	C1.18	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 146C: DBM- (C6)-MMAF ^[488]	146C:	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 164A: DBM- (C6)-MMAF ^[488]	164A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 208A: DBM- (C6)-MMAF ^[488]	208A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 215A: DBM- (C6)-MMAF ^[488]	215A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 230A: DBM- (C6)-MMAF ^[488]	230A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 259A: DBM- (C6)-MMAF ^[488]	259A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 305A: DBM- (C6)-MMAF ^[488]	305A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 353A: DBM- (C6)-MMAF ^[488]	353A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 53A: DBM- (C6)-MMAF ^[488]	53A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 5B: DBM- (C6)-MMAF ^[488]	5B	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 175A: DBM- (C6)-MMAF ^[488]	175A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
CN114230664B 76E1: DBM- (C6)-MMAF ^[488]	760	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	ADC Info
mAb1-MMAE ^[489]	mAb1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb2-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb3-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb4-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb5-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb6-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb7-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb8-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb9-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb10-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb11-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb12-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb13-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb14-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb15-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb16-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb17-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb18-MMAE ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
mAb1-MMAF ^[489]	mAb1	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
mAb2-MMAF ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
mAb3-MMAF ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
mAb17-MMAF ^[489]	Undisclosed	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
US11903948B2 I-1 ^[490]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Dolicatatin 5	Undisclosed	ADC Info
CD44-VCMMAE ^[491]	Undisclosed	CD44 antigen (CD44)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CD44-MMAE ^[491]	Undisclosed	CD44 antigen (CD44)	Monomethyl auristatin E	CN117362435A+SCD44-MMAE+Linker	ADC Info
CD44-DM1 ^[491]	Undisclosed	CD44 antigen (CD44)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
CANO01-MC-MMAF ^[492]	CANO01	Undisclosed	Monomethyl auristatin F	Maleimidocaproyl (me) linker	ADC Info
LR004-VC-MMAE ^[493]	LR004	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
CN112638426B ADC1 ^[494]	mil40	Undisclosed	Tubulin inhibitor B	CN112638426B +ADC1+Linker	ADC Info
CN112638426B ADC2 ^[494]	mil40	Undisclosed	Tubulin inhibitor B	CN112638426B +ADC2+Linker	ADC Info
US11661457B2 Ab-E-12 ^[495]	IGF-1R	Undisclosed	US11661457B2+Ab-E-12+payload	Mc-Val-Cit-PABC	ADC Info
US11661457B2 Ab-G-12 ^[495]	IGF-1R	Undisclosed	US11661457B2+Ab-E-12+payload	6-Maleimidocaproic acid	ADC Info
WO2024099368A1 Tra-CAST-MMAE ^[496]	Undisclosed	Undisclosed	Monomethyl auristatin E	WO2024099368A1+Tra-CAST-MMAE+Linker	ADC Info
DBCO-vc-MMAE ^[497]	HuSS1	Undisclosed	Monomethyl auristatin E	EP4161582A4+DBCO-vc-MMAE+Linker	ADC Info
DBCO-S-DM1 ^[497]	HuSS1	Undisclosed	Mertansine DM1	DBCO-PEG3-amine	ADC Info
BCN-PEG3-VC-PAB-MMAE ^[497]	HuSS1	Undisclosed	Monomethyl auristatin E	EP4161582A4+BCN-PEG3-VC-PAB-MMAE+Linker	ADC Info
DBCO-PEG3-2 (PEG3-VC-PAB-MMAE) ^[497]	HuSS1	Undisclosed	Monomethyl auristatin E	EP4161582A4+DBCO-PEG3-2 (PEG3-VC-PAB-MMAE)+Linker	ADC Info
IgG2a-Val-Cit-Pab-MMAE ^[498]	Undisclosed	Undisclosed	Monomethyl auristatin E	WO2024102603A1+lgG2a-Val-Cit-Pab-MMAE+Linker	ADC Info
IgG2a-PEG8-MMAE ^[498]	Undisclosed	Transmembrane 4 L6 family member 1 (TM4SF1)	Monomethyl auristatin E	WO2024102603A1+lgG2a-PEG8-MMAE+Linker	ADC Info
CN114106088A ADC1 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	ADC Info
CN114106088A ADC2 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	ADC Info
CN114106088A ADC3 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	ADC Info
CN114106088A ADC4 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	ADC Info
CN114106088A ADC5 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	ADC Info
CN114106088A ADC6 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	ADC Info
CN114106088A ADC7 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	ADC Info
CN114106088A ADC8 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	ADC Info
CN114106088A ADC9 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	ADC Info
CN114106088A ADC10 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	ADC Info
LN401-20-1 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	ADC Info
LN401-20-2 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	ADC Info
LN401-89-5 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	ADC Info
LN401-89-6 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	ADC Info
LN401-88-5 ^[499]	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	ADC Info
LN401-31-1 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	ADC Info
LN401-31-2 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	ADC Info
LN401-90-5 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	ADC Info
LN401-90-6 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	ADC Info
LN401-90-4 ^[499]	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (HER2)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	ADC Info
KR1020250008730A ADC1 ^[500]	B62-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
KR1020250008730A ADC2 ^[500]	B31-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
KR1020250008730A 99961.1-MMAE ^[500]	99961.1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
US20240091372A1 3H9-KGDEVD-MMAE ^[501]	3H9	Prion-like protein doppel (PRND)	Monomethyl auristatin E	KGDEVD linker	ADC Info
US20240091372A1 3D1-KGDEVD-MMAE ^[501]	3D1	Interleukin-3 receptor subunit alpha (IL3RA)	Monomethyl auristatin E	KGDEVD linker	ADC Info
US20240091372A1 3D5-KGDEVD-MMAE ^[501]	3D5	Prion-like protein doppel (PRND)	Monomethyl auristatin E	KGDEVD linker	ADC Info
US20240091372A1 4D1-KGDEVD-MMAE ^[501]	4D1	Prion-like protein doppel (PRND)	Monomethyl auristatin E	KGDEVD linker	ADC Info
US20240091372A1 3H9-vc-MMAE ^[501]	3H9	Prion-like protein doppel (PRND)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
US20240091372A1 3D1-vc-MMAE ^[501]	3D1	Interleukin-3 receptor subunit alpha (IL3RA)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
US20240091372A1 3D5-vc-MMAE ^[501]	3D5	Prion-like protein doppel (PRND)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
US20240091372A1 4D1-vc-MMAE ^[501]	4D1	Prion-like protein doppel (PRND)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
US20240091372A1 3H9-DEVD-MMAE ^[501]	3H9	Prion-like protein doppel (PRND)	Monomethyl auristatin E	DEVD linker	ADC Info
F314-MC-VC-PAB-MMAE ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
F314-SMCC-DM1 ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
F314-C4-VC-PAB-MMAE ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C4-VC-PAB	ADC Info
F314-C5-VC-PAB-MMAE-0.8 ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	ADC Info
F314-C5-VC-PAB-MMAE-1.8 ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	ADC Info
F314-C5-VC-PAB-MMAE-2.3 ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	ADC Info
F314-C5-VC-PAB-MMAE-3.0 ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	ADC Info
F314-C6-VC-PAB-MMAE ^[502]	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C6-VC-PAB	ADC Info
F1-SMCC-DM1 ^[502]	F1	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
WO2023232144A1ADC-1 ^[503]	anti-HER2 antibody mAb-1	Receptor tyrosine-protein kinase erbB-2 (HER2)	WO2023232144A1, ADC-1, Payload	WO2023232144A1, ADC-1, linker	ADC Info
WO2023232144A1ADC-4 ^[503]	anti-TROP2 antibody mAb-2	Tumor-associated calcium signal transducer 2 (TACSTD2)	WO2023232144A1, ADC-1, Payload	WO2023232144A1, ADC-1, linker	ADC Info
WO2025019776A2ADC 22-2 ^[504]	A22	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Monomethyl auristatin E	WO2025019776A2, ADC 22-2, Linker	ADC Info
WO2025019776A2ADC 33-2 ^[504]	A33	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Monomethyl auristatin E	WO2025019776A2, ADC 22-2, Linker	ADC Info
WO2025019776A2ADC 52-2 ^[504]	A52	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Monomethyl auristatin E	WO2025019776A2, ADC 22-2, Linker	ADC Info
IMGN529 ^[505]	Naratuximab	Leukocyte antigen CD37 (CD37)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
AU2023279443A1 Example 2 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-031	AU2023279443A1, Example 3, Linker	ADC Info
AU2023279443A1 Example 4 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-031	AU2023279443A1, Example 4, Linker	ADC Info
AU2023279443A1 Example 5 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-031	AU2023279443A1, Example 5, Linker	ADC Info
AU2023279443A1 Example A1 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Undisclosed	ADC Info
AU2023279443A1 Example A3 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-031	AU2023279443A1, Example A3, Linker	ADC Info
AU2023279443A1 Example A3b ^[506]	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	U-031	AU2023279443A1, Example A3, Linker	ADC Info
AU2023279443A1 Example A3c ^[506]	Cetuximab	Epidermal growth factor receptor (EGFR)	U-031	AU2023279443A1, Example A3, Linker	ADC Info
AU2023279443A1 Example A4 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-003	Undisclosed	ADC Info
AU2023279443A1 Example A5 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-029	Undisclosed	ADC Info
AU2023279443A1 Example A6 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	AU2023279443A1, Example A6, Linker	ADC Info
AU2023279443A1 Example A7 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	AU2023279443A1, Example A7, Linker	ADC Info
AU2023279443A1 Example A8 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	RU20241285-9-linker	ADC Info
AU2023279443A1 Example A9 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-036	RU20241285-9-linker	ADC Info
AU2023279443A1 Example A12 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-035	AU2023279443A1, Example A12, Linker	ADC Info
AU2023279443A1 Example A14 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	RU20241285-9-linker	ADC Info
AU2023279443A1Example A15 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-031	AU2023279443A1, Example A15, Linker	ADC Info
AU2023279443A1 Example A16 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	AU2023279443A1, Example A16, Linker	ADC Info
AU2023279443A1 Example A17 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	AU2023279443A1, Example A17, Linker	ADC Info
AU2023279443A1 Example A18 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	AU2023279443A1, Example A18, Linker	ADC Info
AU2023279443A1 Example A19 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	U-031	AU2023279443A1, Example A19, Linker	ADC Info
AU2023279443A1 Example A21 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	AU2023279443A1, Example A21, Linker	ADC Info
AU2023279443A1 Example A22 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	AU2023279443A1, Example A22, Linker	ADC Info
AU2023279443A1 Comparative Control Compound-1 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
AU2023279443A1 Comparative Control Compound-2 ^[506]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Eribulin	Mal-PEG2-Val-Cit-PAB	ADC Info
WO2024181570A1 ADC1 ^[507]	Antibody 1	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
WO2024181570A1 ADC2 ^[507]	Antibody 2	Syndecan-1 (SDC1)	Mertansine DM4	SPDB	ADC Info
WO2024181570A1 ADC3 ^[507]	Antibody 1	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC4 ^[507]	Antibody 1	Syndecan-1 (SDC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC8 ^[507]	Antibody 3	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC9 ^[507]	Antibody 4	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC10 ^[507]	Antibody 5	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC11 ^[507]	Antibody 6	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC12 ^[507]	Antibody 10	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC13 ^[507]	Antibody 11	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2024181570A1 ADC14 ^[507]	Antibody 12	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WO2020252015A1 ADCLP-1 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
WO2020252015A1 ADCLP-11 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	DBCO-SO3-PEG4-Val-Cit-PABC	ADC Info
WO2020252015A1 ADCLP-12 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO sidechain PEG12 ValLys-pAB	ADC Info
WO2020252015A1 ADCLP-13 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO SIDECHAIN PEG12-PAB	ADC Info
WO2020252015A1 ADCLP-21 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-nAA-PEG13-VKG	ADC Info
WO2020252015A1 ADCLP-22 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-AA-PEG13-AAN	ADC Info
WO2020252015A1 ADCLP-23 ^[508]	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	SC209	DBCO-6.4nnAA-B-Glucuronide-PEG12	ADC Info
Anti-HER-MC-VC-FABC-MMAE ^[509]	Anti-Her2 WT	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Aminooxy-Cys linker	ADC Info
AntiHER-AO-Cys-MC-VC-FABC-MMAE ^[509]	Anti-Her2 WT	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Aminooxy-Cys linker	ADC Info
Anti FAF BI1-MC-VC-FABC-MMAE ^[509]	Anti-FAF B11	Fibroblast growth factor (FGF)	Monomethyl auristatin E	Aminooxy-Cys linker	ADC Info
Anti FAF B11-AO-Cys-MC-VC-FABC-MMAE ^[509]	Anti-FAF B11	Fibroblast growth factor (FGF)	Monomethyl auristatin E	Aminooxy-Cys linker	ADC Info
SWY2110-VC-MMAE ADC ^[510]	SWY2110	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
VH4Vk3-MC-VCP-MMAE ADC ^[511]	VH4Vk3	Ephrin type-A receptor 5 (EPHA5)	Monomethyl auristatin E	MC-VCP linker	ADC Info
VH4Vk3-ThioBridge-VCP-MMAE ADC ^[511]	VH4Vk3	Ephrin type-A receptor 5 (EPHA5)	Monomethyl auristatin E	ThioBridge®-VCP linker	ADC Info
AbT-EXP9 ^[512]	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP9-linker	ADC Info
AbT-EXP10 ^[512]	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP10-linker	ADC Info
AbT-EXP11 ^[512]	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP11-linker	ADC Info
AbT-EXP12 ^[512]	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP12-linker	ADC Info
mAb-P5 (PEG12)- VC-PAB-MMAE ^[513]	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG12)- VC-PAB linker	ADC Info
mAb-P5 (PEG24)- VC-PAB-MMAE ^[513]	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG24)- VC-PAB linker	ADC Info
mAb-P5 (PEG2)- VC-PAB-MMAE ^[513]	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG2)- VC-PAB linker	ADC Info
mAb-P5 (PEG12)-VA-PAB-MMAE ^[513]	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG12)-VA-PAB linker	ADC Info
mAb-P5 (PEG2)-VA-PAB-MMAE ^[513]	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG2)-VA-PAB linker	ADC Info
mAb-P5 (PEG24)-VA-PAB-MMAE ^[513]	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG24)-VA-PAB linker	ADC Info
IgG-DM1 ^[514]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
ICAM1-DM1 1-10 ^[514]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
IgG-MMAE 1-10 ^[514]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
ICAM1-MMAE 1-10 ^[514]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
IgG-MMAF ^[514]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	6-Maleimidocaproic acid	ADC Info
ICAM1-MMAF 1-10 ^[514]	Undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	6-Maleimidocaproic acid	ADC Info
CN106714844B ADC-141 ^[515]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
ZHER2-Gly3-VC-PAB-MMAF ^[516]	ZHER2	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin F	Gly3-VC-PAB	ADC Info
ZHER2-Gly3-VC-PAB-MMAE ^[516]	ZHER2	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Gly3-VC-PAB	ADC Info
CN113286618A ADC-3 ^[517]	alpha-HMGB1Ab	High mobility group box 1 protein (HMGB1)	Mertansine DM1	CN113286618A-ADC-3-linker	ADC Info
CN113286618A ADC-4 ^[517]	alpha-KLHAb	Hemocyanin 1 (KLH1)	Mertansine DM1	Undisclosed	ADC Info
huM25-vcMMAE ADCs ^[518]	huM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
Anti-huLRRC15 ADCs ^[518]	huM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin F	6-Maleimidocaproic acid	ADC Info
CN114306633A A-1 ^[519]	pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	CN114306633A-A-1-linker	ADC Info
CN114306633A C-3 ^[519]	pertuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	CN114306633A-C-3-linker	ADC Info
CN110974975B C-00 ^[520]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	CN110974975B-C-00-linker	ADC Info
SCT-200-M-1 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-M-1-linker	ADC Info
SCT-200-M-2 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-M-2-linker	ADC Info
SCT-200-M-3 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-M-3-linker	ADC Info
SCT-200-C-1 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-1-linker	ADC Info
SCT-200-C-2 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-2-linker	ADC Info
SCT-200-C-3 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-3-linker	ADC Info
SCT-200-C-4 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-4-linker	ADC Info
SCT-200-C-5 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-5-linker	ADC Info
SCT-200-R-1 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-R-1-linker	ADC Info
SCT-200-R-2 ^[521]	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-R-2-linker	ADC Info
(RC48-vc-MMAE) ^[522]	RC48	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Mc-Val-Ala-PABC	ADC Info
PCAD-mab2-L4-P1 ^[523]	PCAD-mab2	Cadherin-3 (CDH3)	L4P1 payload	L4-P1 linker	ADC Info
PCAD-mab2-L6-P1 ^[523]	PCAD-mab2	Cadherin-3 (CDH3)	L4P1 payload	L6-P1 linker	ADC Info
IgG-L4-P1 ^[523]	Undisclosed	Cadherin-3 (CDH3)	L4P1 payload	L4-P1 linker	ADC Info
IgG-L6-P1 ^[523]	Undisclosed	Cadherin-3 (CDH3)	L4P1 payload	L6-P1 linker	ADC Info
TW202506738A C-332 ^[524]	Undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-327-LINKER	ADC Info
TW202506738A C-333 ^[524]	Undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-333-LINKER	ADC Info
TW202506738A C-334 ^[524]	Undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-333-LINKER	ADC Info
TW202506738A C-335 ^[524]	Undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-335-LINKER	ADC Info
CN113874046B ADC-1 ^[525]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	CN113874046B-ADC-1-LINKER	ADC Info
CN113874046B ADC-4 ^[525]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	CN113874046B-ADC-4-LINKER	ADC Info
CN113874046B ADC-7 ^[525]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	CN113874046B-ADC-7-LINKER	ADC Info
AZO-ADC-0 ^[526]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Solubilizing group-PEG0-Hypoxia sensitive linker-Azobenzene	ADC Info
AZO-ADC-2 ^[526]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Solubilizing group-PEG2-Hypoxia sensitive linker-Azobenzene	ADC Info
AZO-ADC-4 ^[526]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Solubilizing group-PEG4-Hypoxia sensitive linker-Azobenzene	ADC Info
AZO-ADC-6 ^[526]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Solubilizing group-PEG6-Hypoxia sensitive linker-Azobenzene	ADC Info
AZO-ADC-8 ^[526]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	Solubilizing group-PEG8-Hypoxia sensitive linker-Azobenzene	ADC Info
Trastuzumab-BUPY-DM1 ^[527]	Trastuzumab-BUPY	Receptor tyrosine-protein kinase erbB-2 (HER2)	Mertansine DM1	N3-SMCC	ADC Info
IgG (8)-m- (b-PEG12)-VC-MMAE ^[528]	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	IgG (8)-m- (b-PEG12)-VC-MMAE	ADC Info
Mb (4)-m- (b-PEG12)-VC-MMAE ^[528]	Minibody (4 cys)	Receptor tyrosine-protein kinase erbB-2 (HER2)	Monomethyl auristatin E	IgG (8)-m- (b-PEG12)-VC-MMAE	ADC Info
NAPC-ADC ^[529]	sibrotuzumab	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	MC-Radiation-responsive linker	ADC Info
ALE.P02	Anti-CLDN1 antibody	Claudin-1 (CLDN1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SYS6005	Anti-ROR1 Fc-silenced mAb	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	A cleavable linker	ADC Info
DXC-008	Anti-PSMA/STEAP1 dual-target antibody	Glutamate carboxypeptidase 2 (FOLH1); Metalloreductase STEAP1 (STEAP1)	Tubulysin B analog	A cleavable linker	ADC Info
Debio 1562M	Naratuximab	Leukocyte antigen CD37 (CD37)	DM1	Multilink^TM Cleavable Linker	ADC Info
HY0001a	HY0001	CUB domain-containing protein 1 (CDCP1)	Monomethyl auristatin E	A cleavable linker	ADC Info
HDM2005	Anti-ROR1 antibody	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
MRG004A	MAB804	Tissue factor (F3)	Monomethyl auristatin E	BCN-Val-Cit linker	ADC Info
laventatug tivedotin	Laventatug	Zinc transporter ZIP6 (SLC39A6)	Monomethyl auristatin E	BrAc-Val-Cit-PABC	ADC Info
VBC101-F11	Anti-EGFR/c-Met bsAb	Hepatocyte growth factor receptor (MET); Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Undisclosed	ADC Info
PF-08046054	Undisclosed	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
WEF-001	Undisclosed	Undisclosed	Monomethyl auristatin E	Undisclosed	ADC Info
PF-08052667	Anti-ITGB6 mAb	Integrin beta-6 (ITGB6)	Monomethyl auristatin E	Mal PEG12 based β-glucuronide linker	ADC Info
BL-M24D1	Undisclosed	Undisclosed	WA-00	Undisclosed	ADC Info
HX111	Anti-OX40 antibody	Tumor necrosis factor receptor superfamily member 4	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
sacituzumab vedotin	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	ADC Info
SG2918	Anti-LILRB4 mAb	Leukocyte immunoglobulin-like receptor subfamily B member 4	Monomethyl auristatin E	A cleavable linker	ADC Info
CKD-703	Anti-c-Met antibody	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	ADC Info
ARX305	Anti-CD70 mAb	CD70 antigen (CD70)	Amberstatin 269 (AS269)	Oxime-PEG3	ADC Info
JNJ-95298177	Anti-PSMA IgG1k mAb	Glutamate carboxypeptidase 2 (FOLH1)	Amberstatin 269 (AS269)	Oxime-PEG3	ADC Info
AVID100	MAB100	Epidermal growth factor receptor (EGFR)	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	ADC Info
AGS-16M8F	Anti-ENPP3 antibody	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3)	Monomethyl auristatin F	Maleimido-caproyl	ADC Info
MBRC-101	Anti-EphA5 mAb	Ephrin type-A receptor 5 (EPHA5)	Monomethyl auristatin E	ThioBridge bis-sulfone Val-Cit linker	ADC Info
NC18	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (HER2)	AF-HEA	PHF polymer linker	ADC Info
MHB118C	Anti-IGF-1R antibody	Insulin-like growth factor 1 receptor (IGF1R)	Undisclosed	Undisclosed	ADC Info
LY203725	KS1/4	Undisclosed	4-desacetylvinblastine (DAVLB)	A cleavable linker	ADC Info
LY256787	KS1/4	Undisclosed	4-desacetylvinblastine (DAVLB)	A cleavable linker	ADC Info

References

Ref 1	Immunoconjugates targeting cd138 and uses thereof; 2009-07-02.
Ref 2	Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers
Ref 3	Introduction to basic information on ADC drug trastuzumab vedotin.
Ref 4	FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas
Ref 5	Trastuzumab emtansine: first global approval
Ref 6	Tisotumab Vedotin: First Approval
Ref 7	Mirvetuximab Soravtansine: First Approval
Ref 8	FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Ref 9	Belantamab Mafodotin: First Approval
Ref 10	[Relation between goiter endemia and iodine content of the drinking water in some zones of Piedmont and Sardinia]
Ref 11	89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Ref 12	Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors. Blood (2013) 122 (21): 1637.
Ref 13	IMGN853, a Folate Receptor- (FR)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FR-Expressing Tumors. Mol Cancer Ther. 2015 Jul;14(7):1605-13.
Ref 14	Introduction to basic information on ADC drug anti-FR (clone M9346A)-SPDB-DM4.
Ref 15	Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting. Mol Cancer Ther. 2018 Nov;17(11):2412-2426.
Ref 16	Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade. Mol Cancer Ther. 2022 Sep 6;21(9):1462-1472.
Ref 17	Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models. Front Oncol. 2022 May 4;12:856424.
Ref 18	High-throughput membrane-anchored proteome screening reveals PIEZO1 as a promising antibody-drug target for human esophageal squamous cell carcinoma. Cancer Med. 2022 Oct;11(19):3700-3713.
Ref 19	Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer. Int J Mol Sci. 2022 Feb 18;23(4):2264.
Ref 20	Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model. Cancer Cell Int. 2022 Dec 27;22(1):417.
Ref 21	Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer. Neoplasia. 2023 Jan;35:100853.
Ref 22	Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target. RSC Chem Biol. 2021 May 31;2(4):1206-1220.
Ref 23	An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer. Eur J Med Chem. 2022 Nov 5;241:114617.
Ref 24	Enzymatic glycan remodeling-metal free click (GlycoConnect) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering. MAbs. 2022 Jan-Dec;14(1):2078466.
Ref 25	Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res. 2008 Nov 15;68(22):9280-90.
Ref 26	Biological Evaluation of Maytansinoid-Based Site-Specific Antibody-Drug Conjugate Produced by Fully Chemical Conjugation Approach: AJICAP. Front Biosci (Landmark Ed). 2022 Aug 5;27(8):234.
Ref 27	Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766.
Ref 28	Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics. 2021 Nov 3;13(11):1847.
Ref 29	Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker. Mol Cancer Ther. 2016 Jun;15(6):1301-10.
Ref 30	Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker. Mol Cancer Ther. 2016 Jun;15(6):1301-10. doi: 10.1158/1535-7163.MCT-15-0570. Epub 2016 Mar 4.
Ref 31	A glypican-1-targeted antibody-drug conjugate exhibits potent tumorgrowth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma. Neoplasia. 2021 Sep;23(9):939-950.
Ref 32	Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma. Mol Cancer Ther. 2021 Sep;20(9):1713-1722. doi: 10.1158/1535-7163.MCT-21-0015. Epub 2021 Jun 17.
Ref 33	Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer. Mil Med Res. 2021 Dec 9;8(1):63.
Ref 34	A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors. Mol Oncol. 2022 Mar;16(6):1290-1308.
Ref 35	Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers. Cancer Discov. 2017 Sep;7(9):1030-1045.
Ref 36	Novel peptide linkers for highly potent antibody-auristatin conjugate. Bioconjug Chem. 2008 Oct;19(10):1960-3. doi: 10.1021/bc800289a. Epub 2008 Sep 20.
Ref 37	Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation. Mol Cancer Ther. 2017 May;16(5):879-892.
Ref 38	Protease-activated drug development. Theranostics. 2012;2(2):156-78.
Ref 39	The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo. Clin Cancer Res. 2009 Jun 15;15(12):4028-37.
Ref 40	Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells. Blood. 2004 Dec 1;104(12):3688-96.
Ref 41	AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage. Acta Pharmacol Sin. 2023 Jun;44(6):1290-1303.
Ref 42	Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. Nat Med. 2018 Feb;24(2):203-212.
Ref 43	Targeting and pharmacology of an anti-IL13R2 antibody and antibody-drug conjugate in a melanoma xenograft model. MAbs. 2021 Jan-Dec;13(1):1958662.
Ref 44	Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nat Commun. 2021 Jun 10;12(1):3528.
Ref 45	Compact hydrophilic electrophiles enable highly efficacious high DAR ADCs with excellent in vivo PK profile. Chem Sci. 2023 Jan 3;14(9):2259-2266. doi: 10.1039/d2sc05678j. eCollection 2023 Mar 1.
Ref 46	A new immunochemical strategy for triple-negative breast cancer therapy. Sci Rep. 2021 Jul 21;11(1):14875.
Ref 47	Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation. Bioorg Chem. 2021 Nov;116:105366.
Ref 48	Cyclopentadiene as a Multifunctional Reagent for Normal- and Inverse-Electron Demand Diels-Alder Bioconjugation. Bioconjug Chem. 2022 Sep 21;33(9):1609-1619.
Ref 49	Synthesis and Evaluation of Three Azide-Modified Disaccharide Oxazolines as Enzyme Substrates for Single-Step Fc Glycan-Mediated Antibody-Drug Conjugation. Bioconjug Chem. 2022 Jun 15;33(6):1179-1191.
Ref 50	General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates. ACS Chem Biol. 2021 Nov 19;16(11):2502-2514.
Ref 51	Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation. Bioconjug Chem. 2022 Jun 15;33(6):1192-1200.
Ref 52	EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing. Biol Chem. 2021 Sep 20;403(5-6):525-534.
Ref 53	A FZD7-specific Antibody-Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models. Mol Cancer Ther. 2022 Jan;21(1):113-124.
Ref 54	Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies. Mol Pharm. 2022 May 2;19(5):1422-1433.
Ref 55	Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity. Biomed Pharmacother. 2023 Jan;157:114047.
Ref 56	An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs. Cancer Lett. 2023 Feb 1;554:216024.
Ref 57	Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release. Bioconjug Chem. 2022 Aug 17;33(8):1474-1484.
Ref 58	The HB22.7 Anti-CD22 Monoclonal Antibody Is an Effective Platform for CD22-Targeted Antibody Drug Conjugates for Treatment of Lymphoma and Acute Lymphoblastic Leukemia. Blood. 2012 ;120(21):-. doi: 10.1182/blood.V120.21.1653.1653.
Ref 59	Anti-tumor efficacy of GMF-1A3, an MMAE-based antibody drug conjugate targeting cell surface cleaved Amphiregulin in breast cancer. Cancer Res (2023) 83 (7_Supplement): 562.
Ref 60	Introduction to basic information on ADC drug IN30705.
Ref 61	Izeltabart tapatansine by MacroGenics for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval; 30 May 2023.
Ref 62	Discovery of A Novel EGFR-Targeting Antibody-Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies. Mol Cancer Ther. 2019 Jun;18(6):1104-1114. doi: 10.1158/1535-7163.MCT-18-0854.
Ref 63	Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies. Blood. 2019 ;134():-. doi: 10.1182/blood-2019-132062.
Ref 64	Preclinical Development of a Bcma Targeting Antibody-Drug Conjugate with Novel Payload for Multiple Myeloma Therapy. Blood. 2019 ;134():-. doi: 10.1182/blood-2019-132080.
Ref 65	Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989.
Ref 66	RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models. Mol Cancer Ther. 2016 Nov;15(11):2698-2708. doi: 10.1158/1535-7163.MCT-16-0431. Epub 2016 Aug 31.
Ref 67	RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models. Oncotarget. 2018 Sep 11;9(71):33446-33458. doi: 10.18632/oncotarget.26002. eCollection 2018 Sep 11.
Ref 68	NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells. Cell Rep Med. 2021 May 18;2(5):100279. doi: 10.1016/j.xcrm.2021.100279. eCollection 2021 May 18.
Ref 69	Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer. Sci Rep. 2019 Jun 10;9(1):8420. doi: 10.1038/s41598-019-44874-0.
Ref 70	Mediapharma product pipeline
Ref 71	FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther. 2012 Oct;11(10):2222-32. doi: 10.1158/1535-7163.MCT-12-0087. Epub 2012 Jul 17.
Ref 72	Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates. Chem Sci. 2017 Jan 1;8(1):366-370. doi: 10.1039/c6sc01831a. Epub 2016 Aug 22.
Ref 73	Evaluation of endoglin/CD105 as a tumor vasculature target with antibody drug conjugates. Cancer Res (2018) 78 (13_Supplement): 2900.
Ref 74	Introduction to basic information on ADC drug IMB-101 and IMB-102.
Ref 75	Cybrexa therapeutics product pipeline
Ref 76	Introduction to basic information on ADC drug Oberotatug ravtansine.
Ref 77	Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy. Mol Ther Oncolytics. 2021 Apr 29;21:329-339. doi: 10.1016/j.omto.2021.04.013. eCollection 2021 Jun 25.
Ref 78	Spirea secures more capital to develop nextgeneration ADC cancer therapeutics; 2020
Ref 79	Develop highly specific cell engager constructs with improved function and safety by understanding target-effector cell avidity.
Ref 80	Adcitmer , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. Br J Dermatol. 2022 Feb;186(2):295-306. doi: 10.1111/bjd.20770.
Ref 81	Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer. Bioconjug Chem. 2022 Feb 16;33(2):418-426. doi: 10.1021/acs.bioconjchem.2c00015. Epub 2022 Feb 1.
Ref 82	Divinylpyrimidine reagents generate antibody-drug conjugates with excellent in vivo efficacy and tolerability. Chem Commun (Camb). 2022 Feb 8;58(12):1962-1965. doi: 10.1039/d1cc06766d.
Ref 83	Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer. Cancer Chemother Pharmacol. 2019 Jul;84(1):61-72. doi: 10.1007/s00280-019-03848-9. Epub 2019 Apr 29.
Ref 84	MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy. J Exp Clin Cancer Res. 2020 Sep 22;39(1):198. doi: 10.1186/s13046-020-01711-x.
Ref 85	Old target, but new approach: Targeting cancer-associated MUC1 with ADC and Car-T. Cancer Res (2020) 80 (16_Supplement): 6530.
Ref 86	Preclinical characterization of a novel SSEA-4-targeting antibody drug conjugate, OBI-998. Cancer Res (2021) 81 (13_Supplement): 955.
Ref 87	ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. Blood Adv. 2020 Oct 27;4(20):5203-5214. doi: 10.1182/bloodadvances.2020002395.
Ref 88	Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. J Clin Invest. 2018 Jul 2;128(7):2927-2943. doi: 10.1172/JCI120481. Epub 2018 Jun 4.
Ref 89	Introduction to basic information on ADC drug IMAB362-VCMMAE.
Ref 90	Preclinical characterization of the safety and antitumor activity of IMAB027-vcMMAE, an anticlaudin 6 antibody-drug conjugate. Cancer Res (2018) 78 (13_Supplement): 1778.
Ref 91	Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody libraries. Sci Rep. 2021 Jul 29;11(1):15430. doi: 10.1038/s41598-021-94902-1.
Ref 92	Introduction to basic information on ADC drug Bstrongximab ADC (CureMeta).
Ref 93	The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells. Mol Med. 2021 May 7;27(1):46. doi: 10.1186/s10020-021-00306-2.
Ref 94	An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells. Leuk Res. 2021 Sep;108:106626. doi: 10.1016/j.leukres.2021.106626.
Ref 95	Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy. J Immunother Cancer. 2019 Sep 13;7(1):250. doi: 10.1186/s40425-019-0732-8.
Ref 96	Introduction to basic information on ADC drug GB-7008-01-vcMMAE.
Ref 97	Development of Cirmtuzumab Antibody-Drug Conjugates (ADCs) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1). Blood. 2018 ;132():-. doi: 10.1182/blood-2018-99-119447.
Ref 98	Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. Nat Commun. 2022 Jul 5;13(1):3869. doi: 10.1038/s41467-022-31601-z.
Ref 99	Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model. Bioconjug Chem. 2021 Mar 17;32(3):595-606. doi: 10.1021/acs.bioconjchem.1c00058. Epub 2021 Feb 25.
Ref 100	Avibodie are engineered, bivalent antibody fragments, precisely loaded with imaging or cytotoxic payloads
Ref 101	Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. Oncotarget. 2018 May 1;9(33):23289-23305. doi: 10.18632/oncotarget.25289. eCollection 2018 May 1.
Ref 102	Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors. J Nucl Med. 2018 Mar;59(3):494-501. doi: 10.2967/jnumed.117.196279. Epub 2017 Nov 16.
Ref 103	FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther. 2012 Oct;11(10):2222-32. doi: 10.1158/1535-7163.MCT-12-0087. Epub 2012 Jul 17.
Ref 104	Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates. Mol Cancer Ther. 2016 May;15(5):938-45. doi: 10.1158/1535-7163.MCT-16-0038. Epub 2016 Mar 4.
Ref 105	Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease. Sci Rep. 2017 Sep 6;7(1):10735. doi: 10.1038/s41598-017-11255-4.
Ref 106	A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models. Signal Transduct Target Ther. 2021 Sep 3;6(1):320. doi: 10.1038/s41392-021-00666-5.
Ref 107	Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible Antigen. Clin Cancer Res. 2021 Jun 1;27(11):3224-3233. doi: 10.1158/1078-0432.CCR-20-1725.
Ref 108	Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Ann Oncol. 2017 Apr 1;28(4):769-776. doi: 10.1093/annonc/mdw678.
Ref 109	Introduction to basic information on ADC drug ST1.
Ref 110	A novel pegylated bispecific antibody-drug conjugate (P-BsADCpb-adc) targeting cancers co-expressing PD-L1 and CD47. Cancer Res (2023) 83 (7_Supplement): 6307.
Ref 111	Antibody-Drug Conjugates Used in Breast Cancers. J Oncol. 2021 Jun 24;2021:9927433. doi: 10.1155/2021/9927433. eCollection 2021.
Ref 112	LCB97, an antibody drug conjugate (ADC) targeting a novel tumor antigen for the treatment of multiple solid tumors. Cancer Res (2023) 83 (7_Supplement): 5653.
Ref 113	Legochem biosciences biopharmaceutical company product pipeline
Ref 114	Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies. Mol Cancer Ther. 2015 Sep;14(9):2081-9. doi: 10.1158/1535-7163.MCT-15-0312. Epub 2015 Jul 16.
Ref 115	Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol. 2018 Apr 1;29(4):917-923.
Ref 116	Introduction to basic information on ADC drug DM003.
Ref 117	Anti-MSLN ADC against cancer; institute of pharmaceutics development center for biotechnology; 2020
Ref 118	A first-in-class anti-HER2/TROP2 bispecific antibody-drug conjugate (YH012) exhibits potent anti-tumor efficacy. Cancer Res (2023) 83 (7_Supplement): 2977.
Ref 119	YH013, a novel EGFR x MET bispecific antibody-drug conjugate, exhibits potent antitumor efficacy. Cancer Res (2023) 83 (7_Supplement): 2978.
Ref 120	Identification of DM004, a first-in-class anti-5T4/MET bispecific antibody-drug conjugate. Cancer Res (2023) 83 (8_Supplement): LB213.
Ref 121	A novel EGFR x MUC1 bispecific antibody-drug conjugate, BSA01, targets MUC1 transmembrane cleavage products and improves tumor selectivity. Cancer Res (2023) 83 (7_Supplement): 6325.
Ref 122	Discovery of BCG033, a novel anti-PTK7 x TROP2 bispecific antibody-drug conjugate with promising efficacy against triple-negative breast cancer. Cancer Res (2023) 83 (8_Supplement): LB216.
Ref 123	BCG022: A novel bispecific antibody-drug conjugate targeting HER3 and MET. Cancer Res (2023) 83 (8_Supplement): LB212.
Ref 124	NextGen conditionally active biologic (CAB) anti-Nectin-4-ADC with improved stability and safety. Cancer Res (2023) 83 (7_Supplement): 1541.
Ref 125	Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors. Cancer Res (2020) 80 (16_Supplement): 4560.
Ref 126	A CD79b Targeting ADC with Superior Anti-Tumor Activity and Safety Resulting in Significantly Improved Therapeutic Index (TI): Safe and Efficacious CD79b ADC. Blood. 2022 ;140():11568-11569. doi: 10.1182/blood-2022-160056.
Ref 127	A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers. Cancer Res (2014) 74 (19_Supplement): 4494.
Ref 128	Anwita biosciences product pipeline
Ref 129	Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers. Mol Cancer Ther. 2017 Jul;16(7):1299-1311. doi: 10.1158/1535-7163.MCT-16-0839. Epub 2017 Apr 4.
Ref 130	A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells. mBio. 2022 Feb 22;13(1):e0338421. doi: 10.1128/mbio.03384-21. Epub 2022 Jan 18.
Ref 131	Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody-Drug Conjugate LR-DM1 for Pancreatic Cancer. J Med Chem. 2022 May 26;65(10):7141-7153. doi: 10.1021/acs.jmedchem.1c01920. Epub 2022 May 6.
Ref 132	Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis. Neoplasia. 2017 Sep;19(9):716-733. doi: 10.1016/j.neo.2017.07.001. Epub 2017 Aug 19.
Ref 133	EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma. Cancers (Basel). 2018 Dec 17;10(12):519. doi: 10.3390/cancers10120519.
Ref 134	Antibody-drug conjugates targeting CD248(+) myofibroblasts effectively alleviate renal fibrosis in mice. FASEB J. 2022 Feb;36(2):e22102. doi: 10.1096/fj.202101441R.
Ref 135	A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer. Adv Sci (Weinh). 2020 Nov 3;7(24):2002852. doi: 10.1002/advs.202002852.
Ref 136	A ca6 antigen-specific cytotoxic conjugate and methods of using the same; 2005-02-03
Ref 137	Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy. Clin Cancer Res. 2014 Dec 1;20(23):6045-58. doi: 10.1158/1078-0432.CCR-14-0898. Epub 2014 Oct 7.
Ref 138	Antibody-Drug Conjugate to Treat Meningiomas. Pharmaceuticals (Basel). 2021 May 2;14(5):427. doi: 10.3390/ph14050427.
Ref 139	A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer. Breast Cancer. 2022 Nov;29(6):1121-1132. doi: 10.1007/s12282-022-01393-7. Epub 2022 Aug 18.
Ref 140	Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft. Oncotarget. 2019 Feb 1;10(10):1031-1044. doi: 10.18632/oncotarget.26613. eCollection 2019 Feb 1.
Ref 141	Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy. Eng Life Sci. 2020 Oct 7;21(1-2):37-44. doi: 10.1002/elsc.202000027. eCollection 2021 Jan.
Ref 142	Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines (Basel). 2021 Aug 10;9(8):882. doi: 10.3390/vaccines9080882.
Ref 143	Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer. Anticancer Res. 2022 Jul;42(7):3453-3461. doi: 10.21873/anticanres.15832.
Ref 144	Bispecific HER2 ADC: Making more potent HER2 ADC by improving target internalization; Cancer Res (2019) 79 (13_Supplement): 233..
Ref 145	Post translational modification therapeutics product pipeline
Ref 146	Antibody drug conjugate using CTAT linker technology shows superior efficacy in xenograft trial; 2015
Ref 147	Introduction to basic information on humanized anti-HER2 mab-maytansine conjugate(Anhui Anke Biotechnology/Wuxi Pharmatech).
Ref 148	Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C-Lock linker. Cancer Med. 2019 Apr;8(4):1793-1805. doi: 10.1002/cam4.2066. Epub 2019 Mar 7.
Ref 149	CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Am J Obstet Gynecol. 2021 Feb;224(2):197.e1-197.e23. doi: 10.1016/j.ajog.2020.08.028. Epub 2020 Aug 19.
Ref 150	N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability. MAbs. 2021 Jan-Dec;13(1):1914885. doi: 10.1080/19420862.2021.1914885.
Ref 151	Antibody targeting of B-cell maturation antigen on malignant plasma cells. Mol Cancer Ther. 2007 Nov;6(11):3009-18. doi: 10.1158/1535-7163.MCT-07-0464.
Ref 152	An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers. Adv Sci (Weinh). 2021 Dec;8(23):e2102414. doi: 10.1002/advs.202102414. Epub 2021 Oct 18.
Ref 153	Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy. J Control Release. 2021 Aug 10;336:433-442. doi: 10.1016/j.jconrel.2021.06.041. Epub 2021 Jun 29.
Ref 154	EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma. J Control Release. 2018 May 10;277:48-56. doi: 10.1016/j.jconrel.2018.03.016. Epub 2018 Mar 14.
Ref 155	Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016 Dec 1;126(12):4640-4653. doi: 10.1172/JCI85856. Epub 2016 Nov 14.
Ref 156	MP-EV20-ADC: humanized anti-HER3 antibody drug conjugate
Ref 157	AVIPEP Therapeutics product pipeline
Ref 158	Preclinical evaluation of NC-6201, an antibody/drug-conjugated micelle incorporating novel hemiasterlin analogue E7974.
Ref 159	Utilization of the Angiopep platform to enable brain penetration of therapeutic mAbs or Antibody-Drug Conjugates for treatment of brain tumors. Cancer Res (2014) 74 (19_Supplement): 2657.
Ref 160	Aphios biotechnology company product pipeline
Ref 161	Compounds, linker-drugs and ligand-drug conjugates; 2020-06-16
Ref 162	Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry. Bioconjug Chem. 2015 Nov 18;26(11):2249-60. doi: 10.1021/acs.bioconjchem.5b00359.
Ref 163	Dantari biotechnology company product pipeline
Ref 164	Stable and Potent Selenomab-Drug Conjugates. Cell Chem Biol. 2017 Apr 20;24(4):433-442.e6. doi: 10.1016/j.chembiol.2017.02.012.
Ref 165	Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance. J Immunother. 2016 Apr;39(3):117-26. doi: 10.1097/CJI.0000000000000115.
Ref 166	Introduction to basic information on eribulin ADC (Jiangsu hengrui)
Ref 167	Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate. Mol Cancer Ther. 2021 Jun;20(6):1121-1132.
Ref 168	Coare biopharmaceutical company product pipeline
Ref 169	MI130004, a Novel Antibody-Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors. Mol Cancer Ther. 2018 Apr;17(4):786-794. doi: 10.1158/1535-7163.MCT-17-0795. Epub 2018 Feb 13.
Ref 170	CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110. J Hematol Oncol. 2020 Apr 7;13(1):32. doi: 10.1186/s13045-020-00865-7.
Ref 171	Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice. Br J Cancer. 1994 Feb;69(2):279-85. doi: 10.1038/bjc.1994.52.
Ref 172	Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. Blood. 1995 Apr 15;85(8):2139-46.
Ref 173	Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development. PLoS One. 2021 Jan 27;16(1):e0246197. doi: 10.1371/journal.pone.0246197. eCollection 2021.
Ref 174	Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Br J Cancer. 2001 Feb;84(4):571-8. doi: 10.1054/bjoc.2000.1633.
Ref 175	Application of a Biocatalytic Strategy for the Preparation of Tiancimycin-Based Antibody-Drug Conjugates Revealing Key Insights into Structure-Activity Relationships. J Med Chem. 2023 Jan 26;66(2):1562-1573. doi: 10.1021/acs.jmedchem.2c01771.
Ref 176	A novel molecule with profound tumor killing activity. Cancer Res (2019) 79 (13_Supplement): 353.
Ref 177	Bliss Biopharmaceutical company product pipeline
Ref 178	Novel peptide linker-based nectin-4 targeting ADC shows improved tolerability with long-lasting anti-tumor efficacy at low doses. Cancer Res (2023) 83 (8_Supplement): LB221.
Ref 179	Mediapharma product pipeline
Ref 180	The antibody-drug conjugate GENA-111 conjugated to auristatin F shows therapeutic potency in BCAM positive epithelial cancer. 2022.
Ref 181	Novel antibody drug conjugate to inhibit mesothelioma tumor growth. Cancer Res (2019) 79 (13_Supplement): 210.
Ref 182	Novel antibody conjugates and uses thereof; 2014-08-28.
Ref 183	Anti-huLRRC15 antibody drug conjugates and methods for their use. 2017-06-08
Ref 184	MAbs. 2023 Jan-Dec;15(1):2149057. doi: 10.1080/19420862.2022.2149057.
Ref 185	A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Sci Adv. 2023 May 5;9(18):eabq7866. doi: 10.1126/sciadv.abq7866. Epub 2023 May 5.
Ref 186	Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjug Chem. 2023 Mar 15;34(3):538-548. doi: 10.1021/acs.bioconjchem.2c00611. Epub 2023 Mar 1.
Ref 187	Human antibodies targeting ENPP1 as candidate therapeutics for cancers. Front Immunol. 2023 Jan 25;14:1070492. doi: 10.3389/fimmu.2023.1070492. eCollection 2023.
Ref 188	AB-3A4: A novel KAAG1-targeting antibody-drug conjugate is active in models of ovarian carcinoma, triple-negative breast cancer and castration-resistant prostate cancer. Cancer Res (2014) 74 (19_Supplement): 666.
Ref 189	Introduction to basic information on ADC drug IGN-786
Ref 190	ADC review AVID-300
Ref 191	Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells. ACS Omega. 2023 Jan 17;8(4):4026-4037. doi: 10.1021/acsomega.2c06844. eCollection 2023 Jan 31.
Ref 192	Old Drug, New Delivery Strategy: MMAE Repackaged. Int J Mol Sci. 2023 May 10;24(10):8543. doi: 10.3390/ijms24108543.
Ref 193	Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell Biosci. 2023 Apr 11;13(1):72. doi: 10.1186/s13578-023-01015-5.
Ref 194	Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma. Mol Oncol. 2023 Aug;17(8):1460-1473. doi: 10.1002/1878-0261.13453. Epub 2023 Jun 7.
Ref 195	Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs. J Control Release. 2023 Mar;355:515-527. doi: 10.1016/j.jconrel.2023.02.005. Epub 2023 Feb 14.
Ref 196	Development of a new minimally invasive phototherapy for lung cancer using antibody-toxin conjugate. Thorac Cancer. 2023 Mar;14(7):645-653. doi: 10.1111/1759-7714.14776. Epub 2023 Jan 19.
Ref 197	Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects. Bioorg Chem. 2023 Aug;137:106575. doi: 10.1016/j.bioorg.2023.106575. Epub 2023 Apr 26.
Ref 198	DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis. Front Immunol. 2023 Jan 26;14:1051506. doi: 10.3389/fimmu.2023.1051506. eCollection 2023.
Ref 199	Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of Sarcoma. Mol Cancer Ther. 2023 Feb 1;22(2):240-253. doi: 10.1158/1535-7163.MCT-22-0312.
Ref 200	An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer. J Immunother Cancer. 2023 Mar;11(3):e006274. doi: 10.1136/jitc-2022-006274.
Ref 201	Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids. Bioorg Med Chem. 2020 Dec 1;28(23):115785. doi: 10.1016/j.bmc.2020.115785. Epub 2020 Oct 11.
Ref 202	Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. Cancers (Basel). 2020 Mar 21;12(3):744. doi: 10.3390/cancers12030744.
Ref 203	Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model. Monoclon Antib Immunodiagn Immunother. 2020 Apr;39(2):37-44. doi: 10.1089/mab.2020.0001. Epub 2020 Mar 17.
Ref 204	Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. Br J Cancer. 2020 Apr;122(9):1333-1341. doi: 10.1038/s41416-020-0781-2. Epub 2020 Mar 10.
Ref 205	Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer. Theranostics. 2020 Jan 12;10(5):2095-2114. doi: 10.7150/thno.30736. eCollection 2020.
Ref 206	Chemical Artificial Internalizing Receptors for Primary T Cells. Adv Sci (Weinh). 2020 Jul 26;7(18):2001395. doi: 10.1002/advs.202001395. eCollection 2020 Sep.
Ref 207	Antibody-Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome-Disruptive Peptide. ACS Omega. 2019 Jul 31;4(7):12955-12968. doi: 10.1021/acsomega.9b01585. eCollection 2019 Jul 31.
Ref 208	Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. Antibodies (Basel). 2019 Nov 5;8(4):54. doi: 10.3390/antib8040054.
Ref 209	Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models. MAbs. 2019 Jan;11(1):153-165. doi: 10.1080/19420862.2018.1541370. Epub 2018 Nov 8.
Ref 210	Antibody-Mediated Endocytosis of Polysialic Acid Enables Intracellular Delivery and Cytotoxicity of a Glycan-Directed Antibody-Drug Conjugate. Cancer Res. 2019 Apr 15;79(8):1810-1821. doi: 10.1158/0008-5472.CAN-18-3119. Epub 2019 Feb 26.
Ref 211	Anti-tumor activity of antibody drug conjugate targeting aspartate--hydroxylase in pancreatic ductal adenocarcinoma. Cancer Lett. 2019 May 1;449:87-98. doi: 10.1016/j.canlet.2019.02.006. Epub 2019 Feb 12.
Ref 212	APOMAB Antibody-Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo. Mol Cancer Ther. 2019 Feb;18(2):335-345. doi: 10.1158/1535-7163.MCT-18-0842. Epub 2018 Nov 9.
Ref 213	Aryl Sulfate is a Useful Motif for Conjugating and Releasing Phenolic Molecules: Sulfur Fluorine Exchange Click Chemistry Enables Discovery of Ortho-Hydroxy-Protected Aryl Sulfate Linker. Bioconjug Chem. 2019 Jul 17;30(7):1957-1968. doi: 10.1021/acs.bioconjchem.9b00340. Epub 2019 Jun 28.
Ref 214	Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase. Mol Pharm. 2018 Aug 6;15(8):3260-3271. doi: 10.1021/acs.molpharmaceut.8b00298. Epub 2018 Jun 26.
Ref 215	Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. J Drug Target. 2018 Dec;26(10):905-912. doi: 10.1080/1061186X.2018.1450413. Epub 2018 Apr 13.
Ref 216	Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids. Bioorg Med Chem. 2018 May 15;26(9):2271-2279. doi: 10.1016/j.bmc.2018.02.025. Epub 2018 Feb 21.
Ref 217	Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor?2-positive gastric cancer. Oncol Rep. 2018 Mar;39(3):1396-1404. doi: 10.3892/or.2018.6201. Epub 2018 Jan 9.
Ref 218	Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer. Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.
Ref 219	Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3). Anticancer Drugs. 2020 Jun;31(5):463-472. doi: 10.1097/CAD.0000000000000878.
Ref 220	A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation. Mol Pharm. 2019 Sep 3;16(9):3926-3937. doi: 10.1021/acs.molpharmaceut.9b00529. Epub 2019 Jul 31.
Ref 221	A coiled-coil masking domain for selective activation of therapeutic antibodies. Nat Biotechnol. 2019 Jul;37(7):761-765. doi: 10.1038/s41587-019-0135-x. Epub 2019 May 27.
Ref 222	A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer. Biochem Biophys Res Commun. 2019 Jun 11;513(4):1083-1091. doi: 10.1016/j.bbrc.2019.04.046. Epub 2019 Apr 19.
Ref 223	Novel b7-h3 binding molecules, antibody drug conjugates thereof and methods of use thereof; 2017-10-19.
Ref 224	Antibody molecules and conjugates; 2023-05-19.
Ref 225	CA6 antigen-specific cytotoxic conjugate and methods of using the same; 2017-11-21.
Ref 226	Anti-integrin immunoconjugates, methods and uses; 2008-01-17.
Ref 227	Folate receptor 1 antibodies and immunoconjugates and uses thereof; 2011-09-01.
Ref 228	Introduction to basic information on ADC drug 1C1-mcMMAF
Ref 229	Compositions and methods related to anti-cd19 antibody drug conjugates; 2017-03-30.
Ref 230	Compositions and methods related to anti-egfr antibody drug conjugates; 2017-03-30.
Ref 231	Antibody-drug conjugate; 2016-08-25.
Ref 232	Tissue factor-targeted antibody-drug conjugate; 2018-03-01.
Ref 233	Anti-claudin 18.2 antibody and antibody-drug conjugate thereof; 2022-11-17.
Ref 234	Antibody-drug conjugates comprising branched linkers and methods related thereto; 2017-06-01.
Ref 235	Antibody-drug conjugate comprising antibody against human ror1, and use for the same; 2021-04-01.
Ref 236	Beta-glucuronide-linker drug conjugates; 2007-10-25.
Ref 237	Methylene carbamate linkers for use with targeted-drug conjugates; 2015-06-25.
Ref 238	Anti-c-met antibody-drug conjugate and applications thereof; 2022-03-10.
Ref 239	Anti-mesothelin antibody and antibody-drug conjugate thereof; 2019-11-28.
Ref 240	Hydrophilic antibody-drug conjugates; 2015-08-20.
Ref 241	Anti-cd228 antibodies and antibody-drug conjugates; 2022-02-10.
Ref 242	A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma. Front Oncol. 2019 Apr 10;9:258. doi: 10.3389/fonc.2019.00258. eCollection 2019.
Ref 243	A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors. Theranostics. 2019 Jul 13;9(18):5412-5423. doi: 10.7150/thno.33598. eCollection 2019.
Ref 244	Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate. PLoS One. 2018 Apr 19;13(4):e0195823. doi: 10.1371/journal.pone.0195823. eCollection 2018.
Ref 245	Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers. PLoS One. 2018 Feb 8;13(2):e0192194. doi: 10.1371/journal.pone.0192194. eCollection 2018.
Ref 246	Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR(+) and Heterogeneous Tumor Models. Mol Cancer Ther. 2018 Aug;17(8):1752-1760. doi: 10.1158/1535-7163.MCT-18-0073. Epub 2018 Jun 4.
Ref 247	Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice. Nat Commun. 2018 Jun 28;9(1):2512. doi: 10.1038/s41467-018-04982-3.
Ref 248	Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility. Antibodies (Basel). 2018 Mar 22;7(2):15. doi: 10.3390/antib7020015.
Ref 249	Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer. Sci Rep. 2019 Oct 17;9(1):14934. doi: 10.1038/s41598-019-51453-w.
Ref 250	Integrin 10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival. Cancers (Basel). 2019 Apr 25;11(4):587. doi: 10.3390/cancers11040587.
Ref 251	Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy. Cancers (Basel). 2019 Jul 8;11(7):957. doi: 10.3390/cancers11070957.
Ref 252	Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates. Sci Rep. 2019 Feb 21;9(1):2443. doi: 10.1038/s41598-019-38745-x.
Ref 253	Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases. Theranostics. 2019 Feb 7;9(4):1154-1169. doi: 10.7150/thno.29146. eCollection 2019.
Ref 254	An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. Int J Cancer. 2019 Oct 1;145(7):1838-1851. doi: 10.1002/ijc.32273. Epub 2019 Apr 1.
Ref 255	Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer. J Immunother Cancer. 2019 Oct 29;7(1):280. doi: 10.1186/s40425-019-0765-z.
Ref 256	Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates. Org Biomol Chem. 2018 Mar 14;16(11):1882-1889. doi: 10.1039/c7ob02780j.
Ref 257	Peroxide-cleavable linkers for antibody-drug conjugates. Chem Commun (Camb). 2023 Feb 9;59(13):1841-1844. doi: 10.1039/d2cc06677g.
Ref 258	Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) c-MET Antibodies and Antibody-Drug Conjugates. J Biol Chem. 2016 Nov 25;291(48):25106-25119. doi: 10.1074/jbc.M116.753491. Epub 2016 Sep 30.
Ref 259	ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen. Cancer Res. 2020 Oct 15;80(20):4552-4564. doi: 10.1158/0008-5472.CAN-20-1418. Epub 2020 Aug 31.
Ref 260	MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FR Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17(12):2665-2675. doi: 10.1158/1535-7163.MCT-17-1215. Epub 2018 Sep 27.
Ref 261	Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance. Front Pharmacol. 2022 Jun 17;13:764540. doi: 10.3389/fphar.2022.764540. eCollection 2022.
Ref 262	Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors. J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646.
Ref 263	A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and Selectivity. Bioconjug Chem. 2022 Oct 19;33(10):1860-1866. doi: 10.1021/acs.bioconjchem.2c00314. Epub 2022 Sep 15.
Ref 264	One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling. Bioconjug Chem. 2021 Aug 18;32(8):1888-1897. doi: 10.1021/acs.bioconjchem.1c00314. Epub 2021 Aug 5.
Ref 265	Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. Blood. 2022 Apr 21;139(16):2471-2482. doi: 10.1182/blood.2021015161.
Ref 266	Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766. doi: 10.1080/10717544.2022.2039807.
Ref 267	Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation. Org Lett. 2020 Nov 6;22(21):8419-8423. doi: 10.1021/acs.orglett.0c03049. Epub 2020 Oct 19.
Ref 268	Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. Int J Mol Sci. 2020 Sep 19;21(18):6882. doi: 10.3390/ijms21186882.
Ref 269	Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models. Am J Cancer Res. 2020 Aug 1;10(8):2387-2408. eCollection 2020.
Ref 270	Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer. Br J Cancer. 2020 Nov;123(10):1502-1512. doi: 10.1038/s41416-020-01046-6. Epub 2020 Sep 11.
Ref 271	Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells. PLoS One. 2020 Sep 28;15(9):e0239813. doi: 10.1371/journal.pone.0239813. eCollection 2020.
Ref 272	Divinylsulfonamides enable the construction of homogeneous antibody-drug conjugates. Bioorg Med Chem. 2020 Dec 1;28(23):115793. doi: 10.1016/j.bmc.2020.115793. Epub 2020 Oct 6.
Ref 273	Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect. Bioeng Transl Med. 2022 Aug 21;7(3):e10388. doi: 10.1002/btm2.10388. eCollection 2022 Sep.
Ref 274	Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminase. RSC Adv. 2022 Nov 22;12(52):33510-33515. doi: 10.1039/d2ra05630e. eCollection 2022 Nov 22.
Ref 275	Hiding Payload Inside the IgG Fc Cavity Significantly Enhances the Therapeutic Index of Antibody-Drug Conjugates. J Med Chem. 2023 Jan 12;66(1):1011-1026. doi: 10.1021/acs.jmedchem.2c01812. Epub 2022 Dec 30.
Ref 276	AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage. Acta Pharmacol Sin. 2023 Jun;44(6):1290-1303. doi: 10.1038/s41401-022-01047-6. Epub 2023 Jan 17.
Ref 277	Anti-cdh6 antibody and anti-cdh6 antibody-drug conjugate.
Ref 278	Cysteine engineered antibodies and conjugates.
Ref 279	Conjugates comprising self-immolative groups and methods related thereto.
Ref 280	Bcma monoclonal antibody-drug conjugate.
Ref 281	Site-specific antibody-drug conjugation through glycoengineering.
Ref 282	An overview of huPr1-vcMMAE.
Ref 283	Site-specific conjugation of linker drugs to antibodies and resulting adcs.
Ref 284	Anti-cxcr4 antibodies and antibody-drug conjugates.
Ref 285	Covalent linkers in antibody-drug conjugates and methods of making and using the same.
Ref 286	Tridentate connexon and use thereof.
Ref 287	Antibody drug conjugates.
Ref 288	Antibody drug conjugates.
Ref 289	Anti-egfr antibodies and antibody drug conjugates.
Ref 290	Introduction to basic information on ADC drug Alpha-CD70-Mc-MMAF
Ref 291	Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. Mol Pharm. 2015 Jun 1;12(6):1863-71. doi: 10.1021/mp500666j. Epub 2015 Feb 9.
Ref 292	Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer. Oncotarget. 2019 Oct 22;10(58):6234-6244. doi: 10.18632/oncotarget.27263. eCollection 2019 Oct 22.
Ref 293	Recombinant anti-cd30 antibodies and uses thereof; 2006-02-02
Ref 294	Tasly pharma announcement; 2020
Ref 295	Introduction to basic information on EGFRvIII/MMAE antibody drug conjugate(Abgenix, Inc.).
Ref 296	Introduction to basic information on ADC drug C-met monoclonal antibody-drug conjugate
Ref 297	Introduction to basic information on ADC drug ADC-W-2589.
Ref 298	In vitro and in vivo activity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugate. Cancer Res (2015) 75 (15_Supplement): 1680.
Ref 299	Antibody-drug conjugates and related compounds, compositions, and methods.
Ref 300	Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer. PLoS One. 2016 Jun 23;11(6):e0157762. doi: 10.1371/journal.pone.0157762. eCollection 2016.
Ref 301	Anti-ROR1 antibodies and antibody conjugates, compositions comprising Anti-ROR1 antibodies or antibody conjugates, and methods of making and using Anti-ROR1 antibodies and antibody conjugates
Ref 302	A phase Ia/Ib study of CBP-1008, a bispecific ligand drug conjugate, in patients with advanced solid tumors. Journal of Clinical Oncology 2022 40:16_suppl, 3000-3000.
Ref 303	DAC biotechnology company product pipeline
Ref 304	Introduction to basic information on ADC drug ZV203; 6 Jan 2020.
Ref 305	Conjupro biotherapeutics product pipeline
Ref 306	MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors. Mol Cancer Ther. 2019 Sep;18(9):1533-1543. doi: 10.1158/1535-7163.MCT-18-0624. Epub 2019 Jun 21.
Ref 307	Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer. Mol Cancer Ther. 2016 Mar;15(3):439-47. doi: 10.1158/1535-7163.MCT-15-0693.
Ref 308	Introduction to basic information on ADC drug trastuzumab botidotin.
Ref 309	Novel development strategies and challenges for anti-Her2 antibody-drug conjugates. Antib Ther. 2022 Jan 27;5(1):18-29. doi: 10.1093/abt/tbac001.
Ref 310	Novel bispecific antibody-drug conjugate targeting PD-L1 and B7-H3 enhances antitumor efficacy and promotes immune-mediated antitumor responses
Ref 311	A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
Ref 312	A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer
Ref 313	A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
Ref 314	A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin-cleavable ADC linkers
Ref 315	A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders
Ref 316	Development of a MMAE-based antibody-drug conjugate targeting B7-H3 for glioblastoma
Ref 317	A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer
Ref 318	Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates
Ref 319	Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates
Ref 320	Generation and Characterization of SORT1-Targeted Antibody-Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor
Ref 321	An Anti-CD147 Antibody-Drug Conjugate Mehozumab-DM1 is Efficacious Against Hepatocellular Carcinoma in Cynomolgus Monkey
Ref 322	Design and synthesis of novel site-specific antibody-drug conjugates that target TROP2
Ref 323	Targeting CD44 Variant 5 with an Antibody-Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
Ref 324	A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors
Ref 325	A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo
Ref 326	Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models
Ref 327	Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability
Ref 328	AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy
Ref 329	Synthesis and evaluation of antibody-drug conjugates with high drug-to-antibody ratio using dimaleimide-DM1 as a linker- payload
Ref 330	PEGylation of Dipeptide Linker Improves Therapeutic Index and Pharmacokinetics of Antibody-Drug Conjugates
Ref 331	A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)
Ref 332	Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates
Ref 333	Development of a Cytotoxic Antibody-Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells
Ref 334	Disulfide re-bridging reagents for single-payload antibody-drug conjugates
Ref 335	Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer
Ref 336	An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
Ref 337	Use of a Cyclic α-Alkylidene-β-Diketone as a Cleavable Linker Strategy for Antibody-Drug Conjugates
Ref 338	Production of site-specific antibody conjugates using metabolic glycoengineering and novel Fc glycovariants
Ref 339	Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer
Ref 340	CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma
Ref 341	Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting
Ref 342	A novel and promising therapeutic approach for treating pancreatic cancer: Nectin-4-targeted antibody-drug conjugates alone or combined with autophagy inhibitors
Ref 343	Phenyldivinylsulfonamides for the construction of antibody-drug conjugates with controlled four payloads
Ref 344	A novel anti-HER2/EGFR bispecific antibody-drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
Ref 345	Biological Evaluation of Antibody-Drug Conjugates Produced by Tag-Free Lipoate Ligase A Modification
Ref 346	A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
Ref 347	Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
Ref 348	hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer
Ref 349	A simple and highly sensitive LC-MS workflow for characterization and quantification of ADC cleavable payloads
Ref 350	Broadening the Therapeutic Window of ADCs Using Site-Specific Bioconjugation Showcased by an MMAE-Containing Peptide Linker in a CD79b-Targeting ADC
Ref 351	Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy
Ref 352	Evaluating the Potential of Cyclodextrins in Reducing Aggregation of Antibody-Drug Conjugates with Different Payloads
Ref 353	Affinity-Directed Site-Specific Protein Labeling and Its Application to Antibody-Drug Conjugates
Ref 354	Reducing target binding affinity improves the therapeutic index of anti-MET antibody-drug conjugate in tumor bearing animals
Ref 355	Evaluation of Potency and Specificity of Cryptophycin-Loaded Antibody-Drug Conjugates
Ref 356	CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate
Ref 357	AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis
Ref 358	Design, Synthesis, and In Vitro and In Vivo Evaluation of Cereblon Binding Bruton's Tyrosine Kinase (BTK) Degrader CD79b Targeted Antibody-Drug Conjugates
Ref 359	Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity
Ref 360	Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1
Ref 361	Tuneable thiol exchange linkers for traceless drug release applications in prodrugs and ADCs
Ref 362	NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate
Ref 363	Direct Preparation of Site-Specific Antibody-Drug Conjugates with Unpurified Antibodies in Culture Medium
Ref 364	A Recognition Tag of Human Origin for Bioorthogonal Generation of Antibody-Drug Conjugates using Microbial Biotin Ligase
Ref 365	Generation and characterization of 7DC-DM1: a non-cleavable CD47-targeting antibody-drug conjugates with antitumor effects
Ref 366	Fine-tuning phenoxy silyl scaffolds for the development of glutathione-responsive prodrugs and antibody-drug conjugates
Ref 367	Harnessing acylhydrazone-oxime exchange reaction to achieve diverse synthesis of glycosite-specific antibody-drug conjugates
Ref 368	Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody-drug conjugates
Ref 369	An antibody-drug conjugate targeting soluble and membrane-bound TGFα is effective against pancreatic tumors
Ref 370	Anti-CD64(scFv)-SNAP-Auristatin F: An in vitro proof of concept study for a recombinant antibody conjugate targeting CD64(+) acute monocytic leukemia
Ref 371	Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer
Ref 372	Site-Specific Antibody Conjugation Using Modified Bisected N-Glycans: Method Development and Potential toward Tunable Effector Function
Ref 373	CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment
Ref 374	Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models
Ref 375	Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model
Ref 376	In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment
Ref 377	TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
Ref 378	Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates
Ref 379	A HER2 Specific Nanobody-Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models
Ref 380	Site-Selective Tyrosine Reaction for Antibody-Cell Conjugation and Targeted Immunotherapy
Ref 381	TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers
Ref 382	Copper assisted sequence-specific chemical protein conjugation at a single backbone amide
Ref 383	AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage
Ref 384	Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein
Ref 385	Efficient intracellular drug delivery by co-administration of two antibodies against cell adhesion molecule 1
Ref 386	Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab-Auristatin Conjugate with a Wide Therapeutic Window
Ref 387	Probing the Internalization and Efficacy of Antibody-Drug Conjugate via Site-Specific Fc-Glycan Labelling of a Homogeneous Antibody Targeting SSEA-4 Bearing Tumors
Ref 388	Linker and Conjugation Site Synergy in Antibody-Drug Conjugates: Impacts on Biological Activity
Ref 389	Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases
Ref 390	PK/PD of Positively Charged ADC in Mice
Ref 391	An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer
Ref 392	A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer
Ref 393	T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers
Ref 394	NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease
Ref 395	ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
Ref 396	Half-life extension of single-domain antibody-drug conjugates by albumin binding moiety enhances antitumor efficacy
Ref 397	Ortho-functionalized pyridinyl-tetrazines break the inverse correlation between click reactivity and cleavage yields in click-to-release chemistry
Ref 398	Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase
Ref 399	CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment
Ref 400	Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4
Ref 401	An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1
Ref 402	Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer
Ref 403	Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy
Ref 404	MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment
Ref 405	PF-08046032: A Novel, Investigational CD25-Directed Antibody-Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
Ref 406	PCO25-210: Design of Novel Antibody Drug Conjugates Using a Fully Humanized Monoclonal Antibody Targeting the Human Neuronal Pentraxin Receptor (YB800-ADCs) for Therapeutic Intervention in Oncology
Ref 407	Correction to: Method development of a novel PK assay for antibody-conjugated drug measurement of ADCs using peptide-linker drug analyte
Ref 408	TAVO605, a novel CD318 (CDCP1) ADC, for the treatment of solid cancers that are non-responding or resistant to Enhertu treatment
Ref 409	Preclinical development of TGW101, a first in class click-cleavable ADC with MMAE against non-internalizing pan-carcinoma marker TAG72
Ref 410	A next generation ADC: AR153, pH-dependent anti-B7H3 MMAE
Ref 411	IDP-001 is a potent bispecific ADC with in vivo activity against mouse xenograft tumor models expressing EGFR and CDCP1
Ref 412	Preclinical evaluation of SDV2102, a novel PSMA-targeting DAR1 ADC for mCRPC treatment
Ref 413	AT2604 is a highly efficacious ADC targeting alkaline phosphatases ALPP and ALPPL2
Ref 414	Development and preclinical activity of BSI-721, a novel antibody-drug conjugate (ADC) targeting cadherin 17 (CDH17) in gastrointestinal cancers
Ref 415	Development and characterization of an antibody-drug conjugate (ADC) utilizing PB-223, a novel monoclonal antibody (mAb) specifically targeting core 2 O-glycans on human carcinomas
Ref 416	The anti-tumor activity of a novel anti-Her2 and anti-c-Met bispecific antibody-drug conjugate
Ref 417	Assessing efficacy of anti-glypican-1antibody-drug conjugate as potential therapeutic approach for gastric cancer
Ref 418	PLB-002 is a novel Claudin 6 antibody-drug conjugate for ovarian cancer and testicular germ cell cancer
Ref 419	Novel tryptophan-based antibody-drug conjugate (ADC) targeting EGFR-positive lung cancer demonstrates robust antitumor efficacy by triggering immunogenic cell death
Ref 420	PF-08046031: A promising first-in-class antibody-drug conjugate for targeting novel tumor antigen in melanoma
Ref 421	Translational medicine studies of BR111, a biparatopic anti-ROR1 antibody drug conjugate for hematological and solid tumor treatment
Ref 422	Development of potent FGFR4-targeted antibody-drug conjugate therapies for rhabdomyosarcoma and other cancers expressing FGFR4
Ref 423	ADRX-0134 as a novel auristatin-based NaPi2b antibody-drug conjugate with widened therapeutic window
Ref 424	Antibody-drug conjugates
Ref 425	Conjugate antibody-drug comprising human trop2 antibody and use of the same
Ref 426	Antibodies targeting ITGA2 and antibody-drug conjugates comprising the antibodies
Ref 427	CD38 antibody-drug conjugates
Ref 428	CD44-specific antibodies
Ref 429	Antibody-drug conjugates based on eribulin and methods of use
Ref 430	Fan bracket
Ref 431	Anti-cd48 antibody, antibody drug conjugate and its use
Ref 432	Antibodies against monomethyl auristatin E and uses thereof
Ref 433	Novel anti-prostate-specific membrane antigen (PSMA) antibody drug conjugates
Ref 434	Allenamide linkers for antibody-drug conjugates
Ref 435	Methods of using antibody-drug conjugates
Ref 436	Methods for treating AXL-expressing cancer with anti-AXL antibodies, antibody fragments and their immune conjugates
Ref 437	Screening of site-specific conjugation sites of cysteine-engineered antibody-toxin complexes (TDCs)
Ref 438	Intercellular adhesion molecule 1 (ICAM1) antibody drug conjugate and uses thereof
Ref 439	Antibody binding specifically to GRP94 or antibody drug conjugate containing his antigen binding fragment and drug
Ref 440	Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
Ref 441	Methods and compositions for determining the biodistribution of activatable anti-CD166 antibody conjugates
Ref 442	Antibodies, expression vectors, recombinant prokaryotic host cells, pharmaceutical compositions, and uses of the antibody
Ref 443	Novel maytansinoids as ADC payloads and their use for the treatment of cancer
Ref 444	Antibody-drug conjugate and application thereof
Ref 445	Binding molecules targeting ROR1 and uses thereof
Ref 446	Antibody-drug conjugate
Ref 447	Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
Ref 448	Anti-CD228 antibodies and antibody-drug conjugates
Ref 449	Glyco-engineered antibody-drug conjugates comprising an oxime linker
Ref 450	Anti-MERTK agonistic antibodies and uses thereof
Ref 451	Anti-EGFR antibodies, antibody-drug conjugates, pharmaceutical compositions and uses for treating cancer and inhibiting or reducing solid tumor growth
Ref 452	Anti-mesothelin antibodies and uses thereof
Ref 453	Monoclonal antibodies targeting GPC3 and antibody-drug conjugates comprising the antibodies
Ref 454	Targeted delivery of dual payloads of MMAF or MMAE and TLR7 agonists for the treatment of cancer
Ref 455	Anti-sez6l2 antibodies and antibody-drug conjugates
Ref 456	Anti-TPBG/MET antibodies and uses thereof
Ref 457	Antibody-drug conjugate comprising modified antibody
Ref 458	Tetravalent antibody-drug conjugates and uses thereof
Ref 459	Selenium antibody conjugates
Ref 460	Anti-CD6 antibody conjugates for treating t-cell and b-cell mediated disorders, and t-cell and b-cell cancers
Ref 461	Antibody conjugate comprising anti-P-cadherin antibody and uses thereof
Ref 462	Antibody-drug conjugates for removing hematopoietic stem cells
Ref 463	Anti-ror1 antibodies and their uses
Ref 464	Antibody-drug conjugates targeting uPARAP comprising irinotecan derivatives
Ref 465	Methods for producing antibody-linker conjugates
Ref 466	Linker, antibody-drug conjugate including same, and uses thereof
Ref 467	Use of hydroxypropyl-β-cyclodextrin in stabilizing antibody-drug conjugate formulations
Ref 468	Antibody-drug conjugates
Ref 469	Improved antibody-payload conjugates (APCs) prepared by site-specific conjugation utilizing genetic code expansion
Ref 470	Antibody-drug conjugate intermediate SET0562, and its preparation and uses
Ref 471	Antibodies specifically binding ROR1, their drug conjugates, preparation methods and uses
Ref 472	CD70 antibody drug conjugates and methods of using the same
Ref 473	Humanized L1CAM antibody-drug conjugate
Ref 474	Anti-EDB antibodies and antibody-drug conjugates
Ref 475	Anti-ROR1 antibodies and antibody conjugates, compositions comprising Anti-ROR1 antibodies or antibody conjugates, and methods of making and using Anti-ROR1 antibodies and antibody conjugates
Ref 476	Anti-mesothelin antibody and antibody drug conjugate thereof
Ref 477	Ph-dependent Anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate
Ref 478	Anti-basal cell adhesion molecule antibody-drug conjugate
Ref 479	Binding molecule directed to ror1 and its use
Ref 480	Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
Ref 481	Antibody compositions comprising Fc mutations and site-specific conjugation properties for use in treating cancer, immunological disorders, and methods thereof
Ref 482	Pharmaceutical composition comprising anti-CD79b antibody-drug conjugate and use thereof
Ref 483	Anti-CEA antibody drug conjugates and methods of use
Ref 484	Anti-PSMA antibody-drug conjugates and their preparation methods and applications
Ref 485	Antibody-drug conjugates cleavable in a tumor microenvironment
Ref 486	TRBC targeting antibody-drug conjugates
Ref 487	Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
Ref 488	Anti-C10orf54 antibodies and uses thereof
Ref 489	Antibody-drug conjugates and production thereof
Ref 490	Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof
Ref 491	CD44-specific antibodies and their antibody-drug conjugates
Ref 492	Preparation and use of anti-FSHR antibody and antibody-drug conjugate thereof
Ref 493	Application of ALK inhibitors together with EGFR-targeted antibody-drug conjugates in the preparation of medicines for treating lung cancer
Ref 494	Nitroaryl-based linkers, antibody-drug conjugates comprising the linkers and uses thereof
Ref 495	IGF-1R antibody-drug conjugate and its use for the treatment of cancer
Ref 496	Peptide tags, compositions and methods for site-specific protein conjugation
Ref 497	Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof
Ref 498	Bisecting-glycan bridged conjugation for producing glycoprotein conjugates
Ref 499	Bromomethylpyrazine-based drug conjugates and ADCs
Ref 500	Ror1-targeted binding molecules and their Applications
Ref 501	Anti-doppel antibody drug conjugates
Ref 502	Anti-CD39 antibody-drug conjugate and use thereof
Ref 503	Oligosaccharide linkers, linker-payloads comprising the linkers, and glycan chain-remodeled antibody-drug conjugates, preparation methods and uses thereof
Ref 504	Interleukin-13 receptor subunit alpha-2 antibody-drug conjugates and uses thereof
Ref 505	Anti-CD37 antibody-drug conjugate
Ref 506	Antibody-multidrug conjugate
Ref 507	Antibody-drug complexes containing anti-CD138 antibodies
Ref 508	Immunomodulator antibody drug conjugates and uses thereof
Ref 509	Site-specific antibody-drug conjugation through glycoengineering
Ref 510	Uses of an antibody-drug conjugate
Ref 511	Antibody-drug conjugates targeting receptor tyrosine kinase EphA5
Ref 512	p-Aminobenzyl linkers, preparation methods and uses in conjugates
Ref 513	Novel antibody drug conjugates with novel NaPi2b antibodies, therapeutic methods and uses thereof
Ref 514	Intercellular adhesion molecule 1 (ICAM1) antibody-drug conjugates and uses thereof
Ref 515	Anthracycline disulfide intermediates, antibody-drug conjugates and methods
Ref 516	Methods for preparing protein-small-molecule drug conjugates and applications thereof
Ref 517	Antibody-drug conjugates and applications in antibody-mediated drug delivery
Ref 518	Anti-huLRRC15 antibody drug conjugates and methods for their use
Ref 519	Preparation method for doubly substituted bridge-linked antibody-drug conjugates
Ref 520	Rapid-release antibody-drug conjugates
Ref 521	Anti-human EGFR antibody-drug conjugates and their preparation methods and applications
Ref 522	Pharmaceutical compositions of anti-HER2 antibody-drug conjugate
Ref 523	Antibody drug conjugates having linkers comprising hydrophilic groups
Ref 524	Site-specific conjugation of antibodies
Ref 525	Peptide linkers containing glycosides for antibody-drug conjugates
Ref 526	Azobenzene-Based Linker Strategy for Selective Activation of Antibody-Drug Conjugates
Ref 527	Site-Selective Antibody Conjugation with Dibromopyrazines
Ref 528	Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer
Ref 529	Radiotherapy activates picolinium prodrugs in tumours

Target Information

Citation

Visitor Map

Correspondence

Prof. Feng ZHU (zhufeng@zju.edu.cn)

Prof. Xiaowu DONG (dongxw@zju.edu.cn)

Prof. Luo FANG (fangluo@zjcc.org.cn)